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Abstract  
Introduction:  Anxiety is cited as one of the most common mental disorders of youth, 
with serious implications for academic and social outcomes and future 
psychopathology. Research has increased greatly in the last 25 years but there are 
still large gaps in our understanding of the descriptive epidemiology of anxiety and the 
majority of research focuses on the aetiology of adult disorder.  The aim of this thesis 
was to use the best available evidence from studies using a prospective design and 
diagnostic outcome measures, to understand the onset and trajectory of anxiety 
through the lifespan and to determine whether childhood anxiety predicts adult anxiety 
disorders 
 
Method:  Principal Investigators from all prospective longitudinal studies of child 
mental health were approached in order to gain access to diagnostic data relating to 
anxiety disorders in youth.  Two studies released appropriate data which are analysed 
here to determine prevalence, first onset, and course of anxiety, with adult outcome 
assessed in the one cohort that released appropriate adult data.  These data are then 
synthesised with the published data in order to provide a coherent summary of the 
current picture of the descriptive epidemiology of anxiety disorders, in particular social 
anxiety and generalised anxiety or overanxious disorder. 
 
Results: New data from a UK birth cohort show the different anxiety disorders to have 
specific patterns of prevalence and onset, suggesting early onset for separation 
anxiety and specific phobia.  Analysis of data from New York suggests moderate 
homotypic continuity of social anxiety and overanxious disorder in childhood and 
adolescence.  When examined together the available data show the importance of 
methodological considerations when determining the prevalence of anxiety in 
childhood and suggest that although substantial proportions of children will suffer from 
anxiety most will be disorders of short duration with favourable outcomes.  There are, 
however, consistently across studies 20-30% with chronic anxiety who are likely to 
have poor outcomes.  It is clear that a substantial proportion of adult sufferers have 
early onset but the figures are inconsistent across different studies. 
 
Discussion: The results are discussed in light of the wider literature, and implications 
for methodology and clinical applications are presented.  The limitations of the current 
approach and directions for future research are briefly outlined.       
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Chapter One: Introduction. 
Overview. 
This thesis uses data from around the world to attempt to understand the onset, 
course, and outcome of one of the most prevalent forms of psychopathology – anxiety 
disorders.  When determining the most effective timing and methods of prevention 
and intervention, and allocating precious resources, we need to consider the question; 
do anxious children grow up to become anxious adults? 
 
This chapter will give a clear rationale for a project that will analyse novel prospective 
data and attempt to synthesise these new data with existing findings from longitudinal 
epidemiological studies in the United States, Europe and New Zealand.  The aim of 
the project is to better understand the distribution of anxiety disorders in time and 
space through the lifespan.  It is hoped that by accurately describing the epidemiology 
of anxiety disorders in young people we can reliably inform research in the aetiology 
and interventions for anxiety disorders, and develop a better understanding of the 
risks associated with anxiety in childhood and adolescence.  A literature review will 
collate and critique evidence from baseline and cross-sectional studies of the onset, 
course, and outcome of anxiety disorders, in order to give an overview of how anxiety 
disorders in childhood and adolescence have largely been described and understood.  
The review will highlight the areas that remain controversial or unclear.   This chapter 
will also outline the problems with using cross-sectional designs, the use of clinical 
samples, and provide a clear rationale for using prospective longitudinal studies with 
standardised diagnostic data, to understand the epidemiology of anxiety.  This is 
followed by a detailed summary of the existing analysis from the prospective data 
sources and the areas of consensus and confusion will be highlighted to direct further 
analysis and synthesis of data. 
Literature Review. 
Progress so far: Research into child and adolescent anxiety disorders. 
A recent systematic review of published research into childhood and adolescent 
anxiety disorders in the last 25 years demonstrated that peer reviewed research has 
significantly increased over recent decades.  In comparison to research into adult 
disorders, however, child and adolescent papers make up approximately 10% of 
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published research (Muris and Broeren, 2009).  Furthermore, when examining the 
focus of these papers, Post Traumatic Stress Disorder and Obsessive Compulsive 
Disorder receive the majority of research attention despite comparatively low 
prevalence rates in this population.  In their review Muris and Broeren, alongside other 
recent authors in the field, point to a lack of understanding of descriptive epidemiology 
(namely the onset, course and outcome) of specific disorders; an important area that 
the current project hopes to address.  
 
A sound empirical knowledge of the onset, course, and outcome of anxiety disorders 
in childhood and adolescence in the general population is proposed in this thesis to be 
an important endeavour.  It provides the starting point for conducting relevant 
research into the aetiology of childhood anxiety and for the successful implementation 
of treatment and prevention programmes.  The societal burden of disease in young 
people referred for treatment has been shown to be significant, suggesting a renewed 
focus on intervention is important and necessary (Bodden, Dirkson, & Bögels, 2008).  
Non-clinical community samples will be the focus of the current study, as drawing 
conclusions regarding the epidemiology of anxiety from clinical data presents a 
number of difficulties.  Firstly, many cases of clinically significant disorder never seek 
professional help - in one large community study it was shown that only 14.3% of 
diagnosed cases of anxiety disorders had ever had contact with a mental health 
professional, (Costello, Egger, & Angold, 2005).  Secondly, it has been shown that 
clinically referred samples may not be representative of the majority of those suffering 
from anxiety disorders; for example, they experience significantly increased 
comorbidity (Carron & Rutter, 1991).  A focus on community samples allows a better 
understanding of the incidence of disease in the population, and allows more accurate 
understanding of the need and focus for public health interventions. 
Describing the development of childhood anxiety in time and space: the difficulties in 
using cross-sectional designs. 
A clear understanding of the onset, course, and outcomes of child and adolescent 
anxiety is vital in understanding how best to direct and use resources.  It allows us to 
better understand the aetiology, determine malign and benign course and outcomes, 
and effectively target prevention and treatment of anxiety disorders for young people.  
It is argued that anxiety in early life is prevalent, causes distress and interferes with 
developmental processes, and is associated with greater psychopathology in later life.  
There is, therefore, a possible need to redress the balance between the amount of 
research conducted in adult and child samples illustrated by Muris and Broeren (2009) 
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in order to better understand these processes in younger populations. It is proposed 
that a clear overview of the descriptive epidemiology is crucial to highlighting the 
populations at risk, providing a rationale to ensure that the available resources are 
deployed as efficiently and effectively as possible.   
 
It is argued that studies of a cross sectional design are less useful when attempting to 
fully understand the trajectory of anxiety disorders through the lifespan, due to a 
number of considerable difficulties that arise in understanding and combining data 
from such sources.  The current project will attempt to synthesise published data from 
longitudinal, prospective studies regarding prevalence, age at onset, course and 
outcome of the different childhood anxiety disorders, and to add to this evidence 
through the analysis and synthesis of data collected from prospective longitudinal 
studies but so far not analysed.  Throughout the report it will be argued that 
prospective longitudinal data, preferably from birth cohorts, are the best 
epidemiological data we have available; these data will therefore be the main focus of 
this thesis. 
 
Anxiety is widely cited as one of the most prevalent forms of mental disorder with the 
earliest onset (see for example Kessler et al. 2005; Merikangas, Nakamura, & 
Kessler,2009; Pine and Klein, 2008).  However, detailed data regarding the onset, 
course and outcome are absent and prevalence estimates are frequently based on 
self report measures administered at one time point (cross-sectional data).  It has 
been suggested that cross-sectional studies may underestimate the prevalence of 
psychiatric disorders in the population.  Jaffa, Harrington, Cohen, & Moffitt (2005), 
point out that prospective studies consistently show the cumulative prevalence of 
receiving a diagnosis of any psychiatric disorder before the age of 16 to be just under 
40%: 36.7% (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003) 38.3% (Kim-Cohen 
et al., 2003) and 39% (Cohen et al., 1993).  These rates are significantly higher than 
those reported by cross-sectional research.  Jaffa and colleagues therefore conclude 
that single wave studies, are highly likely to significantly underestimate the prevalence 
of psychiatric disorders in childhood and adolescence.  It is, therefore, suggested that 
cross-sectional research will also significantly underestimate anxiety disorders in this 
population.   
 
There is a growing body of research using standardised diagnostic measures, which 
aim to improve the reliability of data on mental disorders.  The prevalence rates that 
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are reported by such studies, however, can still vary greatly as they are sensitive to a 
number of factors, in particular the criteria that were employed for diagnosis, the 
range of ages included in the study, and the source of symptom information.  Even 
within individual studies, outcomes can vary substantially dependent upon the 
methods that were used to produce the final prevalence rates.  For example, Breton et 
al. (1999) found prevalence rates of any anxiety disorder ranging from 3.9% to 14.6% 
within the same sample of 6-14 year olds, when using different informants and 
methods of combining informant information.  Also the use of impairment as a criterion 
for diagnosis can have a major effect on the prevalence rate reported within one 
sample; Romano, Tremblay, Vitaro, Zocolillo, & Pagani (2001) found that rates 
decreased from 21.9% to 8.9% within one large sample of 14-17 year olds, when 
impairment was required for diagnosis.  These issues all can be seen when 
standardised measures of anxiety are used in prospective studies; however, the 
multiple follow ups means that we can still see meaningful patterns within the data.  It 
makes comparisons between studies difficult (this will be discussed further later in the 
thesis) but in cross-sectional studies these differences make comparisons extremely 
difficult and often meaningless.   
 
The major problem is that cross sectional studies often examine a rather limited age 
range, e.g. Kashani et al. (1987) examined only 14-16 year olds, and Lavigne et al. 
(1996) looked at 2-5 year olds.  This makes it impossible to examine changes in the 
prevalence of disorder through the course of childhood and adolescence, or to discern 
when the disorder becomes most prevalent and has its peak onset.  Unfortunately, it 
is not possible to compare across cross-sectional studies that have examined different 
age ranges, in order to get an overview of a wider age range, because of 
methodological differences in the studies and the way they apply the diagnostic 
interview (as discussed above).  To illustrate these difficulties, consider the following 
cross-sectional studies: Puura et al. (1998) used diagnostic interviews to ascertain 
prevalence in a large sample of 8-9 year olds in Finland; Breton et al. (1999) provides 
prevalence rates for French Canadian 9-11 year olds; Lynch, Mills, Daly, & Fitzpatrick 
(2006) provide prevalence rates for Irish 12-15 year olds; and Kashani et al. (1987) 
also used diagnostic interviews to assess prevalence in 14-16 year olds in the USA.  
These studies provide prevalence estimates for large samples, and together provide 
data from middle childhood through adolescence.  However, the use of different 
sampling techniques and diagnostic tools and possible cultural differences makes it 
impossible to use these disparate cross-sectional studies to plot the change in 
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prevalence of anxiety disorders from 9-16 years and to expect to form a valid or 
reliable picture of how anxiety develops from childhood into adolescence.  
 
In summary, a cross-sectional design can be useful in planning service provision for a 
specific age group in a specific location; however, it is less useful when attempting to 
gain a wider understanding of the development of anxiety, and for plotting the onset 
and course of psychiatric disorders through childhood and adolescence.    
Anxiety in childhood: A normal part of growing up?  
Anxiety disorders are among the most prevalent disorders in adulthood with 
(according to one major European study) approximately 6% of the population suffering 
clinical impairment from such a disorder over a twelve month period and 14% 
reporting that they have experienced it in their lifetime, (Alonso et al., 2004).  
Retrospective reports from clinically anxious adults suggest that the majority of these 
disorders began at an early age, (Christie-Burke, Burke, Regier, & Rae, 1990; Kessler 
et al., 2005; Manfro et al., 2003).  In childhood samples, a systematic review of cross-
sectional data suggests that anxiety is more prevalent than depressive or 
conduct/oppositional disorders in preadolescent children, (Cartwright-Hatton, McNicol, 
& Doubleday, 2006).  It is widely written and accepted that anxiety disorders are the 
most common psychopathology in both childhood and adolescence (see for example 
Merikangas et al. 2009 or Pine & Klein, 2008).  When looking at early childhood even 
the most conservative methodology suggests that over 3% of children in a large UK 
sample of under 10’s (N=7997) suffer from anxiety with impairment to their functioning 
in a 12 month period, (Ford, Goodman, & Meltzer, 2003).  Two large prospective 
studies of psychopathology in late childhood and adolescence estimated the 
cumulative risk of developing an anxiety disorders before the age of 16 to be 
approaching 10% (Costello et al. 2003; Lewinsohn, Rohde, Seeley, & Fischer, 1993). 
Furthermore, prevalence rates of most anxiety disorders (excluding separation anxiety 
disorder and overanxious disorder) have been shown to steadily increase throughout 
adolescence, (Beesdo-Baum, Knappe, & Pine, 2009; Bittner et al., 2007; Offord et al., 
1992). 
Childhood and Adolescent Anxiety: A growing problem?  
A review, that included two meta analyses, carried out in the United States examined 
the reported prevalence of anxiety symptoms from the 1950’s to the 1990’s and 
suggested that anxiety in both college students and children has increased 
significantly over this period (Twenge, 2000).  In her extensive paper Twenge carried 
  
15 
 
out a meta-analysis of 99 studies that used a well validated self report tool, the 
Children’s Manifest Anxiety Scale (CMAS) with school children aged between nine 
and seventeen.  The cohort data and demographic information were used to 
determine the association between self reported levels of anxiety and the year of birth.  
Significant associations were found even when controlling for geographical location, 
socio economic factors, race, and urban vs. rural setting.  The increase in anxiety 
across this period was large; 0.99 SD higher in 1981 than in 1954.  Twenge reports 
that school children in the 1980’s were on average more anxious than psychiatric 
patients in the 1950’s.  It is notable that the year of birth explained over 20% of the 
variance; more than that explained by family or environmental factors.  When 
attempting to explain this increase she examined economic differences in the cohorts; 
however, this did not explain the differences over time.   
 
A review of time trends internationally reports an unclear picture of the changing 
trends in emotional disorders, with parents and children reporting stable or declining 
levels of emotional disorders between 1970’s and 1990’s in Scandinavia; alternatively, 
young people in Greece and Scotland report significant increases between the early 
1980’s and late 1990’s (Maughan, Lervolino, & Collishaw, 2005).   A study carried out 
in the UK that examined trends in mental disorders between 1974, 1986, and 1999 in 
adolescents found a more recent increase in emotional disorders between 1986 and 
1999; no change was found between 1974 and 1986 (Collishaw, Maughan, Goodman, 
& Pickles, 2004).  Using standardised measures with imputed adjustments to ensure 
accurate compatibility, 15-16 year olds in 1999 were demonstrated to be 1.5 times as 
likely to report clinical levels of emotional disorders than in 1986 (OR = 1.5; 95% CI 
.93-2.42).  Collishaw, Maughan, Natarajan, & Pickles (2010) went on to examine more 
recent changes in emotional disorders over the twenty year period between 1986 and 
2006.  Similarly they found increases in both parent and child reported emotional 
problems for girls and in parent reported emotional problems for boys.  These findings 
suggest that emotional disorders including anxiety are a growing problem, particularly 
in the UK.   
 
If these cohort changes hold true and continue to increase they are an important 
consideration not just for clinical psychology and psychiatry but for politicians and 
policy makers.  Changes in the prevalence of distress that has been demonstrated by 
comparing birth cohorts leads us to ask questions about the causes of causes; i.e. 
what are the social conditions that drive the psychological or intrapersonal “causes” 
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that clinical psychologists might be interested in?  It might be postulated that 
economic hardship is a driver of anxious psychopathology but this was not found to be 
the case by Twenge (2000).  Maughan et al. (2005) demonstrate the international 
differences in time trends, not all nations are experiencing this increase in population 
levels anxiety, and Wilkinson and Pickett (2009) use international data to suggest that 
social inequality, rather than economic hardship is responsible for the increase in 
psychological distress.  By examining anxiety in nations (and different American 
states) where there are different levels of inequality, correlational data is used to 
demonstrate an association between increasing levels of anxiety and a larger gap 
between rich and poor.  They postulate that this inequality may underlie some of the 
aetiological factors investigated in relation to increased anxiety (e.g. parenting 
efficacy).  All of the data described above are based upon self reported symptoms of 
anxiety, when we look to the diagnostic tools used in many of the prospective studies 
we can see that these studies are relatively recent in their data collection.  For 
example, the Gallagher (2008) review covered seven cohorts born between 1965 and 
1985.  The vast majority of these prospective studies, however, are cohorts that were 
born in the 1970’s giving a limited range to examine time trends.  Furthermore, there 
are currently no diagnostic data available for different birth cohorts from the same 
country.  Information about time trends using diagnostic data rather than self report is 
currently lacking and would add a great deal to the argument regarding the changing 
prevalence of psychopathology in young people over time.  It is hoped that the 
detailed analysis of descriptive epidemiology will make this task easier for future 
researchers comparing anxiety diagnoses across different cohorts. 
What are the implications of anxiety disorders for young people? 
As well as being highly and increasingly prevalent, anxiety disorders in childhood and 
adolescence are thought to be harmful in a number of domains.  For instance, 
childhood anxiety has been found to be associated with poor social and academic 
outcomes (Chansky & Kendall 1997; King & Ollendick 1989; Last, Hansen, & Franco, 
1997; Strauss, Frame, & Forehand, 1987) and evidence from longitudinal research 
also suggests that pre-pubertal anxiety is a significant risk factor for later suicidal 
behaviour, substance misuse, and conduct problems, (Weissman et al. 1999,) major 
depression (Wittchen, Nelson, & Lachner, 1998), and for severe anxiety in later life, 
(e.g. Gregory et al.  2007). The weight of evidence is compelling.  It is possible, 
however, that a third variable could be the “causal” association between childhood 
anxiety and such outcomes; poor attachment, a negative family environment, or 
economic and social deprivation could feasibly cause children to both suffer with 
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clinical levels of anxiety in childhood and to develop significant problems later in life, 
and the mediating or moderating influence of anxiety disorder is yet to be fully 
investigated.  A study that has examined the greatest range of outcomes for young 
people is the Christchurch Health and Development Study in New Zealand 
(Woodward & Fergusson, 2001).  Young people who met diagnostic criteria for 
anxiety disorders between 14 and 16 years old were shown to have a greater risk not 
just for later anxiety disorders but also for drug dependence, nicotine and alcohol 
dependence, suicidal behaviour, underachievement in education and early 
parenthood.  An impressive number of covariates were examined that included 
individual factors (the presence of any other DSM-III disorders at baseline), family 
factors (parental alcoholism and discipline style), and social factors (maternal 
educational qualifications and social class).  When including these covariates 
adolescent anxiety disorders was still associated with more anxiety disorders, 
depressive disorders, illicit drug use, and lower educational attainment in later life.  
This suggests that the presence of anxiety disorders in this age group adds further 
developmental risk to individual, family, and social risk factors.            
What can be done about it?  Treatment and prevention programmes for anxiety in 
young people. 
We are aware that a proportion of young people are suffering from anxiety disorders 
that impair their functioning and that these disorders are associated with poor 
outcomes for the young person; so what do we have to offer?  Psychological 
interventions for anxiety in adolescence have received increasing research attention 
in the last 25 years and effective Cognitive Behavioural Therapies (CBT) have been 
developed for this population.  A review of Randomised Controlled Trials (RCT) is 
beyond the scope of this thesis; however, a meta-analysis carried out in 2004 
suggests that CBT for anxiety in adolescents to be an efficacious treatment; however, 
the review highlighted the lack of data for interventions in younger children 
(Cartwright-Hatton, Roberts, Chitsaban, Fothergill, & Harrington, 2004).  A later review 
and meta-analysis of 20 studies that examined CBT in samples ranging from 3-16 
years, with most studies beginning in middle childhood (six to eight years old) found 
an extremely  impressive pre-post Effect Sizes (d= 0.94).  When compared to a 
control group an effect size of d= 0.61 suggests CBT to be a relatively efficacious 
treatment for children and adolescents (Ishikawa, Okajima, Matsuoka, & Sakano, 
2007).  It has been proposed that the use of adult models to understand childhood 
anxiety and to develop treatments appear to be effective in  older children and 
adolescents but it seems possible that younger children are less likely to be able to 
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make use of such therapy due to their stage of cognitive development (Piacentini & 
Bergman, 2001).  In their review Ishikara and colleagues included CBT aimed at 
parents, as this is one way to administer to younger children who may not have the 
cognitive capacity to engage with CBT and they found that there is little difference 
between effect sizes for interventions aimed at children, parents, or the family as a 
whole.   A recent RCT made use of an adapted behavioural parent training 
programme for parents of young anxious children (aged three to ten) with impressive 
results (Cartwright-Hatton et al. 2011).  Following ten weekly two hour parenting 
groups over 60% of the treated group were free of their primary anxiety disorders 
diagnosis, compared to only 15% of those in the treatment as usual group.  These 
gains were maintained at 12 month follow up and parental report measures continued 
to improve over this period.  The Macquarie University Preschool Intervention Project 
in Australia also uses a parenting intervention for very young children who are 
displaying behavioural inhibition, a temperament characterised by withdrawal and 
hesitancy in novel situations, which has been shown consistently to be a risk factor for 
the development of anxiety disorders.  Intervention at this early point has been shown 
to be effective at reducing the number of diagnosable anxiety disorders in childhood 
(Rapee, 2002; Rapee, Kennedy, Ingram, Edwards, & Sweeney, 2005).  These 
important developments mean that we now have evidence based psychological 
interventions for children and young people at all stages of development. 
 
In terms of preventing anxiety disorders, a great deal of work in Australia has been 
ongoing in the last twelve years to evidence a programme that can be delivered in 
schools to help children develop confidence, resilience, and social skills with the aim 
of preventing the development of anxious and depressive psychopathology.  The 
FRIENDS for life programme has a growing and impressive evidence base that now 
shows it to be effective in reducing anxiety and depression up to six years after 
exposure.  The programme can be adapted to be effectively delivered to both children 
and adolescents and can be delivered by psychologists, or is also effective when 
delivered by teachers and school nurses (Dadds, Spence, Holland, Barrett, & 
Laurens, 1997; Farrell & Barrett, 2007; Hau, 2001; Lock & Barrett, 2003; Lowry-
Webster, Barrett, and Dadds, 2001).   
 
The technology is, therefore, available to intervene effectively in young people’s 
distress and to reduce or prevent the number of people suffering from anxiety.  A 
better understanding of the descriptive epidemiology allows us to effectively target 
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these interventions and prevention programmes and adult follow up data allows us to 
ask questions about the necessity and cost effectiveness of, large scale strategies 
such as the FRIENDS programme and its ability to produce better outcomes for 
anxious children and adults. 
Summary. 
Anxiety disorders are a prevalent disorder in adulthood and cross-sectional data 
suggests that they are also highly prevalent in early life and that adolescent anxiety 
disorders are associated with poor outcomes in later life (in addition to confounding 
developmental risks).  Cross-sectional data, however, have some important 
limitations, which may lead to underestimates of prevalence and has limited utility in 
describing the onset, course, and outcomes of anxiety.  There are concerns that 
anxiety is a growing problem in the UK and it represents a substantial burden of 
disease.  We have effective treatments and prevention programmes for tackling 
anxiety in childhood and adolescence so it is argued that the identification of children 
who are suffering childhood anxiety disorders and the effective targeting of 
intervention, is best served through an accurate understanding of the epidemiology of 
anxiety disorders.  I will now briefly discuss the relevant findings from clinical, self 
report, and cross-sectional studies of anxiety disorders before reviewing the 
prospective findings.    
When are anxiety disorders most prevalent: The clinical picture.  
Clinical data from referred children show separation anxiety and simple phobias to be 
the most prevalent disorders of childhood and adolescence.  Last, Perrin, Hersen and 
Kazdin (1992) examined 188 consecutive referrals for children with anxiety disorders 
over three years and found in nearly 30% the primary diagnosis was for separation 
anxiety, 20% were simple phobia, 15% social anxiety, 10% panic and less than 10% 
were diagnosed with obsessive compulsive disorder or post traumatic stress disorder.  
In this sample of 5-18 year olds the youngest reported onset was for separation 
anxiety (7.5 years) and the latest for panic disorder (14.1 years).  There were few 
reported differences across gender and high rates of comorbidity both with other 
anxiety disorders and heterogenous psychopathology including behavioural problems.   
Community studies of anxiety disorders. 
The first review of epidemiological data from community (i.e. non-clinical) samples 
was undertaken sixteen years ago (Angold & Costello, 1995).  The most remarkable 
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finding was that of unanimity across different designs and populations; demonstrating 
far more robust estimates than found in clinical samples.  This review suggested that 
anxiety was a prevalent disorder in childhood and adolescence.  The most recent 
unpublished review and meta-analysis of the prevalence of anxiety through early 
childhood to late adolescence shows the growing attention to the epidemiology of 
anxiety in such samples, and presents interesting findings (Costello, Egger, Copeland, 
Erkanli, & Angold, in prep).  This review includes over 50 epidemiological studies 
using community samples of between two and 18 year olds and uses statistical 
methods to combine large quantities of prevalence data from studies using varying 
designs (see Table 1).  The findings demonstrate that anxiety disorders are highly 
prevalent throughout childhood and adolescence, and show that these estimates are 
stable and reliable in adolescence despite the differing populations and methods 
employed.  It is notable that the percentage of young people reporting that they suffer 
from anxiety disorders is not markedly different to some of the large studies reporting 
prevalence of anxiety in adulthood (Alonso et al 2004).  These data alone suggest that 
we look again at the vastly increased resources focused on adult anxiety; however, in 
order to provide robust evidence for this redirection we need to understand not just 
prevalence but also be able to determine between the many cases of anxiety that 
spontaneously remit and have a benign course and outcome, and those that interfere 
with development and confer risk for later life.  
 
Table 1. Calculated Prevalence for individual anxiety disorders in childhood and 
adolescence (Costello et al. in prep) 
 Age 6-12 Years    Age 13-18 Years 
Anxiety 
disorders 
Mean 
(%) 
SE 
(%) 
2.5% 97.5%  Mean 
(%) 
SE 
(%) 
2.5% 97.5% 
Any 12.3 5.4 7.1 28.2       11.0 0.5 10.3 12.2 
GAD 1.7 1.2 0.9 5.0       1.9 0.5 1.3 3.3 
Separation 
Anxiety 
3.9 1.5 2.6 8.5       2.3 0.9 1.4 4.8 
Social Anxiety 2.2 2.2 1.0 8.8       5.0 1.3 3.5 8.4 
Specific Phobia 6.7 3.6 4.0 18.0       6.7 1.6 4.7 10.9 
Panic Disorder 1.5 3.2 0.2 8.9       1.1 0.3 0.7 1.8 
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Changing prevalence and patterns of onset. 
The DSM-IV contains ten anxiety disorders (America Psychiatric Association, 1994).  
It has been suggested that these different diagnostic categories may not be applicable 
to younger populations, especially very young children (see for example Merikangas 
et al., 2009).  However, Beesdo-Baum et al. (2009) reviewed the literature in relation 
to the development of DSM V and found that temporal patterns (e.g. age at onset) 
support diagnostic categories for specific phobia, separation anxiety, social anxiety, 
generalised anxiety disorder, panic disorder, and agoraphobia.  When Costello et al 
(in prep) examined individual anxiety disorders, prevalence in children (six to 12 year 
olds) and adolescents (13-18 year olds) appeared mostly consistent across the two 
age groups.  An increase in social anxiety and a decrease in separation anxiety from 
childhood into adolescence is, however, evident (see Table 1) suggesting that 
separation anxiety has early onset with less cases in later life and social anxiety has a 
later onset.  Furthermore, there are some disorders (namely specific phobia) that 
show consistently higher prevalence than many other anxiety disorders (e.g. 
generalised anxiety disorder).  Differences in prevalence and patterns of onset such 
as these are used to argue for the validity and utility of these different diagnostic 
categories in childhood.  In preschool children, however, all disorders have been 
shown to be equally prevalent (Egger & Angold, 2006; Briggs-Gowan Carter, Skuban, 
& Horowitz,  2001) which offers support for the lack of applicability of specific 
diagnostic categories to very young children and general difficulties in the assessment 
of this population (Merikangas et al. 2009).  The reporting of high levels of comorbidity 
in younger children is also used to support the argument that individual diagnostic 
categories are less useful in these younger populations; for example a recent RCT 
reported high levels of comorbidity between diagnoses of anxiety disorders in children 
under ten, (Cartwright-Hatton et al. 2011).   
Understanding the course and outcome of anxiety. 
Despite the difficulties with cross-sectional data outlined previously Costello and 
colleagues (in prep) have provided an extremely useful and concise meta-analysis 
that provides clear evidence that anxiety disorders in childhood and adolescence are 
highly prevalent and suggests that many disorders have their first onset in this early 
stage of development.  However, using prevalence data alone to argue for the 
redirection of resources to understanding anxiety in younger populations is 
insufficient.  There is currently a lack of clarity and contradictory findings regarding 
whether anxiety disorders in children are merely transitory or have a chronic course 
and problematic outcome.  It is possible that the adolescent and childhood samples 
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do not overlap and represent distinct populations; one with a childhood and one with 
an adolescent onset.  It has previously been believed that anxiety disorders remit 
quickly, with a number of studies in clinical populations supporting this hypothesis 
(Aschenbrand, Kendall, Webb, Safford, & Flannery-Schroeder, 2003; Last, Perrin, 
Hersen, & Kazdin, 1996).  In studies of very young children, however, parent reports 
of their children’s emotional problems have been used to demonstrate that symptoms 
are persistent over the course of a year (Briggs-Gowan, Carter, Bosson-Heenan, & 
Horowitz, 2006) and a recent examination of a number of different risk factors in 
preschool children found that anxious symptoms (along with child temperament) in 
preschoolers were the best predictor of anxiety symptoms at 6 and 8 years old (Mian, 
Wainwright, Briggs-Gowan, & Carter, 2011) suggesting in fact that very early 
symptoms are important predictors of later psychopathology.  In longer term follow up 
(at 10 to 11 years old) parent reported internalising and externalising symptoms at 
preschool uniquely predict their diagnostic counterpart (disorder) using the DSM-IV; 
Children with parent reported internalising symptoms in kindergarten have a three -
fold odds of meeting diagnostic criteria for an anxiety or depressive disorder in pre 
adolescence, (Mesman & Koot, 2001).  So there are some difficulties in understanding 
the importance and predictive validity of early disorders and symptoms.  Clinical 
studies show that the majority of childhood anxiety disorders remit, but early 
symptoms have been shown to be persistent over the course of a year and to be 
associated with later disorder.  The recent testing of ecological models of anxiety by 
Mian et al. (2006) suggest that child factors (symptoms) are far better predictors of 
later anxiety than external factors, so the hypothesis that the association between 
early symptoms and later psychopathology is the product of a third social or family 
factor (e.g. social disadvantage or insecure attachment) seems less likely.  There is 
disagreement in the literature as to whether early anxiety is a persistent disorder with 
a malign course or a common disorder with a remitting course.     
 
An additional problem with using prevalence data to argue for the redirection of 
resources is that many of the cross sectional studies citing high prevalence estimates 
have been questioned due to the impairment criterion they use; it is argued, for 
example, that many specific phobias do not interfere with daily living and without this 
impairment to functioning the prevalence estimates are inflated and it is questionable 
if there is any need for intervention; as specific phobias are one of the most common 
in young people the removal of many of these phobias significantly decreases the 
overall prevalence of anxiety.  When strict impairment criteria are applied many 
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disorders prevalence is much reduced but there remains a substantial proportion of 
the population with anxiety diagnoses.  For example Carter et al. (2010) used a 
diagnostic interview to examine anxiety in kindergarten children and when they 
applied the impairment criteria they nearly halved the reported prevalence of anxiety 
disorders; however 9% were diagnosed with specific phobia and 2.2% with separation 
anxiety, still suggesting a high proportion of anxiety in this young population.  It is 
relevant to the current thesis that anxiety disorders have been shown to be most 
affected by changing impairment criterion in comparison to other forms of 
psychopathology.  In one large study using impairment criteria for each symptom and 
then applying a global measure of functioning reduced prevalence by up to 90% when 
compared to impairment applied only at the syndrome level, (Shaffer et al. 1996).  It 
is, therefore, necessary to produce consistent estimates using methods which have 
clear criteria for reaching diagnosis and associated level of impairment. The use of 
standardised diagnostic interviews and DSM-IV or ICD-10 criteria can be helpful in 
alleviating these difficulties and have been demonstrated to reveal a substantial 
proportion of children with functionally impairing anxiety disorders (e.g. Carter et 
al.2010).  The current project will, therefore, only use data from studies that have used 
standardised diagnostic measures with clear impairment criteria.  
What do standardised diagnostic data tell us about the persistence and course of 
childhood and adolescent anxiety disorders? 
Anxiety disorders in adulthood have been shown to be persistent over long term follow 
up.  For example, a study of young adults in Zurich showed panic disorder to be a 
highly stable disorder over the seven-year follow-up (Vollrath & Angst, 1989).  In 
clinical samples stability of panic disorder was supported over a twelve and eight year 
follow up respectively, and similar continuity was found for generalised anxiety 
disorder and social anxiety, (Bruce et al. 2005; Yonkers, Bruce, Dyck, & Keller, 2003).  
As discussed above, parent reports of very young children’s anxious symptoms have 
been shown to be persistent over a 12 month period, (Briggs-Gowan et al. 2001) and 
to be predictive of preadolescent disorder (Mesman & Koot 2001).   In childhood 
samples, however, there are inherent difficulties in distinguishing between 
developmentally normal childhood fears and anxieties, and pathological anxiety, and 
the use of self report tools which provide continuous data make these findings difficult 
to interpret.  It appears that the presence of developmentally normal “fears” 
(Ollendick, Matson, & Helsel, 1985) providing the continuum from normal to abnormal 
anxiety, and the high prevalence of anxiety in young populations, may have led to the 
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contention that anxiety disorders are merely extremes of normal development and, 
therefore, transitory if the sufferer is a child or young person.   
 
As already mentioned in the previous section, the contention that anxiety is not 
persistent and is usually transitory has been supported by a number of short term 
follow up studies of clinical samples that have shown the vast majority of children to 
be free of their primary anxiety diagnosis within a short period of time, leading to the 
conclusion that the course of childhood anxiety disorders is remitting and less 
malignant than the course of adult disorders (Aschenbrand, et al. 2003; Cantwell & 
Baker, 1989; Foley, Pickles, Maes, Silberg, & Eaves, 2004; Last et al. 1997; Last et al. 
1996).  The issue with these studies is that they use a single diagnostic follow up over 
a relatively short period (18 months to five years) to ascertain whether the participant 
is “well” or remains ill, they also often focus upon only one disorder; for example 
Cantwell & Baker, (1989) examined OCD and Foley et al. (2004) looked at separation 
anxiety.  Alternatively the other studies do not distinguish between outcomes of the 
different anxiety disorders and examine “any anxiety disorders”.   
 
A recent naturalistic study carried out by Carballo and colleagues (2010) in paediatric 
psychiatric clinics in Spain, followed nearly 2000 children over fourteen years.  They 
report the persistence of most anxiety disorders (particularly social anxiety and 
specific phobias) to be very high.  Over 80% received the same diagnosis at 75 % of 
consultations (minimum number of consultations was three).  In adolescents the 
persistence was lower (between 60% and 70%).  This is still very high in comparison 
to the other clinical studies cited and may reflect the large sample size offering greater 
accuracy, or alternatively may be a result of the naturalistic design and human 
reasoning, with clinicians being increasingly likely to reassign a diagnosis once they 
have previously recorded it, and those who remit not attending clinic, which could lead 
to an artificial inflation of the persistence of the disorders.  Prospective studies using 
community samples and a standardised diagnostic interview which is administered by 
an interviewer who is “blind” to previous diagnoses offer a valid and reliable method 
without these confounds to explore these discrepant findings in samples other than 
those presenting for treatment.         
 
The current study is interested in whether the contention of a benign course is true for 
most young people and all anxiety disorders, or if anxiety is in fact persistent in some 
cases.  It is suggested that the presence of some anxiety disorders in childhood and 
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adolescence may be more problematic and may cause significant impairment and risk 
for psychopathology in later life.  The fact that studies often treat the anxiety disorders 
as a homogenous group may have contributed to the propagation of the theory that 
anxiety disorders in childhood are transitory, as there is emerging evidence that some 
disorders are at increased risk of later psychopathology (e.g. separation anxiety, 
Bruckl et al. 2007).  It is also proposed that short term studies of clinically referred 
children have previously underestimated the predictive power of early anxiety, due to 
the “waxing and waning” course of many anxiety disorders in early adolescence.  In 
Chapter Two data from the Early Developmental Stages of Psychopathology (EDSP) 
study from Dresden, Germany will be presented, which demonstrate using a 
prospective design that although homotypic continuity (same specific diagnosis at 
baseline and follow up) may be low for anxiety disorders in adolescence, there is a 
great deal of psychopathology associated with a baseline anxiety diagnosis.  This 
finding held true for both a short term (19 months; Wittchen et al. 2000) and long term 
(10 year) follow up, (Beesdo-Baum et al. 2009).  It is clear that in order to understand 
the persistence of anxiety disorders, particularly those that do not seek treatment but 
cause significant impairment, longitudinal studies that regularly use standardised 
diagnostic interviews to examine anxiety disorders throughout the lifespan, provide 
the best empirical data.   
Summary. 
As it is increasingly evident that anxiety is prevalent in early life, there is a need to 
understand the course of anxiety disorders and whether this anxious population of 
children become anxious adolescents and adults.  There are mixed findings from the 
clinical literature with some short term longitudinal studies with relatively small 
samples showing the majority of cases to have remitted, and a longer term naturalistic 
study showing a high degree of persistence of anxiety diagnoses.  A number of 
limitations of both these designs have been outlined; including the lack of data 
available to examine the course of individual disorders.  Some prospective data 
shows that separation anxiety may be a good predictor of later psychopathology and it 
is proposed that the use of large scale epidemiological studies with diagnostic data 
over a long period of development provide the best way to examine persistence of 
anxiety and determine outcomes for these disorders.  It seems important that we fully 
understand these patterns, as it may be possible to identify the disorders and/or 
individuals at risk of persistent disorders so that we can better target resources to 
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those who are least likely to experience spontaneous remission and suffer long term 
risk for psychopathology. 
Age at onset. 
Age at onset is one of the least studied areas of descriptive epidemiology.  Kessler et 
al. (2007) suggest this is due to reluctance amongst researchers to rely on 
retrospective reports to calculate survival distributions and a lack of resources for 
prospective studies of mental disorders to collect diagnostic data at regular enough 
intervals, and with large enough samples, to map distributions across the lifespan.  
Age of onset is important for two main reasons; first it can be used to calculate lifetime 
risk for disorders and secondly it is vital in targeting research on the prevention of 
mental disorders.  Kessler et al (2007) also point to the evidence of a relationship 
between early onset and increased severity of mental disorders (notably generalised 
anxiety disorder; Kessler, Keller, & Wittchen, 2001). 
    
Costello’s review of 50 epidemiological studies provides strong evidence that anxiety 
is prevalent in childhood and adolescence and we can therefore assume that a large 
number of young people have their first onset at this time.  However, specific age of 
onset for anxiety disorders has largely been assessed using retrospective reports 
from clinical samples, i.e. by simply asking sufferers when they first remember 
experiencing key features or symptoms.  Such data, collected from adults, support the 
contention that many anxiety disorders were first experienced in early childhood.  In 
the National Comorbidity Survey  of adults in the USA Kessler et al. (2005) found the 
median reported age of onset for anxiety disorders to be as low as 11 years; despite 
the wide range of ages included in the survey (15-54 years).  In their review of 
retrospective studies of age at onset, Ost & Treffers (2001) report that the mean age 
of onset for animal phobias ranges from 4.4 to12.8 years and for other specific 
phobias it ranges from 8.1 to 20.6 years.  In the same review, social anxiety was 
reported to begin in adolescence, with a mean onset of between 15.7 and 20 years.  
However, the retrospective nature of these reports, with some adults recalling 
symptoms from 50 or 60 years earlier, calls into question the reliability of such data.  
From a recent review of the test-retest reliability of reports of lifetime childhood 
disorders, it could be summarised that retrospective information did not exceed 
moderate reliability, (Muller & Schneider, by personal correspondence).  Mannuzza 
Klein, Klein, Bessler, & Shrout (2002) also found the predictive power of diagnosing 
child psychiatric disorders retrospectively in adulthood to be very low (only 27% of 
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children diagnosed with ADHD were later identified in adulthood) suggesting that this 
method could  underestimate childhood onset, and will often lack specificity.  
 
A number of cross-sectional studies have aimed to address the problems inherent in 
using adult samples to address the question of age at onset by using diagnostic 
interviews with children and adolescents, reducing the time between onset and recall.  
Such studies are relatively scarce and are subject to some of the same 
methodological difficulties as retrospective studies with adults. Three such studies 
findings are summarised in Table 2.  Keller et al. (1992) interviewed 275 parents and 
their children to investigate the onset of separation anxiety and overanxious disorder. 
Giaconia et al. (1994) examined the onset of specific phobias and social anxiety in 
386 adolescents.  Wittchen, Stein, & Kessler (1999) investigated the onset of social 
anxiety in boys and girls separately in the baseline investigation of a sample of 3021  
   
Table 2. Cross sectional mean age of onset data from community samples of children 
and adolescents 
 Specific  
Phobia 
Separation 
Anxiety  
Social  
Anxiety 
OAD Panic  
Disorder 
Agoraphobia 
Giaconia  
et al. 1994 
 
6.7years 
 
   ---- 10.8 
years 
---- ---- ---- 
Keller et al. 
1992 
 
---- 8 years ---- 10 
years 
---- ---- 
Wittchen,  
et al. 1998;  
1999;2000 
---- ---- 11.5 girls 
12.5 boys 
---- 14.5years  12.6 years 
 
14-24 year olds in the Dresden study.  From this same baseline sample Wittchen et 
al. (1998) also examined the onset of panic and agoraphobia. These studies suggest 
that the onset of social anxiety may be much earlier than those reported by adults 
retrospectively, (e.g. Ost & Treffers, 2001).  It is also of note that panic disorder is 
generally thought to be a disorder with a peak onset in early adulthood; however, the 
findings of Wittchen, Lieb, Schuster, & Oldehinkl (2000) suggest it may well have 
significant onset in adolescence.  There is, therefore, cross-sectional evidence using 
large samples of children and adolescents indicating retrospective data from adults 
may underestimate the early onset of disorders, and suggesting that many anxiety 
disorders have their onset in childhood and adolescence.  However, it should be 
noted that the mean age at onset will always be heavily influenced by the age of the 
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sample in which the onset is assessed, making cross sectional cohort data 
problematic for establishing key periods or peak onset.     
 
Costello et al (in prep) attempted to include age at onset in their review; however, only 
the authors’ study  (Great Smoky Mountains Study; Costello et al. 2003) had 
assessed and reported age at onset for anxiety disorders in the diagnostic interview.  
This study reported the median age of onset for any anxiety disorder as eight years 
old, significantly below reported in adult studies ( e.g. 11 years; Kessler et al. 2005).  
When examining the median and interquartile ranges for each disorder, the findings 
demonstrate that the majority of disorders have their onset before the age of 10, with 
only panic and agoraphobia having their onset in adolescence (at 12 and 18 years 
respectively).  It is notable that in a population of 16 year olds, only panic, OCD, and 
generalised anxiety disorder had any reported cases of onset after the age of 11:  
Panic onset range 12-15 years; obsessive compulsive disorder 8-13 years; 
generalised anxiety disorder 0-13 years, (Costello et al. 2004).  Also, using data from 
this same population, the window of onset appears to be large for disorders such as 
generalised anxiety disorder (12 years) but extremely short for other anxiety disorders 
e.g. separation anxiety disorders (four years).  These indications of early onset 
provide support to the adult data and suggest an underestimation of early onset 
(Kessler et al. 2005). Although the Great Smoky Mountains is a longitudinal study, the 
calculation of age at onset relies on parent and child reporting of their first recollection 
of key features of the diagnosis; in essence it is still a cross-sectional and 
retrospective account of age at onset.  Many claims regarding epidemiology, 
particularly age at onset, are made from such data.  For example, Merikangas et al. 
(2009) talk about the temporal patterns of onset taken from prospective studies.  
However, on closer inspection, although the studies discussed are prospective in 
design, the data they refer to are retrospective.   
   
Cross sectional studies of children and young people, whilst an improvement on adult 
retrospective designs, remain limited in a number of respects: Firstly, despite the use 
of standardised diagnostic interviews, when assessing age at onset these studies 
generally ask the parent and child to recall the age at which they first remember key 
symptoms.  Wittchen, Lachner, Wunderlich, & Pfister, (1998) demonstrated that the 
Munich version of the Composite International Diagnostic Interview ((M-CIDI), 
although reliable in later adolescence, is not able to reliably determine age at onset in 
prepubescent participants, and although attempts have been made to alter diagnostic 
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tools in order to make them better at reliably assessing age at onset in children and 
adolescents, (Shaffer et al., 1996; Wittchen et al. 1999), these measures remain 
retrospective in nature, with the inherent error that this brings.  Also, Wittchen et al 
(1998) have demonstrated that 23-32% do not clearly remember when the disorder 
had its onset, calling into question the validity of retrospective measures in many 
cases.  They also found that assessing onset of full diagnostic criteria rather than key 
features of the disorder has a large and significant effect; they demonstrated that 
onset of the full disorder was, on average reported two to three years later. This is an 
important distinction, and one that is often ignored.  Onset questions relating to key 
features of the disorder are advocated in most standardised diagnostic manuals for 
anxiety disorders, depressive conditions require full diagnostic criteria to be met to 
attribute onset of the disorder; however, this is not consistent across all mental 
disorders.  This project will examine age at onset using prospective data and current 
diagnostic criteria in order to address these issues. 
What can we learn from long term follow up? 
Using child or adolescent samples only informs us regarding the age at onset for 
those suffering anxiety in childhood or adolescence.  It cannot provide data regarding 
the onset for those suffering in later life and tell us if these populations overlap.  Do 
young people suffering from anxiety disorders go on to suffer from these same 
disorders in adulthood?  Longitudinal data that follows participants into adulthood is 
required to answer these questions.  By using standardised diagnostic interviews to 
plot prevalence rates through childhood and adolescence into adulthood, and 
calculating first incidence rates at a number of follow ups through the lifespan it is 
hoped that the existing data from childhood and adolescence will be able to 
demonstrate more clearly the peak ages at onset for each anxiety disorder.  The 
longitudinal data from birth cohorts that are now into adulthood are able to provide 
these data without the biases of using a cross sectional sample, which will always be 
influenced by the age of the cohort and impeded by difficulties in recalling symptoms, 
syndromes, and/or diagnostic criteria accurately. 
Summary. 
There exists a large amount of data appertaining to the prevalence of anxiety and 
some data that have attempted to examine the onset and course of anxiety disorders 
in younger populations. Prevalence data suggest anxiety disorders are a big and 
growing problem in childhood.  It is important, however, that we distinguish between 
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disorders that cause the child impairment to functioning (and so require intervention) 
and those that do not.  In order to do this, standardised diagnostic interviews with 
clearly defined impairment criteria, are required. Self report data from parents 
suggests that early symptoms of anxiety are persistent and predictive of later anxiety 
disorders.  Clinical samples suggest that when we follow up anxious children they are 
often well after a period of up to five years; however, the use of only one follow up and 
the focus on individual disorders (e.g. obsessive compulsive disorder and separation 
anxiety) may mask the malign effects of some anxiety disorders and cannot examine 
the possible waxing and waning of disorders through different developmental stages 
or key risk periods. Clinical populations with a single follow up do not allow us to fully 
explore the course and outcome of early anxiety or understand the risk that these 
early anxiety disorders’ confer for later anxiety disorders or other forms of 
psychopathology.  The current cross sectional data demonstrate that anxiety is a 
prevalent disorder in childhood and adolescent populations, suggesting substantial 
onset of disorder in this population.  We know that parents and children report earlier 
onset than have been reported by adults in retrospective studies.  However, the “age 
at onset” findings are always heavily influenced by the age of the sample being 
questioned and we know that asking about symptoms rather than asking about the 
onset of an anxiety disorders can significantly affect the onset by as much to two to 
three years.  It is, therefore, argued that it is necessary to look to the longitudinal, 
prospective data that uses standardised diagnostic interviews at multiple follow ups in 
childhood and adolescence (and preferably into adulthood) in order to provide 
accurate and reliable estimates and better understand the development of anxiety 
disorders through the lifespan.  It must be noted that although diagnostic interviews 
provide the de facto “gold standard” for this kind of research, a recent review and 
meta-analysis found agreement between standardised diagnostic interviews and 
clinician assigned diagnoses to be low to moderate in most disorders, including 
internalising disorders (0.28). Mean kappa levels were reported as higher in child 
samples than in adult sample (0.39 vs. 0.31); however, the child sample was 
substantially smaller and complicated by the combination of informants – the same 
issue faced in many of the current studies (Rettew, Lynch, Achenbach, Demenci, 
Ivanova, 2009).  They conclude that rather than one method of assessment being 
inferior it must be acknowledged that findings from standardised diagnostic interviews 
may not be generalisable to clinical experience and practice.  Wittchen et al (1999) 
suggests that without the clinical “outcome” in a diagnostic interview the respondent 
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may lack motivation to respond honestly and thoughtfully.  The findings, therefore, 
may underestimate disorder and may not map onto clinical cases found in services.           
Prospective Longitudinal Data. 
Gallagher (2008) carried out a systematic search of the literature and collated all 
available publications from seven longitudinal studies meeting the strict inclusion 
criteria (see Appendix One); these studies are presented in Table 3.  All relevant data 
to answer questions regarding prevalence, age at onset and outcome of anxiety 
disorders were reviewed and reported.  The conclusions from the review will now be 
briefly summarised:         
 
Although a large quantity of prevalence data were reported across the seven studies 
reviewed, the selection of data to report and the manner in which they are reported 
varies substantially between and within studies.  To illustrate this point, when 
examining prevalence there are often no reported figures for any anxiety disorders 
and it is not possible to calculate this from the data reported due to high rates of 
comorbidity and the limited number of disorders included.  In other cases, only rates 
for “any” anxiety disorder are reported, meaning that judgements about the individual 
disorders cannot be made.  In none of the studies are publication of rates for both the 
individual disorders and rates for any anxiety disorder available at every follow up; 
therefore, it was not possible to reliably plot the prevalence rates through childhood 
and adolescence for all the studies, or to combine the data across studies.  It was also 
not possible to ascertain the peak age at onset for anxiety disorders.  The review 
confirmed that anxiety disorders are a prevalent problem amongst children and 
adolescents and that the prevalence rates reported in large scale longitudinal 
research are robust despite a range of temporal and geographical differences and 
differing approaches to data collection and analysis.  The evidence reviewed also 
suggests that the majority of adult anxiety disorders have their onset in childhood. 
 
Robust Prevalence Data. 
When examining prevalence in the longitudinal studies reviewed, anxiety disorders in 
later childhood and adolescence have been reported to be present in 9.7% of 11 year 
olds in the Dunedin study, New Zealand (Anderson et al., 1987) 9.2% of 12-13 year 
olds in the Taiwan Panel Study (Gau et al., 2005) and 9.2% of 12-17 year olds in the  
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Table 3. Studies from Gallagher (2008) review. 
Study/Authors Design Published data relating to anxiety 
disorders 
 
Bremen Adolescent Study (BJS.) 
Bremen, Germany. 
Essau (2005);Essau, Conradt & 
Petermann (1999);Essau, Conradt & 
Petermann (2000) 
Essau, Conradt & Petermann (2002) 
 
Diagnostic 
interviews in 
adolescence (12-
17 years) and 15 
months later.  
 
Reported for AAD and specific anxiety 
disorders at baseline and T1. 
 
Christchurch Health &  
Development Study, (CHDS).   
Christchurch, New Zealand 
Fergusson, Horwood & Lynskey (1993) 
Fergusson & Horwood (2001);Horwood 
& Fergusson (1998) 
 
Birth cohort study.  
Diagnostic 
interviews at 15 
and 18 years old 
with both parent 
and child.  
 
Reported for AAD at T1 and T2 
 
Dunedin Study. 
Dunedin, New Zealand.  
Anderson, Williams, McGee, &  
Silva (1987);Feehan, McGee, Raja &  
Williams (1994);Gregory et al (2007) 
Kim-Cohen et al (2003; 
McGee et al (1990);Newman et al 
(1996) 
 
Birth cohort study.  
Diagnostic 
interviews with 
children/adolescent
s at 11, 13, 15, 18, 
21, 26, & 32 
 
Reported for AAD and (in some cases 
specific anxiety disorders) at baseline 
and six follow ups. 
 
 
Great Smoky Mountains 
Study (GSMS) 
North Carolina, USA 
Costello et al (1996); Costello et al 
(1988) Costello, Mustillo, Erkanli. 
Keeler & Angold (2003) 
 
 
Overlapping 
cohorts using 
diagnostic 
assessment. 
Baseline age 9-13. 
 
 
Reported for each age group and 
individual disorders at 9-13.  
 
Children in the Community Study 
(CIC). 
New York State, USA 
Cohen, Cohen & Brook (1993); Cohen 
et al (1993); Pine, Cohen, Gurley, 
Brook& Yuju (1998); 
 
Overlapping 
cohorts’ design of 
children from 10-20 
using diagnostic 
assessments at 2.5 
and 8 year follow 
up.  
 
Reported for Any anxiety disorder, 
OAD, separation and social anxiety 
disorders. 
 
Oregon Adolescent Depression  
Project. 
Oregon, USA 
Lewinsohn et al. (1993) 
 
Single 12 month 
follow up 14-18 at 
baseline. 
 
Point prevalence and lifetime 
prevalence at baseline and T1 
 
Taiwan Epidemiological Study of 
Mental Disorders.  
Taiwan. 
Gau, Chong, Chen & Cheng (2005) 
 
Cohort of 12-13 
years followed up 
using diagnostic 
interviews yearly 
for three years.  
 
Reported for AAD and specific anxiety 
disorders at T1, T2 & T3. 
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Bremen Study, Germany (Essau, Conradt, & Petermann, 2002).  These rates are 
remarkably similar across different studies carried out at different times and in 
different countries.  Rates of separation anxiety also appear relatively robust with 
rates of 3.5% found in the Dunedin study at age 11 (Anderson et al., 1987) and in the 
Great Smoky Mountains Study in the US at age 9-13 (Costello et al., 1996) and rates 
of 3% found in the New York sample, also US, at age 14-16 (Cohen et al., 1993).  The 
prevalence of social anxiety appears more varied, which may indicate that it is less 
stable over the age ranges studied than some of the other disorders. Alternatively, 
changes in diagnostic criteria of social anxiety disorders in childhood from DSM-III to 
DSM-IV, most importantly removing overanxious disorder and implementing 
generalised anxiety disorder, and changing criteria from a phobia to an anxiety 
disorder, may well have influenced the stability of longitudinal assessments of social 
anxiety.  
Childhood Onset and Adult Outcomes. 
Three main lines of evidence were reviewed to understand onset and course of 
anxiety.  These were: follow-back analyses; cumulative prevalence rates; and first 
incidence data.  Follow-back analyses examine adults or adolescents in the later 
assessments who meet diagnostic criteria for an anxiety disorder, to determine at  
what age they first received a diagnosis.  Using follow-back analyses, the Dunedin 
study demonstrated that 80.5% of 21 year olds diagnosed with an anxiety disorders 
had a diagnosis before the age of 18 suggesting persistence in this age group, 
(Newman et al., 1996).  At 26, of those receiving an anxiety diagnosis, 61.5% had 
previously received a diagnosis between the ages of 11 and 15 (Kim-Cohen et 
al.2003).  This figure is higher still when looking at adults with more severe anxiety, 
defined as those accessing treatment suggesting an early onset for many of the 
severe adult anxiety disorders.  The New York study has similar findings when 
examining individual disorders.  In their sample of 17-26 year olds, 81% of those with 
specific phobias had received their diagnosis at baseline or first follow up in early 
adolescence; in those with social anxiety and generalised anxiety disorder the number 
of diagnoses first made in early adolescence was even higher at over 95%, (Pine 
Cohen, Gurley, Brook, & Ma, 1998).   
 
Cumulative prevalence data tell us the percentage of the sample who received at 
least one diagnosis of anxiety before a particular age.  Cumulative prevalence of 
anxiety disorders reported by both the Great Smoky Mountains Study and the Oregon 
Adolescent Depression Project suggest that the number of children and adolescents 
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who will have received a diagnosis by the time they are 16 years old is relatively high.  
The Great Smoky Mountains report a cumulative prevalence by 16 years of 9.9% 
(Costello et al., 2003) and 9.2% in the Oregon study (Lewinsohn et al., 1993).  These 
findings are remarkably similar despite differing methods and follow-up periods.  
Moreover, as previously discussed these prevalence are approaching the lifetime 
incidence reported in the adult literature; e.g. Alonso et al. (2004) lifetime prevalence 
rate of any anxiety disorder of 14%.  The fact that over 9% of 16 year olds have 
reached diagnosis could suggest that a large proportion of lifetime anxiety disorders 
are first diagnosed before the age of 16.  However, this contention must be treated 
with caution as the adult and adolescent study methods are not identical and it is of 
course possible, although unlikely, that the anxious adult population has no overlap 
with the population of anxious children.  Moreover, the retrospective nature of the 
collection of cumulative prevalence data from an adult sample requires people to 
remember diagnoses from, in some cases, 50 to 60 years ago, which introduces a 
measure of error (and most probably underestimation) to such adult studies.   
 
Problems with relying on “lifetime” incidence (asking whether the individual has ever 
experienced symptoms in their lifetime) can be illustrated by comparing them to 12-
month prevalence (have you experienced symptoms in the last twelve months); they 
are often remarkably similar. Costello et al. (2004) note the similarity in lifetime and 
twelve month prevalence found in adults (18-54) and adolescents (15-17) in the 
National Comorbidity Survey (NCS).  They conclude that this either refers to an 
epidemic of anxiety in the 12 months prior to the survey, extreme stability of anxiety 
through the lifespan, or indicates high rates of forgetting for earlier incidences of 
anxiety. Wittchen, Lieb, Pfister, & Schuster (2000) notes a similar trend in the Early 
Development Stages of Psychopathology study in Dresden, and propose that high 
rates of forgetting are the most likely explanation given all other sources of evidence 
for stability.  Comparisons between adult and child cumulative incidence rates are, 
therefore, made tentatively and require longitudinal data to determine any truth in this 
contention.      
 
First incidence data calculate the percentage of participants that are diagnosed with a 
disorder that have not received that diagnosis at any previous follow ups; i.e. those 
receiving that diagnosis for the first time within the study period.  For example, the 
number of a birth cohort who were diagnosis free at baseline (age 10), and at two 
year follow up (age 12) but receive a diagnosis at five year follow up (age 15) will 
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allow us to calculate the percentage of the sample with their first onset at 13 to 15 
years of age in the cohort.  First incidence data from the studies reviewed give the 
onset of a disorder between two specific ages and can be useful in furthering our 
understanding of peak age of onset.  The Bremen study shows that 6.9% of 12-18 
year olds received a diagnosis of an anxiety disorder for the first time during the study 
period of 15 months.  This would suggest that adolescence is a significant period for 
the development of anxiety disorders. Unfortunately these data were not presented for 
each anxiety disorder.   
 
The Oregon Study, using very similar methodology, reports first incidence over the 
study period of 12 months for young people between the ages of 14-18 as much lower 
at just 0.6%, suggesting that peak onset is likely to be either before the age of 14 or 
alternatively in adulthood.  The discrepancy between these two studies is somewhat 
surprising considering the use of similar methods to collect data on incidence over the 
follow up period. The Oregon finding seems low in comparison to other studies and 
could reflect cultural differences between Germany and the USA or alternatively 
reflect differences between the individual disorders each study subsumed under any 
anxiety disorder.  The data reviewed by Gallagher (2008) would suggest that peak 
onset for most disorders are more likely to be before the age of 14 rather than in 
adulthood.  The fact these studies begin collecting data in adolescence presents a 
problem as these may well not be the true first diagnosis.  Also, as illustrated here, the 
use of the any anxiety disorder criterion rather than examining the individual disorders 
is problematic when examining incidence in limited age ranges and may well be 
heavily influenced by a small number of specific anxiety disorders.  Examining 
incidence of individual disorders is important to our understanding of the temporal 
onset of anxiety disorders in this period and will be a focus of the current project.  
Using repeated follow ups to determine the changes in new cases of each disorder 
over time will be most helpful in understanding the patterns of new onset. 
 
Conclusions regarding the outcome of childhood anxiety were limited due to the 
available data; however the review did suggest that the majority of anxious adults 
were first diagnosed in early life.  These conclusions were drawn largely from the 
findings of two major longitudinal studies in the United States (the New York study) 
and New Zealand (Dunedin Study).  The New York study presents a seven year follow 
up of young adults suggesting that childhood anxiety presents, on average a two to 
three fold increased risk for adult anxiety disorders. Interestingly, as reported above, 
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they also found that most adult psychopathology was preceded by a childhood 
diagnosis of anxiety disorders; however, as the prevalence rates in the New York 
study are particularly high (unfortunately no cumulative prevalence data are reported), 
this may not mean that early disorder is a particularly useful predictor of adult 
disorder.  When examining the likelihood of adult disorders having had their onset in 
adolescence this varies but remains consistently high (overanxious disorder OR = 
4.99; social anxiety OR = 5.64; specific phobia = 10.61) Pine et al. (1998).  This 
increasingly strong relationship with adult disorders dependent upon severity of early 
disorders is also shown in reverse (i.e. severe adult disorder is more likely to begin in 
childhood) in the Dunedin data (Gregory et al. 2007).   Authors reporting longer term 
follow up from the Dunedin birth cohort in New Zealand also found that the majority of 
adults diagnosed with anxiety disorders had their first onset in late childhood or 
adolescence; this was particularly evident in severe adult cases, defined as those 
seeking treatment for their disorder (Gregory et al. 2007; Kim-Cohen et al. 2003).  
This was a consistent finding in the two longitudinal studies that examine the 
continuity of disorder from adolescence into young adulthood and is supported by 
data following young adults into later life which show high stability and a low incidence 
of new cases (Vollrath & Angst, 1989; Yonkers et al. 1996).  It is clear that more 
investigation of the longitudinal data into later life is required in order to gain a better 
understanding of the predictive power of early anxiety disorders in adult 
psychopathology and this requires multiple follow ups of cohorts beginning early in 
development and continuing into adulthood.   
Conclusions thus far. 
Prevalence data show childhood to be a significant period of onset for anxiety 
disorders and the most recent review, which statistically combines the findings of 50 
cross-sectional studies showed childhood and adolescent anxiety disorders to be 
equally prevalent but estimates in adolescence to be more reliable. Separation anxiety 
was found to decrease from childhood to adolescence and social anxiety increases in 
adolescence suggesting peak onset for separation anxiety to be earlier and social 
anxiety to be in adolescence, furthermore, providing support for distinct anxiety 
diagnoses in childhood samples.  Cross-sectional prevalence data, even when they 
are determined by standardised diagnostic interviews, are not able to accurately plot 
the onset and course of anxiety though the different developmental stages.  
Longitudinal prospective data are best placed to answer these questions and the 
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available data suggests that cross-sectional data may underestimate prevalence.  
Clinical and self report data have shown inconsistent findings in whether or not 
anxiety in childhood and adolescence is transitory or a stable disorder that leaves the 
sufferer at increased risk of later anxiety or other psychopathology.  The persistence 
of anxiety disorders and their stability over time is important to understanding the 
course of anxiety through the lifespan, and to understanding which disorders carry the 
greatest risk for anxiety in later life.  Again, longitudinal data with multiple follow ups 
from childhood into adulthood is best placed to answer these questions and allow the 
identification of the disorders and age groups at greatest risk of persistent disorders 
and those who may suffer only for a short time.        
 
Early data from retrospective and cross-sectional studies of adults suggest that the 
mean age at onset for anxiety disorders to be around 10 or 11 years; with onset of 
specific phobia and separation anxiety disorders to be in early childhood, social 
anxiety in adolescence, and panic, agoraphobia, and generalised anxiety disorder to 
have their onset in adulthood.  However, evidence from younger samples of children 
and adolescents suggest that these may be missing the early onset of some 
disorders, and is supported by the findings of the Costello review.  Retrospective 
reports using improved methods of data collection (e.g. Wittchen et al., 2000) support 
the early onset of separation anxiety, social anxiety, and specific phobias but show 
significant adolescent onset for disorders previously thought to have their onset in 
adulthood (agoraphobia, generalised anxiety and panic disorder). Problems with 
biases in “onset” according to the age of the population can only be addressed using 
prospective samples with data available into adulthood.  However, prospective age at 
onset data (incidence rates) are currently only available for samples of older 
adolescents (Essau et al 2002; Lewinsohn et al. 1993; Wittchen et al. 2000).  These 
findings suggest that although adolescence has significant onset, it appears likely that 
peak onset is earlier or later in adulthood.  Incidences of specific anxiety disorders 
have not yet been calculated using longitudinal data.   
 
The Gallagher (2008) review of the prospective, diagnostic data relating to anxiety 
disorders concludes that although there is a multitude of data collected around the 
world, there is a distinct lack of data available to plot rates, and compare onset and 
course of anxiety disorders from the seven longitudinal studies identified.  The 
patterns of data, however, do suggest a high prevalence of anxiety disorders amongst 
children and adolescents and provides evidence that longitudinal data produce more 
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robust prevalence than cross sectional data, but not necessarily higher estimates.  
Cumulative incidence at 16 years of age is high and approaching cumulative 
incidence found in adult samples.  Caution is needed in drawing such comparisons 
due to the different methods employed; however, this points to significant early onset 
of disorders that requires further investigation.  Evidence from longitudinal studies that 
follow participants into adulthood suggests that although most childhood disorders 
appear to remit, many adult disorders had their first onset in childhood or 
adolescence.  This is an important contention for supporting the argument for the 
redirection of resources to research into the development of childhood anxiety rather 
than the current focus on adult disorders. These contentions have been given 
increasing credence in recent reviews; however, further understanding of the patterns 
of specific disorders at specific ages will add significantly to our understanding of the 
epidemiology of anxiety disorders and we must be able to identify the children and 
adolescents whose anxiety puts them at risk for future anxiety disorders and those for 
whom the disorder is transitory, in order to make best use of the available resources.          
Aims.    
In this project I plan to analyse data from existing sources of prospective longitudinal 
data to meet three main aims: 
 
1)  To update the systematic search and review of the prospective, longitudinal 
studies examining anxiety disorders of childhood and adolescence that have 
been published to date. 
2)  To gain access to longitudinal data that began collecting standardised 
diagnostic information in childhood or adolescence that has not yet been used 
to plot prevalence and first incidence of anxiety disorders at specific ages or 
developmental stages. 
3)  To use the new data to calculate the stability of anxiety diagnoses through 
the lifespan and determine the outcomes for anxious children in later life.   
4)  To synthesise all published prospective, diagnostic data that relates to the 
onset, stability, and outcome of childhood and adolescent anxiety disorders 
with the new analyses to provide a comprehensive review of the current 
epidemiological data appertaining to anxiety  
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Chapter Two:  A systematic search to update Gallagher (2008) in 2010 
Background. 
A systematic review of the literature was carried out in 2006 (Gallagher, 2008; see 
Appendix One for search/inclusion/exclusion criteria.)  This review revealed 15 
epidemiological studies that had collected diagnostic data regarding anxiety disorders 
from children or adolescents at a minimum of two points in time, (see Appendix Two).  
It was hoped that a full review of these published studies that have employed the most 
robust methodology would allow the mapping of the onset, course, and outcome of 
anxiety disorders across the lifespan.  It was proposed that further comparison and 
synthesis of data from around the world would make the review a robust source of 
developmental epidemiology for clinicians and researchers.  However, the 
conclusions of this review were limited by the lack of analysis and publication of 
epidemiological data relating to anxiety disorders. In many cases data about age at 
onset have been omitted from reporting because the focus of the study was directed 
towards other matters, such as local service planning (e.g. the Great Smoky 
Mountains Study; Costello et al. 1996) or a focus on externalising problems and/or 
social rather than clinical outcomes (e.g. the Christchurch study; Fergusson & 
Horwood, 2001). When data examining anxiety disorders are presented, often the 
focus is on the social and diagnostic correlates, (e.g. GSMS) or age and gender 
differences in anxiety disorders (Children in the Community Study, New York; Cohen 
et al., 1993).  Another issue lies in anxiety disorders being combined with depression 
and analysed and reported as internalising problems or emotional disorders (Ontario 
Child Health Study, Offord et al. 1992; British Child and Adolescent Mental Health 
Survey, Ford et al. 2003).   
Literature Search. 
In order to attempt to answer the research questions outlined in the Introduction 
(Chapter One), the literature search performed in 2006 was carried out again in 
October 2010 in order to establish if any further longitudinal data regarding anxiety 
disorders had been published in the preceding four years.  
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Studies relevant to this review were identified using a number of search strategies.  
First, electronic databases were searched using the search terms [(CHILD* or 
ADOLESCEN*) and (ANXIETY* or PSYCHIATRIC* or DISORDER) and 
(EPIDEMIOLOG* or PREVALENCE or INCIDENCE or ONSET or LONGITUDINAL).  
PsycInfo (2000 -2010) and Medline (2000-2010) were both searched using these 
terms.  The Principal Investigators (PI) and lead researchers/authors associated with 
all 15 studies revealed by the 2006 search (see Appendix Two) were contacted where 
possible and websites were searched for any further publications or articles that may 
be in press.  Finally, the reference lists of all relevant papers were scrutinised for 
further relevant studies.   
 
The search terms located 1185 relevant articles from the year 2000 to the present day 
(October 2010).  The titles and abstracts were searched by the author to establish 
relevance to the research questions, the use of a standardised diagnostic interview to 
determine anxiety status, and a prospective, longitudinal design (data collected at a 
minimum of two points in time,) were required.  Seven relevant articles were identified 
through the electronic and website search.  A critical review of the papers identified, 
the Wittchen et al. (2000) chapter that was omitted from the original 2008 review, and 
with the unpublished review kindly provided by E. J. Costello, Principal Investigator of 
the Great Smoky Mountains Study, will now be presented.  The review aims to build 
upon the literature reviewed in Chapter One to provide an up to date understanding of 
the descriptive epidemiology of anxiety disorders and provide further rationale for the 
novel analysis of existing prospective data. 
The Early Developmental Staged of Psychopathology study (EDSP): 
Dresden, Germany. 
The Dresden study was not included in the Gallagher (2008) review because anxiety 
diagnoses were believed to be published for baseline disorders only.  However, the 
Gallagher (2008) search had failed to pick up data published in a book chapter 
(Wittchen et al. 2000) that was brought to light with the publication of Beesdo-Baum et 
al. (2009).  This chapter draws from data at baseline and first follow up (15-20 
months).  Prevalence and incidence of anxiety disorders in those who were aged 14 
to 17 years at baseline are discussed.  Cumulative or “lifetime” prevalence for anxiety 
is extremely high (27.2%); however, overall prevalence rates for any anxiety disorder 
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fell between baseline and first follow up (14.5% to 10.4%).  Incidence data and lifetime 
prevalence for the anxiety disorders in this period are presented in Table 4. 
   
Table 4. Incidence and lifetime prevalence reported by Dresden study at 20 month 
follow up (Wittchen et al. 1999) 
 
 
The incidence rates reported here are for a similar age range to those reported in the 
Oregon Adolescent Depression Project by Lewinsohn et al (1993); however the 
Dresden incidence is much higher than the 0.6% reported for anxiety disorders in the 
Oregon study.  This may be due to the use of different methods of collecting and 
combining the data.  However, this discrepancy is puzzling as both studies looked at 
similar age ranges, used diagnostic interviews, followed the adolescents up over a 
similar period, and both sought any new anxiety diagnoses since the baseline 
assessment.   
 
There is evidence of reduced reliability of diagnoses reported from over a three month 
period to determine diagnostic criteria (Angold, Erkanli, Costello & Rutter, 1996) and 
this reduced reliability is likely to substantially affect the estimates of incidence when 
asking about symptoms over a period of greater than a year.  Lifetime prevalence as 
calculated from a one off interview is even more problematic as there are significant 
issues with reliability and rates of forgetting of earlier symptoms and distress (Costello 
et al 2004).  In apparent recognition of these issues, Wittchen et al. (2000) also 
reports the point prevalence of the Dresden data (the symptoms must be current and 
present at the time of interview); these data are reproduced in Table 5.  Only panic 
attacks and panic disorder are reported at both follow ups at using these criteria; both 
appear to increase in this period. 
 
Disorder Incidence Lifetime Prevalence 
Any Anxiety Disorder 8% 21.3% 
Panic Attack 2.7% 3.2% 
Panic Disorder 0.6% 0.7% 
Agoraphobia 0.7% 3% 
Phobia NOS 2.1% 6% 
Social Phobia 2.1% 5.8% 
Specific Phobia  3.9% 13.7% 
GAD 0.1% 0.3% 
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The findings from the first follow up demonstrate that although late adolescence 
(between 14 and 19) is a significant period of onset it appears from the comparison 
with lifetime prevalence rates, (which should be treated with caution but are assumed 
to be conservative,) that peak onset for the majority (two thirds) of anxiety disorders 
are earlier in childhood and adolescence. 
 
Table 5. Point prevalence at baseline and 20 month follow up (Wittchen et al. 1999) 
 
 
 
 
 
 
 
 
 
 
 
When examining the stability of disorders in late adolescence Wittchen and 
colleagues (2000) report that 19.7% of those meeting criteria for an anxiety disorder at 
baseline meet full criteria at 20 months.  Fortunately 38.2% were completely well, 
displaying no symptoms at all; however, 47.9% remained symptomatic or met criteria 
for a “subthreshold” diagnosis.  It is unclear why the reported values reach a value 
over 100% as these appear to be mutually exclusive categories.  Panic disorder and 
specific phobias were the most stable with 44% and 30% respectively still meeting 
diagnostic criteria.  Agoraphobia and phobia not otherwise specified were the most 
likely to have remitted; 75.4% and 93% respectively.  These two disorders colour the 
picture of stability significantly.  When examining all anxiety disorders together 87.3% 
have remitted; however this is largely due to agoraphobia and phobia not otherwise 
specified.  It seems that some of the less stable anxiety disorders in the short term 
(e.g. generalised anxiety and panic) actually appear to have the least favourable 
outcomes in the longer term.  For example, only 22% of those with generalised 
anxiety are symptom free at ten year follow up; although the same disorder may have 
low stability it places the individual at risk for later psychopathology and subthreshold 
symptoms are often present.  The heterotypic continuity data are provided in support 
of the contention that rather than being transitory and having a favourable outcome 
 Disorder Point Prevalence 
Baseline 
Point Prevalence  
20 months 
 Any Anxiety Disorder 14.5% ---- 
 Panic Attack 1.9% 3.5% 
 Panic Disorder 0.3% 0.8% 
 Agoraphobia 1.9% --- 
 Phobia NOS 2.9% --- 
 Social Phobia 2.9%  
 Specific Phobia  9% --- 
 GAD 0.2% --- 
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some anxiety disorders wax and wane in their level of symptoms, but confer high risk 
for later psychopathology.  
 
Separation anxiety, as a disorder that remits in adulthood, has been proposed as a 
risk factor for other disorders, namely, panic disorder.  Bruckl et al. (2007) showed 
that separation anxiety in childhood placed the individual at a much increased risk not 
specifically for panic disorder but for a range of psychopathology.  Furthermore, 
Beesdo-Baum and colleagues (2009) present data from four waves of assessment in 
the Dresden study reporting data from ten year follow up of the sample of 14 to 24 
year olds.  Analysis of these data provide further evidence to support the contention 
that anxiety has an unstable course in adolescence with many disorders having only 
moderate stability across the follow up periods.  However, it also clearly demonstrates 
that although anxiety may remit in the short term heterotypic continuity is high; anxiety 
in adolescence is a significant risk factor for anxious and depressive psychopathology 
in adulthood.  Ten year follow up of the 14 to 24 year olds at 23 to 34 years 
demonstrates that a sizeable proportion (35-41%) of adolescents meet criteria for the 
same anxiety disorder (strict homotypic continuity) and what is more only 10 to 14% 
were without psychopathology, with 70% suffering from an emotional disorder 
(depression or anxiety).  Of those who were diagnosed with social anxiety at baseline 
only 13% were free of psychopathology at 10 years; 35% met criteria for social 
anxiety (strict homotypic continuity) and 64% were diagnosed with an anxiety or 
depressive disorder (heterotypic continuity).  When examining generalized anxiety 
disorder and post traumatic stress disorder no one diagnosed at baseline was free 
from psychopathology at ten years.  It is of note that in both generalized anxiety and 
post traumatic stress disorder sample sizes were small as these are rare disorders in 
this age group (generalized anxiety disorders; 0.2% N = 3); however, this is still a 
clinically important finding.  
    
Beesdo-Baum and colleagues (2009) use the prospective data from all follow ups in 
the Dresden data (plus presumably the lifetime prevalence although this is not stated) 
to cumulate recently assessed new cases across the lifespan into adulthood (from 0 
to 34 years) for both males and females for all anxiety disorders.  These graphs 
illustrate the onset of separation anxiety and specific phobia to be in early childhood, 
with the onset of panic, agoraphobia and social anxiety having a less clear peak, with 
somewhat later onset and significant new cases continuing to appear into adulthood.  
Comparison of this data with the use of retrospective data demonstrates that rather 
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than steadily increasing through childhood and adolescence into adulthood there are 
key stages of development where onset is more likely and this differs across anxiety 
disorders.  Most anxiety disorders have their onset prior to 14 where there is a 
flattening of new cases and social anxiety appears to be a disorder that continues to 
have incident cases whereas generalised anxiety has slower onset and a flatter curve 
suggesting less new cases in older adolescents.  Gender differences were few; 
however, males were shown to have an earlier onset for specific phobias and a later 
onset for generalized anxiety disorder.  This is potentially of interest when thinking 
about the direction of resources and prevention programmes.   
 
Summary. 
The Dresden study provides a great deal of insight into the course and outcome of 
anxiety disorders that begin in adolescence.  There are some data relating to new 
onset of cases in adolescence and they show that there are significant “new” cases of 
anxiety appearing in adolescence.  It is likely, however, that some cases of anxiety 
disorder had an earlier onset but as data collection begins late in development earlier 
cases are missed.  Lifetime prevalence has issues with reliability or recall, so caution 
is required when interpreting these survival graphs.  Interesting data relating to the 
persistence of anxiety disorders emerges from the long term follow up of young 
people.  The findings show that, as has been demonstrated previously in clinical 
samples, anxiety disorders are transient and remit in around 80% of cases over the 
course of two years.  However, by using symptoms and subthreshold measures of 
psychopathology and comparing across different disorders to examine outcome there 
appears to be very few anxious young people who can be considered “well” at ten 
year follow up.  The data also highlight the importance of looking at individual anxiety 
disorders, as the seemingly benign course of anxiety from the first look at the analysis 
is largely due to agoraphobia and phobia not otherwise specified.  Furthermore, short 
term transience can be associated with poor long term outcomes in some disorders 
(e.g. generalized anxiety disorder) suggesting that long term follow up is crucial in 
understanding the stability and risk conferred from early anxiety disorders.  The 
Dresden group propose that early anxiety does not have a linear course but anxiety 
disorders remit and change their symptom profile through the course of development 
but in many disorders leave the young person at a much increased risk of later 
psychopathology.   
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The Great Smoky Mountains Study of Youth (GSMS): USA. 
The GSMS data were included in the 2008 review to describe prevalence (in particular 
cumulative prevalence) rates across childhood and adolescence.  The GSMS also 
examined associations between childhood disorders (separation anxiety, overanxious 
or generalized anxiety disorder, and social anxiety) with diagnoses in adolescence.  
Since the 2006 search Costello et al (in prep) have used the data from the GSMS and 
conducted a review and meta-analysis of the prevalence of anxiety through early 
childhood to late adolescence.  This review includes over 50 epidemiological studies 
using community samples of 2 to 18 year olds and uses statistical methods to 
combine large quantities of prevalence data from studies using various designs.  Their 
review demonstrates the growing attention to the epidemiology of anxiety in such 
samples, and presents interesting findings (Costello et al. in prep).   
 
Similar to the conclusions from longitudinal data drawn from Gallagher (2008) Costello 
et al (in prep) conclude that anxiety disorders are highly prevalent in childhood and 
adolescence. Costello and colleagues compare the prevalence of anxiety disorders 
across childhood and adolescence, and proportions appear remarkably similar.  The 
rate of anxiety disorders between two and eight years (9.4%) was only slightly below 
the mean for the whole sample (2 to 18 years; 10.1%) suggesting that anxiety is as 
prevalent in young children as in adolescents.  There is, however, increased variability 
across this younger age range; for example, existing evidence suggests that 
prevalence in four to six year olds is significantly higher than two to three year olds 
(Briggs-Gowan et al. 2001).  Prevalence of anxiety disorders in 6 to 12 year olds was 
calculated to be 12.3%; however, when examining the confidence intervals there is a 
large amount of variability, (95% CI; 7.1-28.2%).  In adolescents (13 to 18 years) rates 
of 11% were calculated, with significantly narrower confidence intervals (95% CI;10.6-
11.4%) reflecting the increasing precision of estimates and consistent findings across 
adolescent studies.  It is as yet unclear whether this is an artefact of the way data is 
combined from parents and children in younger samples, or reflects a true variability 
in the prevalence of anxiety disorders across the various samples.  It is clear from the 
Gallagher (2008) review and similar reviews carried out by other authors (Costello et 
al. 2004; Beesdo-Baum et al 2009) that one of the factors affecting prevalence is the 
assessment period; for example, much lower rates are reported when asking whether 
the child has a symptom present currently (point prevalence estimate) in the last three 
months (three month prevalence estimate), at any point in the last 12 months (12 
month prevalence estimate) or whether they have experienced the symptoms at any 
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point in time (lifetime prevalence estimates). Costello et al (in prep) helpfully 
overcome this problem through their use of complex meta-analytic methods; however 
this is an interesting finding in itself that requires further attention and has implications 
for the descriptive epidemiology of anxiety disorders.   
 
A notable finding of Costello and colleagues (in prep) review, similar to that of 
Gallagher (2008), is that anxiety disorders are, in some cases, shown to be more 
prevalent in child and adolescent samples than in samples of adults (Alonso et al. 
2004; Kessler et al. 2005).  This supports the high cumulative prevalence rates shown 
in the Great Smoky Mountains Study (Costello et al. 2004) and the Oregon 
Adolescent Depression Project, (Lewinsohn et al. 1993).  It cannot be determined 
whether this demonstrates continuity of disorders, as it may not be the same 
population suffering in both childhood and adolescence. However, this evidence 
suggests that the large focus of resources and research upon adult anxiety may 
require further consideration.  This review suggests not only that anxiety disorders are 
prevalent but that they cause significant impairment to young people’s functioning in 
many cases.  The data from this unpublished review have been referred to in some 
detail in Chapter One and so this will not be repeated here (see Table 1).  
 
They do, however, report data from the GSMS regarding age at onset when the 
sample are aged 21 years.  The median age at onset is eight years with new cases of 
all disorders appearing at the age of 21.  However, as demonstrated in Table 6 the 
mean ages of onset for anxiety disorders demonstrate a surprisingly early onset, and 
the interquartile range suggests that “peak” onset may be a suitable description for 
some disorders (e.g. separation anxiety) but not others (e.g. generalised anxiety 
disorder) where onset is over a longer period of time, (see Table 6.) 
 
Table 6. Mean age at onset at age 21 in the Great Smoky Mountains Study. 
 Anxiety Disorder Mean Interquartile Range 
   Lower Upper 
 Any 7 years 6 11 
 Separation Anxiety 6 years 4 8 
 Specific Phobia 6 years 3 11 
 Social Anxiety 9 years 5 12 
 Generalised Anxiety 9 years 0 13 
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These data from an early adult sample show 50% of anxiety disorders to have their 
first onset between 6 and 12 years.  This is compelling evidence for the redirection of 
resources to younger people.  It is unfortunate that it is not clear how these data were 
calculated and whether the authors have used the prospective data to calculate onset 
or used self reported onset.  It seems unlikely that retrospective data would be used in 
this sample; however, these data will be used cautiously in this thesis due to 
uncertainty around the exact methods used. 
The Mannheim Study, Germany. 
The Mannheim study was excluded from the original review as the longitudinal 
diagnostic data were reported only for “emotional” or “neurotic” disorders in the earlier 
publications (Esser, Schmidt, & Woerner, 1990). However, a recent publication from 
the study presents 18 year follow up data using ICD-10 criteria to diagnose anxiety 
disorders (Fichter, Kohlboeck, Quadflieg, Wyschkon, & Esser, 2009).  Children were 
aged three to 15 years at baseline and nine to 22 at first follow up.  The baseline data 
used for this paper is from the first follow up of the study (nine to 22 years) and it is 
unclear if they are using the “current” (i.e. point prevalence) or “past” (symptoms 
present in the last five years).  Unfortunately the sample is relatively small (N=269; 
original sample N=396) and the majority of participants were over 15 years old at what 
will be referred to as “baseline” for this study.  Despite the small sample size Fichter 
and colleagues have presented the data separately for 9-11, 12-14 and 15-22 year 
olds.  The findings support a reduction in psychopathology from childhood into 
adolescence and adulthood and this is true for both anxiety disorders and phobias, 
and is supported by the Dresden data presented above.  At baseline, prevalence is 
measured using symptom criteria plus having a severity rating of two or more (two 
relates to moderate impairment; range 0-4): 23% of 9-11 year olds; 13% of 12-14 year 
old girls and 10% of boys; 16.5% of 15-22 year old females and 10% of males were 
described as suffering from an anxiety or phobic disorder.   
 
When looking at these individuals as adults 18 years later 12 month prevalence is 
much lower.  The same psychiatric interview showed 4.2 - 8.7% of females and 3.4 - 
4.2% of males meeting criteria for anxiety or phobia.  This may be due to the 
comparison between disorders in the “last five years” in childhood and “last twelve 
months” in adulthood.  However this is unclear, so it is possible that it is a comparison 
between point prevalence in childhood and 12 month prevalence in adulthood, which 
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would make the decreases even more striking.  Only two women (0.8%) of the adult 
sample (N=269) met criteria for “severe” anxiety or phobia (rating of 4) at both time 
points (continuous severe anxiety/phobic symptoms.)   In this cohort 3.1% of the 
sample received a diagnosis of “severe” anxiety or phobia in adulthood and had 
reported no symptoms at baseline (i.e. this could be considered the incidence or first 
onset of severe anxiety in adulthood).  The use of this data to talk about adult onset 
must be tentative in a population who has had only one baseline follow up and are 
now aged 27-40 years old; however, the decreasing prevalence supports the 
contention that most adult cases are “new cases” in this sample.  Unfortunately the 
data are not presented as a percentage of the anxious adult sample but for the 
sample as a whole making comparisons with other studies more difficult.   
 
The Mannheim sample is small and the number of cases in adulthood is relatively few, 
so it is difficult to examine patterns of remission and onset in a meaningful way.  None 
of the 9-11 year olds diagnosed with anxiety or phobia meet criteria 18 years later 
suggesting full remission in this small sample (N= 3).   These findings do not appear 
to lend support to the contention that adult disorders most often have an early onset.  
Possible factors to explain this discrepancy with the findings of the Dresden, Dunedin 
and New York studies could be that the Mannheim study has a relatively small 
sample, does not use the same psychiatric interview/criteria at both follow ups, and 
there may be international differences between America, New Zealand, and Germany.  
However, compatible findings between the New York and Dunedin studies and those 
from Dresden, Germany suggest that the cultural explanation is unlikely.  It seems 
more likely that the use of only one baseline assessment and such a long period of 
follow up, coupled with the use of different methods of determining diagnostic status, 
and the relatively small sample explain these discrepant findings.   Despite these 
seemingly contradictory findings relating to the proportion of stable disorders and 
early onset of adult disorders, Odds Ratios show that anxiety and phobias did confer 
risk for adult psychopathology (OR=1.7) and this increased when looking specifically 
at phobias in childhood or adolescence and ICD 10 anxiety disorders at 18 year follow 
up (OR=2.3).  These OR’s are more conservative but comparable to those reported in 
the New York study by Pine and colleagues (1998) over a much shorter follow up. 
 
These findings could be considered problematic in one respect in that they appear to 
show only a limited relationship between early onset anxiety or phobia and later 
anxiety or psychopathology.  However, the data still demonstrate a relationship 
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between early onset and adult disorders, specifically between early phobias and adult 
anxiety disorders.   The use of only two periods of assessment with a small sample, 
over such a long follow up period when the Dresden data is beginning to provide clear 
evidence that anxiety waxes and wanes over childhood and adolescence (Wittchen et 
al. 2000) offers a possible and meaningful explanation of the discrepancy between 
Mannheim and studies such as Dunedin and New York which have larger samples 
and more importantly multiple follow ups across childhood and adolescence.   
Teen Health 2000 (TH2K). 
The TH2K paper was published in 2009.  A cohort of 4,175 11-17 year-olds in Texas, 
USA were interviewed using the Diagnostic Interview Schedule for Children (DISC) to 
establish rates of DSM-IV mental disorders. Of those, 3134 were interviewed one year 
later (Roberts, Roberts, & Chan, 2009).  Prevalence of any anxiety disorder was 6.3% 
(CI 95%; 5.4-7.2%) in this sample.  The proportion of the sample experiencing their 
first incidence of an anxiety disorder in the previous 12 months is reported as 2.9% 
(CI 95%; 2.3-3.6%).  Incidence is then broken down by age.  Twelve month incidence 
of anxiety disorders for those who were 11-12 years old at first interview were found to 
be similar but less than that for the overall sample at 2.6% (CI 95%; 1.4-3.8%).  In 13-
15 year olds there was an increased incidence reported of 3.6% (CI 95%; 2.7-4.6%).  
Going into later adolescence, in 16 to 17 year olds incidence was somewhat lower at 
2.2% (CI 95%; 1.1-3.3%).  This suggests that early adolescence (13 to 15 years old) 
may be an important period of onset, supporting the contention of Wittchen and 
colleagues (2000) that early adolescence is the last stage of significant onset for the 
majority of anxiety disorders.   However, the combining of individual disorders into 
“any anxiety disorder” makes further extrapolation of meaning from these data difficult. 
National Survey of Health and Development (NSHD): Medical Research 
Council  
This UK birth cohort (N= 3279), born between 3rd March and 9th March 1946, were not 
included in the original review because the adolescent measures of anxious 
symptoms were teacher report questionnaires rather than diagnostic interviews.  
Therefore, this study does not meet criteria for inclusion in the original review.  
However, the results of the long term follow up of this cohort are of interest to the 
current research questions.  The baseline assessments took place at 13 and 15 years 
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old.  Colman, Wadsworth, Croudace, & Jones, (2007) report that 70% of individuals 
meeting diagnosis for an internalising disorder at both 13 and 15 (persistent disorders) 
met criteria in adulthood (36, 43 or 53 years) compared to only 25% of those who did 
not meet criteria in adolescence. There was no significant difference between rates of 
adult psychopathology in those who met criteria at either 13 or 15 years and those not 
meeting criteria for an internalising disorder in adolescence.  This suggests that the 
persistence of internalising disorders in adolescence is significant in its prediction of 
adult disorder.  A second paper looks at the course of internalising disorders from 
adolescence to late adulthood (53 years) and distinguished six categories relating to 
the onset, course, and outcome of internalising disorders.  The results are presented 
in Table 7. 
 
Table 7. Continuity and onset of internalising symptoms in NHSD (Colman et al. 2007) 
 Onset and Continuity   N    % 
 No disorder 2071 44.8% 
 Continuous disorder (moderate) 1553 33.6% 
 Continuous disorder (severe) 78 1.7% 
 Onset in adulthood (moderate) 524 11.3% 
 Onset in adulthood (severe) 132 2.9% 
 Onset in adolescence remitted. 269 5.8% 
 
These data must be treated with caution as the “diagnosis” of mental disorder is not 
the same across the five follow ups.  However, the degree of continuity is striking 
across such a long follow up period.  When examining the 1900 individuals who are 
believed to have an internalising disorder in adolescence we can see that adolescent 
disorders do not appear to have a favourable outcome in over three quarters of cases 
(85.8%).  Only 14% of those with adolescent disorder did not meet diagnostic criteria 
in adulthood. Unfortunately the data is not broken down for anxious and depressive 
disorders; this makes the use of this data extremely limited in answering the current 
research questions; however, it does point to the long term continuity of anxiety and 
depression as being moderate (35.3% over forty years) and points to the importance 
of accurate understanding of the stability of disorders in understanding outcome.   
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British Child and Adolescent Mental Health Survey: Office of National 
Statistics. 
The first wave of the British Child and Adolescent Mental Health Survey (BCAMHS) 
was conducted in 1999 using the Development and Wellbeing Assessment (DAWBA) 
diagnostic interview with 12,529 children aged 5 to 15 years; the cross sectional data 
was cited in the introduction of the Gallagher (2008) review (Office of National 
Statistics, 1999).  A 2004 “follow up” used a new sample rendering it a second cross 
sectional study (N = 7977) (Office of National Statistics, 2004).  However, in 2007 the 
second cohort were followed up three years on creating a prospective sample (N = 
7329).  As with the National Survey of Health and Development reported above, 
depression was, unfortunately,  included with anxiety disorders to form the group 
“emotional disorders”.  It is unclear why this decision was taken but the extremely 
small numbers of children reaching diagnostic criteria for depressive disorders may be 
of significance; prevalence of anxiety in the baseline survey were 2.2% for 5 to 10 
year olds and 4.4% for 11 to 16 year olds giving an overall prevalence for the sample 
of 3.3%.  Depressive disorders, however, were present in only 0.9% of children and 
adolescents with rates as low as 0.2% in 5 to 10 year olds, (N = 7797; Office of 
National Statistics 2004).  Despite this limitation the findings are included here as the 
data was stratified by age and offers a UK sample from young children to adolescents. 
This is of particular interest as the current project will analyse data from a UK birth 
cohort in the 1990’s.  Furthermore, the remarkably low incidence of depressive 
disorders in the “Emotional Disorders” sample lends itself to interpretation of the data 
in relation to the course and outcome of anxiety disorders.   
 
Table 8. Persistence of emotional disorders by age: BCAMHS (Office of National 
Statistics 2007) 
 Age at Baseline Persistence 
% of those with emotional  
disorders in 2004 
 5-7 years 26% 
 8-10 years 12% 
 11-13 years 40% 
 14-16 years 21% 
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Emotional disorders were persistent in 30% of children reaching diagnostic criteria 
over the three year follow up (33% girls; 27% boys).  In Table 8 the persistence of 
emotional disorders is presented for each age group (ages given at baseline).  It 
appears that disorders in 11-13 year olds are particularly stable for well over a third of 
cases still meet diagnostic criteria three years later.   
 
When looking at onset of new disorders the incidence or number of new internalising 
diagnoses for the whole sample of children and adolescents was 3% (4% girls, 3% 
boys).  It appears that the three year incidence rate increased with age (see Table 9).  
The use of a measure that asks parents and/or young people to recall symptoms over 
such a long period (three years) will introduce a significant amount of error; it could be 
that these rates are most likely more reflective of a shorter period of time and may 
lead to an underestimation of new cases. 
 
Table 9. Incidence of emotional disorders between 2004 and 2007 
 Age at baseline Incidence Rates 
 5-7 years 2% 
 8-10 years 3% 
 11-13 years 4% 
 14-16 years 5% 
 
Although these data are not suitable for answering the research questions in terms of 
the specific onset, course and outcome of anxiety disorders in this large UK sample 
will provide a useful comparison for the UK data analysed in Chapter Four the Results 
which uses the same diagnostic tool (DAWBA). 
Summary. 
In the four years since the last systematic search a relatively small amount of new 
data has been analysed and published that relates to the onset, course and outcome 
of anxiety disorders in childhood and adolescence.  Some studies that did not meet 
criteria for the original review have been included here in order to try and help build 
the picture of the epidemiology of internalising disorders in general and to understand 
where anxiety fits with this picture.   
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Prevalence. 
Costello and colleagues (in prep) have provided a thorough and illuminating review 
and meta-analysis of prevalence across childhood and adolescence that 
demonstrates the substantial proportion of children and adolescents in the community 
who have significant issues with diagnosable and functionally impairing anxiety 
disorders.  These disorders are demonstrated to be as prevalent in childhood as in 
adolescence and proportions are approaching those found in large scale 
epidemiological studies of adults.  Despite similarities in prevalence of the anxiety 
disorders in childhood and adolescence, separation anxiety stands out as a diagnosis 
of childhood and social anxiety as a disorder of adolescence, as would be expected 
from the clinical and cross-sectional data.  The associated error in the childhood 
estimates is, however, much greater than those reported for studies in adolescence, 
highlighting the difficulties in measuring anxiety in younger populations. 
Age at onset data.   
New data from the TH2K study provide additional data for understanding age at onset.  
The 12 month incidence rates for different age ranges in this cohort give specific data 
that when combined with onset data from other studies supports the contention that 
early adolescence may be a significant stage in development where the onset of 
anxiety disorders is prevalent.  These data are unfortunately not provided for 
individual anxiety disorders and, like other studies reviewed, the first data collection 
was not until late childhood making it impossible to know if the incidence is true first 
onset or whether some anxiety disorders may have been present at earlier ages but 
were not recorded.  These data, however, can add to our understanding of incidence 
in adolescence.  Incidence of individual disorders reported in the Dresden study 
demonstrate substantial proportions of the sample displaying onset of separation 
anxiety and specific phobias in later adolescence; however, these must be examined 
in the context of the differing lifetime prevalence of different disorders (i.e. some 
disorders are simply rarer) and, as in the TH2K “first” onset will most likely be 
underestimated due to the first data collection taking place at such a late stage in 
development when we know that anxiety is prevalent in much younger children.  The 
major limitation of the onset data from these two studies is that patterns of onset 
through development cannot be determined, as incidence is only calculated once and 
samples are not broken down by age.  The data from the Great Smoky Mountains 
Study from when the cohort reach adulthood suggests early onset (middle childhood) 
for most anxiety disorders, with separation anxiety having a short window of peak 
onset and generalised anxiety having a much wider window covering all of childhood 
  
54 
 
and adolescence.  It is unclear how these data are calculated but they do suggest a 
much earlier peak onset for many disorders than has previously been reported with 
very few disorders after the age of 14, as supported by the incidence curves from the 
Dresden data.  
Continuity and stability.   
The Dresden data lend support to the contention that early anxiety disorders do not 
have a linear course and wax and wane through childhood and adolescence but are 
associated with psychopathology in later life, with different patterns emerging for the 
various anxiety disorders.  The Dresden data examine the course and outcome of 
individual disorders and two important patterns emerge from the data: First that the 
seeming “remission” of early anxiety disorders may well be due to the “any anxiety 
disorder” category often employed in longitudinal studies.  The high rates of remission 
reported may, at least in part, be accounted for by a lack of stability in agoraphobia 
and phobia not otherwise; Secondly, that both generalised anxiety and social anxiety, 
which in short term studies appear to be transient, also have the least favourable 
outcomes in the longer term.  These are interesting findings and illustrate the need to 
examine anxiety disorders as separate entities rather than always subsumed under 
“any anxiety disorder” in order to better understand the patterns of disorders through 
the lifespan which can be explored in longitudinal studies.  Importantly the Dresden 
data show that although homotypic continuity of anxiety disorders may be moderate, 
when we look at symptomatic and subthreshold cases of anxiety, and look to other 
forms of psychopathology, (particularly depressive disorders) these young people 
report their disorders to be extremely stable over the long term follow up and have a 
much increased risk of psychopathology, if not mental disorder.        
Adult outcomes. 
Two studies included in the above review have recently followed up cohorts that were 
first examined in childhood and adolescence and are now well into adulthood.  These 
are the Mannheim study (Fichter et al. 2009) and the Medical Research Council 
National Survey of Health and Development (Colman, et al. 2007).  Although these 
studies have flaws in their methodology in terms of inclusion in a meta-analysis they 
provide an opportunity to make comparisons with the compelling data from the 
Dunedin and New York studies that adult onset of many anxiety disorders are rare 
and that the majority of cases have their onset in childhood or adolescence.  The 
Mannheim study has generated diagnostic status in a way that is not easy to compare 
with other similar studies; it does, however, use ICD-10 as the adult outcome 
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measure.  The small sample and use of only two data collection points 18 years apart 
may explain why the data suggest a larger proportion of adult onset than has been 
found in the Dunedin or New York studies, which have the benefit of multiple waves of 
diagnostic assessment.  The Mannheim study would suggest only a small number of 
women remain anxious who had been diagnosed with anxiety disorders in childhood.  
Although the proportion of the sample diagnosed with anxiety decreases substantially 
in adulthood, most of these cases were first diagnosed in adulthood.  Fichter and 
colleagues, however, do report that when using the ICD-10 criteria as an outcome 
variable, there is a moderate predictive relationship between childhood anxiety and 
adult psychopathology more generally (OR = 1.7) and particularly between phobias 
and later anxiety disorders (OR = 2.3).  This finding of a specific relationship between 
early onset anxiety and anxiety in later life supports the findings from the New York 
study (Pine et al. 1998).    
 
The second study with long term follow up (Colman et al. 2007) unfortunately does not 
report anxiety disorders separately from depression.  They report onset and continuity 
of internalising disorders.  The results of their 40 year follow up, however, support the 
findings of the Dunedin and New York studies and suggest a large percentage of 
those with adult disorders were first diagnosed in adolescence with only a small 
proportion of the sample having onset of “severe” disorders in adulthood (2.9%); 
remarkably similar to the reports from the New York and Dunedin follow back 
analyses.  Despite the inclusion of depression this adds credibility to the contention 
that adult psychopathology, particularly significant or severe cases frequently have an 
early onset.  The findings also show that only stable disorders are associated with 
psychopathology in adulthood, an interesting finding that has not been examined 
before. 
UK data on onset and stability of internalising disorders. 
Data from the British Child and Adolescent Mental Health Survey (BCAMHS) were 
included in this chapter despite the fact that data was combined for depression and 
anxiety to make an “emotional disorders” category (Office for National Statistics, 
2007); it is predicted that this may be due to the small numbers of children meeting 
criteria for a depressive disorder, particularly for 5 to 10 year olds.  Inclusion is due to 
the focus of the current project on a large UK birth cohort for which the BCAMHS data 
may provide an interesting and important comparison.  The data are broken down in a 
way which allows persistence and incidence to be examined in a young sample.  
Although the British Child and Adolescent Mental Health Survey appears to 
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demonstrate prevalence rates significantly lower than that of the other studies 
reviewed (e.g. emotional disorder rates that are more similar to rates of individual 
anxiety disorders in other large studies) the data show a steady increase in the 
number of incident cases (first onset) of emotional disorders throughout childhood into 
adolescence.  They also report that emotional disorders appear to be stable in around 
a third of anxious children, with some variability dependent upon the age at first 
diagnosis; children first diagnosed at 11 to 13 years appear to be the most stable over 
a three year period when compared to groups of older adolescents of younger 
children. 
Conclusions. 
The findings presented here from the updated literature review offer some support to 
the major contentions of Gallagher (2008).  It is widely accepted that anxiety disorders 
are prevalent in childhood and adolescence; however, the Costello et al. (in prep) 
meta-analysis suggests that anxiety disorders may be equally prevalent in childhood 
and adolescence (dependent upon diagnosis) but that earlier disorders incur higher 
degrees of measurement error.  Anxiety disorders appear to have an early onset (in 
childhood or early adolescence) with some having a clear peak age at onset and 
others having a larger window of opportunity for new cases to arise.  There remain, 
however, significant issues with data available to assess age at onset prospectively.  
The data collection begins too late in the child’s development, is taken only between 
two time points, or does not distinguish between anxiety and depressive disorders. 
 
The course of anxiety appears to be non-linear in many cases and may wax and wane 
over time, it is increasingly probable that they are, in some cases, significant risk 
factors for adult psychopathology - specifically adult anxiety disorders.  The course 
and outcome for the specific disorders follow individual patterns, therefore, it is 
probable that the favourable outcomes often described in short term follow up studies 
looking at all anxiety disorders together, may reflect the course of a small number of 
prevalent disorders (e.g. phobia not otherwise specified) and so conceals the 
malignant course of other anxiety disorders. 
 
An increased interest in the long term outcomes of adolescent anxiety and depression 
is evident from the evidence reviewed and there is some support for the contention 
that adult anxiety disorders are associated with, and frequently preceded by, earlier 
anxiety disorders.  However, research examining the specific onset and course of the 
individual anxiety disorders is still absent.  Information regarding younger children is 
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also lacking, particularly studies that follow these young children into adulthood to 
determine the outcome of very early anxiety disorders as opposed to those from 
adolescence.  Onset of any anxiety disorder is beginning to be the focus of research 
attention and so can be described for a number of samples; however, the data 
required to answer important questions about the targeting of resources require more 
precise identification of the onset of individual disorders, when they are most likely, 
and the parameters of these “peak” stages of onset.  These data are not yet available.   
 
It remains unclear whether anxiety in childhood and adolescence is stable or 
transitory in the majority of cases.  If anxiety is highly prevalent and most cases of 
childhood and adolescent disorder remit, is early anxiety a good enough predictor of 
adult anxiety disorders for preventative strategies to be effective (and cost effective) in 
reducing the prevalence of adult anxiety disorders?  Alternatively can it be argued that 
the treatment of anxiety disorders in children should be our major focus regardless, in 
order to reduce distress and long term impairment?  The work from the Dresden study 
also suggests that subthreshold disorders may require further attention when 
examining the distress and impairment associated with early onset disorders.  The 
large numbers of children who receive anxiety diagnoses in large epidemiological 
studies, however, may point to anxiety in childhood as a poor predictor of later 
psychopathology and the contention that only persistent internalising disorders are 
reasonable predictors of adult disorders (Colman et al 2007) suggests that more 
powerful ways of predicting poor outcomes require further investigations.      These 
are important questions, as needless intervention in benign cases could have 
unintended consequences, which could interfere in normal development and 
stigmatise children needlessly.  
 
The current study will attempt to analyse new data in light of these findings and 
assimilate them into the current picture of the epidemiology of anxiety with the hope of 
highlighting areas where conclusions appear more robust, and to attempt to answer 
the question of whether the anxious child is likely to become an anxious adult.  
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Chapter Three: Method. 
Recruitment. 
Rather than recruiting individual participants, this study required me to recruit 
prospective longitudinal studies of child and adolescent mental health.  The aim was 
to gain permission from Principal Investigators to access diagnostic data that has 
already been collected but not yet analysed or published relating to the descriptive 
epidemiology of anxiety disorders.  The original review (Gallagher, 2008) 
demonstrated that the data to understand the descriptive epidemiology have been 
collected in many different countries (see Table 3 and Appendix 2).  Most of this data, 
however, has not yet been used to answer questions regarding the epidemiology of 
anxiety in this level of detail.                                                                                    
Figure 1. Age ranges in prospective longitudinal studies 
 
The aim was to acquire the diagnostic status for anxiety disorders, determined by a 
standardised diagnostic interview that has been assigned to each child at baseline 
and any subsequent follow ups.  For some studies this may only be one follow up 
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(e.g. Bremen, Christchurch, and Oregon studies), for others it is as many as eight 
(Dunedin).  Similarly some studies assess over short periods (two years or less) whilst 
others cover up to 40 years (see Figure 1).     
 
By acquiring such data, it would be possible to establish the age (or developmental 
stage) at which a young person is most likely to receive their first diagnosis of each 
anxiety disorder, (determining peak age at onset in a sample) and make comparisons 
across the different samples.   We are also able to examine the continuity of anxiety 
disorders; whether they are stable and continue to present a problem over time, or 
remit as the young person moves into adolescence and adulthood.  Where data have 
been collected into adulthood we are also able to explore outcomes for anxious 
children and adolescents; do they continue to suffer from anxiety or has it ceased to 
be a problem in adulthood? 
Design. 
The original plan was to gain access to enough raw diagnostic data from large 
samples to allow the manipulation of data into a state where they could easily be 
compared and combined.   The data would be broken down into appropriate age 
cohorts to make data sets compatible and then it would be possible to calculate the 
proportion of new cases of each anxiety disorder at each developmental stage, the 
proportion of those with stable anxiety disorders at different points in their 
development, and the risks (as calculated by Odds Ratios) of later disorder for those 
who suffer anxiety early in life, and the proportion of adult disorders that had their 
onset earlier in life.  This would have provided us with a full review and then a meta-
analysis of large scale epidemiological data. 
The proposed analysis. 
The original plan for the analysis, which was presented to the PI’s, based on access 
to the data presented in Figure 1 was the same for all data sets.  They differed only in 
the number of analyses proposed, dependent upon the age ranges and number of 
follow ups in each data set.  For some studies follow back analysis and examining 
adult outcomes are not feasible due to the age ranges included.  A brief outline of 
these proposed analyses will now be presented: 
 
The first step would be to code diagnoses of each anxiety disorder as absent or 
present and then break down cohorts according to their age.  Ideally this will use 
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similar methods for combining informant data, and the same impairment and 
prevalence criteria but these differences can be worked with.  The age groups would 
be dependent upon the age range included and the sample size; ideally there would 
be no more than a three year range in the ages of each group.  This allows 
comparisons between the proportions of children with each anxiety disorder at each 
age/stage, for each follow up; in the past, even cohorts that cover large age ranges 
have often been analysed as a whole.  These data can then be used to determine the 
proportion of children receiving their first diagnosis of each anxiety disorder at each 
follow up.  By calculating the proportion of new cases for each follow up and each age 
we can determine patterns over the life course in order to identify when the highest 
number of emerging cases appear - the peak age at onset.  When samples begin 
collecting data later in life caution must be used in interpreting these as “first” onset. 
The next step is to use samples that have collected data in late adolescence and 
adulthood to look at the diagnostic outcomes for those with and without anxiety in 
early life and determine the risk associated with early anxiety when the individual 
reaches adulthood.  In order to determine these outcomes we would use a number of 
methods.  First, calculating the proportion of child or adolescent anxiety cases that 
meet diagnostic criteria at later follow ups (proportion of anxious children with 
chronically stable disorders), the likelihood (as determined by Odds Ratios) that those 
with child or adolescent anxiety receive a diagnosis in later life; and the proportion of 
adults with anxiety disorders that met diagnostic criteria in early life (follow back 
analysis).  Wherever possible, data sets would then be combined in order to carry out 
the same analysis on a large amalgamated sample.  
 
The planned data analyses are, therefore, relatively simple and largely rely on 
descriptive statistics and contingency tables to calculate proportions and Odds or Risk 
ratios.  Despite this simplicity, if data could be compared and combined across a wide 
range of studies internationally then the picture regarding the onset, stability, and 
outcome would be much clearer, and international comparisons could be useful in 
thinking about the differences and similarities cross-culturally and methodologically 
and ensures that the samples of anxious youths are sufficient to carry out the whole 
range of analysis with suitable power.  Figure 1 demonstrates that although there is a 
wealth of diagnostic data collected, there are no prospective studies that collect 
diagnostic data on preschool children and only very few that begin in middle 
childhood.  This means that calculating first onset for some disorders would be very 
difficult.  Furthermore, very few longitudinal studies have begun collecting data in 
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childhood and continued into adulthood (The Dunedin and New York studies are 
exceptions to this problem).  The majority of studies begin late in childhood or in 
adolescence.  The period between ages 12 and 18 is the age range covered by the 
greatest number of prospective longitudinal studies; the majority of meaningful 
comparisons and synthesis would, therefore, be in this period of adolescence.  
Although some disorders may be associated with adolescent onset, many first onsets 
of anxiety disorders may be missed.  The limitations of a number of these studies for 
answering the questions outlined above and for meta analysis is, therefore, apparent.  
To undertake these analyses requires cooperation from some of the longitudinal 
studies that have collected data over a long period of time - 10 years or more.  A 
number of studies identified New York, Dunedin and Dresden in particular, offer these 
data and their inclusion would be necessary in order for the research aims to be 
feasible. 
Approaching Principal Investigators to share appropriate data. 
In order to gain access to data that could be used to meet the aims of the project, I 
contacted the Principal Investigators (PI) from the studies contained in the 2008 
review (see Table 3), and also the PI from the Dresden study. A letter and an e-mail to 
each individual researcher was written outlining my plans to carry out a large scale 
review and meta-analysis of prospective longitudinal data relating to the epidemiology 
of anxiety disorders.  I requested access to diagnostic data that could be used to 
generate and estimates of the prevalence, onset, stability, course and outcome of 
anxiety disorders in childhood and adolescence, and into adulthood where possible in 
order to amalgamate large data sets and have a large anxious population.  The letters 
and e-mails aimed to establish the research groups’ ability and inclination to share 
longitudinal data regarding diagnostic status of anxiety disorders in their respective 
studies.   
 
The only study that I did not attempt to contact was Dr. Gau from the Taiwan 
Epidemiological Study of Mental Disorders as it was evident that they did not collect 
appropriate data for the majority of the planned analysis of this project.  The Principal 
Investigators were identified using web resources and personal contacts and both e-
mail and postal addresses were sought.  Individual letters were then written and sent 
by both post and e-mail.  Some PI’s were also contacted by telephone or in person by 
a Dutch contact, Prof. Susan Bögels, an internationally prominent researcher in 
childhood anxiety who examined my PhD thesis, which included the Gallagher (2008) 
review.   
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Of the seven studies with appropriate data for inclusion, two responded immediately 
to say that they were unfortunately unable to share data at this time due to constraints 
on visiting researchers and data sharing projects during data collection periods.  
These studies were the Great Smoky Mountains Study (GSMS) in the United States 
and the Dunedin study in New Zealand.  However, Prof Costello the PI from the 
GSMS kindly sent an in prep article (see Chapter One and Two, Costello et al in prep) 
that she thought would be useful to understanding age at onset and stability.  The 
Dunedin study pointed us towards the data that they have already published as this 
contains a large quantity of suitable data appropriate for comparison and inclusion in 
the planned synthesis. The PI of the Bremen Study Prof. Cecilia Essau was contacted 
by Prof Susan Bogels and was reported initially to be very willing to share data but 
there were a number of difficulties negotiating authorship with this research group so 
this offer was subsequently withdrawn.  The Oregon Adolescent Depression Project 
(OADP) in the Unites States and the Christchurch project in New Zealand did not 
respond to any correspondence.  As the age ranges in these two studies are limited to 
later in adolescence this was not followed up further.  The Early Developmental 
Stages of Psychopathology (EDSP) study in Dresden initially responded to say that 
they would be able to share data and negotiations began.  The Children in the 
Community study in New York also agreed to release diagnostic data.  
Application for Data. 
The Avon Longitudinal Study of Parents and Children (ALSPAC; also known as 
“Children of the 90’s”) is a large birth cohort study carried out in Bristol in the UK.  
Children were born between 1991 and 1992.  A formal query was e-mailed to the 
ALSPAC data managers at Bristol University to determine  whether they had collected 
diagnostic outcomes for mental disorders.  This revealed that the Development and 
Wellbeing Assessment (DAWBA) has been collected at ages 7, 10, 13/14, and 17/18 
years.  I was then asked to apply to the ALSPAC team of Principal Investigators 
through a data request application process.  This process checks the feasibility and 
ethics of the request and ensures that no one else would be, or is currently, using 
these data for a similar purpose.  A fee of £700 for the administration and data 
support was also required; I applied to the Max Hamilton fund to ensure this funding 
was available and was successful in both applications. 
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Negotiation. 
Early Developmental Stages of Psychopathology – Dresden, Germany. 
The original request for the data to be used to calculate prevalence, onset, course and 
outcome at all ages (using the sample of 14-17 year olds at baseline), in order for 
them to be included in a meta-analysis with data from Dunedin and New York was 
met with a positive response.  The researchers suggested that data could be shared 
either through the research statistician completing analysis on my behalf, or that I 
would go to Dresden and register as a visiting researcher to carry out the analysis 
with his support. The second option was favoured as this allowed me to learn about 
the processes and systems used in this particular study.  However, after arranging a 
visit and booking flights insufficient data were secured from other studies, which 
precluded the meta-analytic methods that were outlined in the original data request.  
The researchers in Dresden were concerned that I could not publish the EDSP data 
alone as this mapping of the onset, course, and outcome of anxiety disorders is 
something that the research group wished to publish in the future.  Unfortunately this 
venture was curtailed at short notice. 
Children in the Community study (CiC) - New York. 
Personal contact through one of the lead researchers (Daniel Pine) who peer 
reviewed the original Gallagher (2008) review ensured ongoing contact with the PI of 
the New York study Professor Patricia Cohen despite her retirement.  The original 
request was for all data regarding diagnostic status for anxiety disorders at all follow 
ups for those that were “children” (i.e. under 16 years of age) at baseline.  This 
request was met with a positive response; however, Prof. Cohen was clear that there 
are a large number of different issues with these data that meant sharing all the data 
requested was neither possible nor desirable as some diagnoses were not considered 
to be reliable or valid.  Prof. Cohen was able to provide data for the sample who were 
less than 14 at baseline and look at continuity and new onset of anxiety and 
depression over the two follow ups providing data from late childhood/early 
adolescence (<14), later adolescence (<17) and adulthood (+18) for both social 
anxiety disorder and overanxious disorder/generalised anxiety disorder.       
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Methodology of included studies: 
Avon Longitudinal Study of Parents and Children (ALSPAC). 
Participants. 
ALSPAC recruited 14,541 pregnant women resident in Avon, UK with expected dates 
of delivery 1st April 1991 to 31st December 1992.  14,541 is the number of 
pregnancies for which the mother enrolled in the ALSPAC study and had either 
returned at least one questionnaire or attended a “Children in Focus” clinic by 
19/07/99. 
 
Out of the initial 14,541 pregnancies, all but 69 had known birth outcome. Of these 
14,472 pregnancies, 195 were twin, three were triplet and one was a quadruplet 
pregnancy meaning that there are 14,676 foetuses in the initial ALSPAC sample. Note 
that of these 14,676 foetuses, 14,062 were live births and 13,988 were alive at 1 year. 
When the oldest children were approximately seven years of age, an attempt was 
made to bolster the initial sample with eligible cases that failed to join the study 
originally. As a result, when considering variables collected from the age of seven 
onwards (and potentially abstracted from obstetric notes) there are data available for 
more than the 14,541 pregnancies mentioned above. The number of new pregnancies 
not in the initial sample that are currently represented on the built files is 542. Of these 
542 additional pregnancies 6 were twin, meaning that the number of additional 
children that need to be considered is 548. The total sample size for analyses using 
child based questionnaire data collected after age seven is therefore 15,224. Note 
that of the total sample of 15,224 foetuses 14,610 were live births and 14,535 were 
alive at 1 year.  
Standardised diagnostic measures. 
The diagnosis of mental disorders was assigned according to the administration and 
scoring of the Development and Wellbeing Assessment (DAWBA) administered to 
families at ages 7, 10, 13/14, and 17/18.  This is a valid and reliable measure of 
diagnostic status of mental disorders using ICD-10 and DSM-IV (Goodman, Ford, 
Richards, Gatward, Meltzer, 2000).  Respondents were the target child’s biological 
mother in over 97 % of cases, with fathers, step fathers, mother figures, and the child 
themselves completing in a small proportion of families.  Diagnostic status for the 
children at 17/18 years old was not yet calculated and so was not made available for 
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this thesis.  In the first instance the diagnostic status was calculated using the original 
method of clinicians’ rating symptoms, syndromes, and disorders.  Goodman et al 
(2010) then developed a computer algorithm in order to identify probabilities of 
caseness.  This algorithm was then applied to the DAWBA at all follow ups producing 
five levels of probability: <0.01; 0.05; 0.15; 0.50; >0.70.  A mental disorder is assigned 
at a value of 0.50 or >0.70.   
Ethical approval for the use of DAWBA data. 
ALSPAC has its own Law and Ethics Committee that reviews all proposals for new 
data collection and approves policies for data handling and analysis. Proposals for 
new data collection are also approved by the Local Research Ethics Committees 
(LRECs). Ethical approval for this study was, therefore, obtained from the ALSPAC 
Law and Ethics Committee.     
The Children in the Community (CiC) Study, New York. 
During the early and middle 70's, Drs. Leonard Kogan and Shirley Jenkins co-directed 
a national study in the United States designed to develop an indicator of the physical 
health and the social, emotional, and cognitive functioning of children in geographic 
areas based on local census and county-level indicators. The resulting index included 
Divorce rate, Infant mortality, percentage in Poverty, Out-of-wedlock births, and rate of 
Venereal disease and was labeled Disorganized Poverty or DIPOV (employing the 
initials of the indicators). The DIPOV indices for the 62 counties of New York state in 
1970, 1971, and 1972 were examined and two counties were selected for study: 
omitting the New York City area as too unique to be representative of the USA, 
Albany County was identified on the DIPOV scale as one of the counties with the 
highest DIPOV index and adjacent Saratoga county as one of the lowest. Census 
tracts or block groups were selected with a range of DIPOV scores roughly 
representing the US as a whole in rural, small town, suburban, city, and central city 
sites.  In each area a target child was randomly selected for inclusion in each 
household with one or more children between the ages of 1 and 10. Mothers or 
mother-substitutes were interviewed with regard to the family and environment as a 
whole and in depth with regard to the randomly sampled child.  About 85% of qualified 
households completed interviews.  This constitutes the “baseline” of the New York 
study. 
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The Children in the Community study has collected data on about 800 families since 
1975. Over 225 articles and two books have explored wide-spread issues regarding 
mental health and mental disorders. Grant support has come from three institutes of 
the National Institutes of Health (NIMH, NICHD, NIDA), the National Institute of 
Justice, and the William T. Grant Foundation. 
 
This entire sample includes subjects who were born from late 1964 to early 1975. 
Major waves of data collection have been carried out at mean ages 5, 14, 16, 22, 33 
and 38.  The data that were released for inclusion in the current study were selected 
by Professor Cohen in order to address the research questions regarding onset, 
stability, course and outcome of child and adolescent anxiety disorders.  Only 
diagnostic data for social anxiety and overanxious disorder (later generalised anxiety 
disorder) were released and the data were provided for three follow ups where the 
mean age of the original sample were 14, 16, and 22 years.  The sample used for the 
new analysis included only those who were under 14 at baseline so the sample is 
significantly reduced (N= 436) and the groups are defined as childhood/early 
adolescence (< 14 years), later adolescence (< 17 years), and adulthood (over 18 
years). 
Analysis and synthesis of data. 
With the data that were made available the analysis plan was significantly reduced as 
not all of the planned analysis aims could be met using the small number of studies 
available for inclusion.  Amalgamation of the data sets to conduct a meta-analysis was 
not possible.  
ALSPAC 
The ALSPAC data offer a unique opportunity to examine age at onset in a young 
sample of children in the UK and to plot the prevalence and age at onset in an 
extremely large birth cohort and examine continuity of anxiety disorders in this age 
range. 
 
A large amount of data were released, including demographics, questionnaire 
measures (who completed the questionnaire; when, etc) and scores for each 
individual item on the DAWBA for all anxious and depressive disorders.  The first task 
was to analyse the missing data; to determine the demographic differences between 
families who had chosen to complete the DAWBA at baseline and those who had not.  
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This was done using the SPSS file to create contingency tables and calculate Odds 
Ratios and Effect Sizes.  The missing cases were coded separately for each follow up 
to allow analysis of drop out through the course of the study. 
 
Prevalence of anxiety at age 7, 10 and 13 were then calculated using SPSS 
descriptive statistics.  New cases of onset were determined using contingency tables 
to determine the proportion of the sample at each follow up who had received a 
diagnosis who had not met criteria at an earlier follow up (new onset).  These 
proportions were recorded for each anxiety disorder at each stage of follow up.  
Figure 2 demonstrates how these contingency tables were calculated and presented. 
 
 
 
Time 1 
 
 
 
The proportion of those who had met criteria for an anxiety disorder and continued to 
do so at the next follow up (stability) was also calculated for anxiety disorders as a 
whole but not for each anxiety disorder as confidence intervals showed an 
unacceptable degree of imprecision due to the extremely small numbers.  The 
proportion of stable disorders over the course of the study so far were also calculated 
as any person who was diagnosed with anxiety at two or more follow ups.   
 
No follow back analysis or Odds Ratios were calculated as age 13 to 14 is still 
considered to be early in development and so not represent a good measure of 
“outcome” or address the research questions proposed. 
New York. 
The data received from the New York sample was in a form that meant very little 
analysis was required or indeed possible.  Professor Cohen had used my analysis 
plan to allow her to undertake all the data cleaning.  She had, therefore, extracted the 
data that were both appropriate and necessary to determine proportions of onset, 
stability and outcome in children who were under 14 at baseline.  Unfortunately these 
data were only provided for social anxiety, overanxious disorder at baseline and 
generalised anxiety in the follow ups, and depressive disorders.  The other anxiety 
disorders had inconsistencies in coding and diagnostic categories that Professor 
                              Time 2 
 Yes No 
Yes Stable Disorder Remitted Disorder 
No New onset  Never anxious. 
Figure 2. Demonstration contingency table. 
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Cohen felt would render them unreliable in this analysis.  Data was presented in 
contingency tables. 
 
Prevalence of each disorder was calculated as the proportion of the sample meeting 
criteria for each disorder in early adolescence, later adolescence and adulthood.  No 
prevalence for “any anxiety disorder” could be calculated but for social anxiety and 
generalised anxiety.  Then we calculated the proportion of cases that were considered 
“new”; i.e. the young person had not met criteria at any of the previous waves of data 
collection for both social anxiety and overanxious/generalised anxiety disorder; those 
who had met criteria for overanxious disorder at baseline were not considered to have 
a new case of generalised anxiety disorder if they were diagnosed at follow up.  The 
proportion of cases of social anxiety and overanxious disorder that continued to meet 
criteria was also calculated (stable disorders) at first and second follow up.  It was not 
possible to produce estimates for all of those who had met criteria at two or more 
follow ups from the contingency tables.  However, follow back analyses were used, 
calculating the proportion of adults who had received a diagnosis at either of the 
earlier waves of data collection.    
Synthesis. 
As there was not sufficient data available to perform the planned meta-analysis, the 
synthesis relied upon the comparisons of proportions, and the use of graphical 
displays to examine patterns in the data that suggest robust findings, contradictions, 
and methodological problems in drawing conclusions regarding the epidemiology of 
anxiety disorders.   
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Chapter Four: Results. 
Analysis of New Data. 
The analysis of the ALSPAC data from the UK will be discussed first as it is a larger 
data set, which has allowed the current study to conduct more novel analysis.  This 
will be followed by the presentation of the data released from the Children in the 
Community study carried out in New York.  These data refer to overanxious/ 
generalised anxiety disorder and social anxiety only. 
ALSPAC 
The data had been coded by the ALSPAC team into diagnostic categories using the 
algorithms outlined in Goodman et al. (2010).  PASW 15 (SPSS) was used to analyse 
the diagnostic data and Confidence Interval Analysis (Altman, 2005) was used to 
calculate confidence intervals.  The demographics, raw item data, and probability 
ratings generated by the computer algorithms were sent to the author in an SPSS file.  
The initial data set that was received contained diagnostic status at age seven 
determined using clinician ratings; the second database included diagnostics 
computed solely by the algorithms and also included diagnostic status at age 10 and 
age 13/14.  The latter was therefore used for the analyses.  Table 10, however, 
contains comparisons of the two prevalence estimates, determined either by clinician 
ratings or the computer algorithm at age seven to understand the effects of employing 
such a method to calculate diagnostic status. 
 
Table 10 shows that the prevalence of any anxiety disorder appears higher when the 
clinician rating is applied rather than the DAWBA algorithm.  Children are nearly twice 
as likely to be diagnosed with any anxiety disorder when they are assessed by a 
clinician rather than when applying the DAWBA algorithm (OR = 1.8).  With individual 
disorders the differences appear smaller and suggest that this differential might be 
due to the inclusion of “anxiety not otherwise specified” in the original analysis of the 
DAWBA data (NB this diagnosis is not computed using the algorithm.)  For some 
individual disorders, however, such as generalised anxiety disorder, a larger effect is 
demonstrated (OR = 2.4) with clinician ratings meaning a diagnosis  is two to three 
times as likely as when using the algorithm.  The method of rating had no effect on the 
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diagnosis of separation anxiety suggesting that some anxiety diagnoses are less likely 
using the DAWBA algorithm while others are more robust to the application of 
different criteria.  It seems fair to conclude that this computerised method, despite 
offering advantages in terms of time and cost efficiency, may lead to conservative 
estimates of anxiety in young children.  Unfortunately the data were not available to 
determine whether this discrepancy remains true as the sample become older.  
 
Table 10. Prevalence of anxiety disorders determined by clinician rating or computer 
algorithm. 
 DAWBA clinician 
% (95% CI) 
DAWBA algorithm 
% (95% CI) 
Any Anxiety Disorder 3.11% 
(2.8 - 3.5%) 
1.7% 
(1.5 - 2.0%) 
Generalised Anxiety Disorder  0.5% 
(0.4 - 0.7%) 
0.2% 
(0.1 - 0.3%) 
Obsessive Compulsive Disorder 0.1% 
(0.1 - 0.2%) 
0.01% 
(0- 0.1%) 
Separation Anxiety 0.8% 
(0.7-1.1%) 
0.8% 
(0.7 - 1.1%) 
Social anxiety 0.3% 
(0.2 - 0.4%) 
0.1% 
(0.1 - 0.2%) 
Specific Phobia 1.0% 
(0.9 - 1.3%) 
0.9% 
(0.7 - 1.1%) 
Anxiety Not Otherwise Specified  
(NOS) 
0.8% 
(0.6 - 1.0%) 
--- 
Missing Data. 
The ALSPAC birth cohort is extremely large (N = 15 211) and of those children 55% 
(N = 8252) completed the Development and Wellbeing Assessment (DAWBA), a 
standardised diagnostic assessment of mental disorders (Goodman et al. 2000) at 
aged seven.  At aged ten 51.4% (N=7820) completed the DAWBA, and at aged 13-14 
years 46.7% (N = 7102) completed the DAWBA.  In such a large cohort, determining 
whether there are important demographic differences between those who completed 
the baseline DAWBA at age seven and those who did not, is a difficult task - even 
small differences reach statistical significance.  I examined five variables: Mother’s 
age at birth; mothers educational qualifications; ethnicity; social class; parents’ marital 
status.  Effect Size (ES) was calculated for the continuous variable of mother’s age at 
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birth.  We calculated mean age at birth of those responding (M = 28.97) and of those 
not responding (M = 26.64) and used the pooled standard deviation (SD = 4.868) to 
calculate Effect Size (Cohen’s d = 0.48) which suggested a small effect, (Cohen,   
 
Table 11. Demographic differences in the DAWBA completers and non-completers 
Demographic Data Baseline 
DAWBA 
completed (N 
= 8252) 
Baseline 
DAWBA not 
completed (N 
= 6958) 
Chi Square. 
Mothers 
Highest 
Educational 
Qualification 
A levels or 
degree. 
N=3324  
40% 
N= 1086 
15.6% 
2 = 397.2; 
df = 2; N 
=12483;  
p<0.001 
 O levels, CSE’s 
or vocational 
qualifications 
N= 4661 
56.5% 
 
Missing = 
3.5% 
N= 3412 
49% 
 
Missing = 
35.4% 
 
 
Child Ethnicity White N= 7555 
92% 
 
N= 3976 
57.1% 
2 = 64.2; df 
= 1; N = 
12142; 
p<0.001 
 None White N = 301 
3.6% 
 
Missing = 
4.4% 
N= 310 
4.5% 
 
Missing = 
38.4% 
 
 
Social Class I, II, III (non 
manual) 
N = 5726 
69.4% 
N=2376 
34.1% 
 
2  = 161.1; 
df = 1; N = 
10111; 
P<0.001 
 III (manual), IV, 
V 
N= 1117 
13.5% 
 
Missing = 
7.1% 
N=892 
12.8% 
 
Missing = 
53.4% 
 
 
Marital Status Widowed, 
Divorced, 
Separated 
N= 396 
4.8% 
N=3593 
51.6% 
2 = 352.0; 
df = 2; 
N=13236; 
p<0.001 
 Married N= 6256 
75.8% 
 
N=415 
6% 
 
 
 Never Married N= 1134 
13.7% 
 
Missing = 
5.7% 
N= 1442 
20.7% 
 
Missing = 
21.7%  
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1992).  Mother’s age appears to have a “small” effect on families’ choice to take part 
in the diagnostic interview with those who were older more likely to take part Table 11 
reports Chi Square tests of association, which demonstrate significant relationships 
between the four demographic variables examined and completion of the DAWBA at 
baseline.  These data suggest that those who completed the DAWBA are mothers 
who are better educated, have higher social status, are more likely to be married, and 
are less likely to have non-white children.  The demographic data for the children who 
did not complete the DAWBA was also, as might be expected, more likely to be 
missing (see Table 11) ;for example only 47% of families who had not completed the 
DAWBA had data for social class recorded in comparison to 83% of respondents who 
completed the DAWBA.  It is, therefore difficult to draw firm conclusions regarding the 
comparisons of the two samples; however, the trend in the missing data clearly 
suggests that disadvantaged families are less likely to be represented in the sample 
that was assessed for mental disorders.   
Prevalence 
The prevalence of any anxiety disorder in the birth cohort at ages 7, 10 and 13/14 
years was calculated, looking at possible sex differences. 
 
Figure 3. Point Prevalence of any anxiety disorder in the ALSPAC study. 
 
Figure 3 shows the percentage of children meeting criteria for any anxiety disorder at 
ages 7, 10 and 13 years.  In the baseline sample (aged seven; N = 8252) 142 children 
met diagnostic criteria for any anxiety disorder; 1.7% (95% CI; 1.5 - 2.0%).   At age 10 
(N = 7820) three years later 166 children met diagnostic criteria for any anxiety 
disorder; 2.1% (95% CI; 1.8 - 2.5%).  This dropped at age 13/14 (N = 7102), 109 
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young people met diagnostic criteria for any anxiety disorder; 1.5% (95% CI; 1.3 - 
1.8%) 
 
When examining gender differences more males than females received a diagnosis of 
any anxiety disorder at age seven; 2% (N = 86) of males versus 1.4% (N = 56) of 
females (OR = 1.5; 95% CI; 1.1-2.0%); 2 (1, N = 8252) = 4.86 p = 0.03.  Gender 
differences in prevalence are no longer significant at ages 10 and 13 years; p = 0.88 
and p = 0.23 respectively.  As we are interested in the patterns of onset and course of 
anxiety in the sample, and the prevalence of diagnosable disorder are low the data 
will be analysed as a whole sample in order to increase precision of estimates.  
However this increased prevalence of anxiety disorders in young boys will be 
discussed in relation to previous research in the Discussion (Chapter Five). 
 
Table 12. Point and cumulative prevalence (with 95% confidence intervals) for anxiety 
disorders in the ALSPAC cohort 
 GAD OCD Separation 
Anxiety 
Social 
anxiety 
Specific 
Phobia 
7 Years 
(N = 8252) 
0.2%  
 (0.1-0.3%) 
0.01% 
 (0-0.1%) 
0.8% 
 (0.7-1.1%) 
0.1%  
 (0.1-0.2%) 
0.9% 
 (0.7-1.1%) 
 
10 Years 
(N= 7820) 
 
0.4%  
(0.3-0.6%) 
 
0.1% 
(0.0-0.1%) 
 
1.1% 
(0.9-1.3%) 
 
0.3% 
(0.2 -0.5%) 
 
0.9% 
(0.7-1.1%) 
 
13 Years 
(N= 7102) 
 
0.4% 
(0.3-0.6%) 
 
 
0.1% 
(0.0-0.1%) 
 
0.6% 
(0.4-0.7%) 
 
0.5% 
(0.3-0.6%) 
 
0.5% 
(0.4-0.7%) 
Cumulative 
Prevalence 
0.8% 
(0.6-1%) 
0.4% 
(0.1-0.4%) 
2% 
(1.7-2.4%) 
0.7% 
(0.5-0.9%) 
2% 
(1.7-2.4%) 
 
The prevalence data in Figure 3 and Table 12 demonstrate that the proportion of 
children currently meeting DAWBA diagnostic criteria for any anxiety disorder is 
highest at 10 years old in this sample, largely due to the number of children meeting 
criteria for specific phobia and separation anxiety at this age.  The prevalence of 
social anxiety steadily increases through childhood to 0.5% in early adolescence.  
Generalised anxiety disorder and obsessive compulsive disorder are relatively rare 
with generalised anxiety slowly increasing.  Specific phobia remains constant between 
7 and 10 years but nearly halves between 10 and 13 suggesting remission and 
reduced incidence of specific phobias in early adolescence.  This finding is supported 
by the first onset data shown in Figure 4.  Although the proportions of anxiety disorder 
are relatively low the confidence intervals demonstrate precise estimates in this 
sample.  
  
74 
 
Onset. 
Onset data were calculated using contingency tables to determine the number of 
children receiving their first diagnosis of an anxiety disorders at age 7, 10 and 13/14 
years.  Onset or first incidence refers to the number of children who currently meet 
diagnostic criteria who have not previously received a diagnosis.  The proportions of 
new cases at each age are displayed in Figure 4. 
 
Despite the small numbers of children meeting diagnostic criteria prospective data 
clearly show specific patterns in the onset of anxiety disorders emerging as childhood 
moves into adolescence (see Figure 4 and Table 13).  New onset of any anxiety 
disorder decreases steadily through late childhood into early adolescence largely due 
to the decline in incidence of separation anxiety and specific phobia.  This finding 
supports the contention that the peak onset for both separation anxiety and specific 
phobia is in middle childhood.  Social anxiety and obsessive compulsive disorder on 
the other hand shows increasing numbers of new cases into later childhood and 
adolescence; this pattern is similar for GAD with incidence increasing between seven 
and 10.   
 
Figure 4. First onset of anxiety disorders at ages 7, 10 and 13-14 years in the 
ALSPAC cohort. 
 
Chi Square test of Linear by Linear association was used to determine whether these 
trends were statistically significant.  The decrease in any anxiety disorder was shown 
to be significant 2 (1, N= 6315) = 8.26 p = 0.004.   The decrease in onset of 
separation anxiety was also found to be significant 2 (1, N=6315) = 19.28 p =0.001 
as was the case for specific phobia 2 (1, N = 6315) = 11.96 p = 0.001.  The 
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increasing incidence of social anxiety in this period is also significant 2 (1, N = 6315) 
= 7.4 p = 0.007 as was the increase in generalised anxiety disorder 2 (1, N = 6315) = 
4.4 p = 0.036.  The slight increase in obsessive compulsive disorder did not reach 
statistical significance (p = 0.17).   
 
Table 13. New onset of anxiety: percentage of the sample with a new incidence of 
anxiety disorders (95% Confidence Intervals) 
 Any 
Anxiety 
Disorder 
Generalised 
Anxiety 
Disorder 
Obsessive 
Compulsive 
Disorder. 
Separation 
Anxiety 
Social 
Phobia 
Specific 
Phobia 
7 
Years 
(N= 
8252) 
1.7% 
(1.1-2.0%) 
0.2%  
(0.1-0.3%) 
0.01% 
(0- 0.1%) 
0.8% 
 (0.7-1.1%) 
0.1%  
(0.1-0.2%) 
0.9% 
(0.7-0.1%) 
10 
Years 
(N= 
6679) 
1.6% 
(1.3-1.9%) 
0.4% 
(0.2-0.5%) 
0.1% 
(0. - 0.1%) 
0.8% 
(0.6-1.1%) 
0.3% 
(0.2-0.4%) 
0.7% 
(0.5-0.9%) 
13 
Years 
(N= 
6315) 
1.2% 
(0.9-1.4%) 
0.4% 
(0.3-0.6%) 
 
0.1% 
(0-0.2%) 
0.4% 
(0.2-0.5%) 
0.4% 
(0.3-0.6%) 
0.4% 
(0.3-0.6%) 
 
Table 13 reports the proportion of new cases of each disorder.  Confidence intervals 
demonstrate these estimates to be precise.  In order to be able to compare the 
ALSPAC data with those reported by other cohort studies we also calculated the 
cumulative incidence of anxiety disorders.  The results can be found in Table 12 and 
are displayed in Figure 5. 
Figure 5. Cumulative incidence of anxiety disorders in the ALSPAC study 
 
Cumulative incidence represents the total number of young people who have met the 
diagnostic criteria for an anxiety disorder over the course of the study.  We can see 
0.00%
0.50%
1.00%
1.50%
2.00%
2.50%
3.00%
3.50%
4.00%
4.50%
5.00%
7 Years 10 Years 13/14 Years
AAD
GAD
OCD
Separation Anxiety
Social Phobia
Specific Phobia
  
76 
 
that nearly one in 20 thirteen year olds have met criteria for an anxiety disorder at one 
of the three points of data collection (4.7%; 95% CI 4.2-5.2%).  As would be expected 
from the onset data we can see that separation and specific phobia flatten off and 
social anxiety steadily increases.   Obsessive compulsive disorder and generalised 
anxiety disorder are rare and show small increases. 
Course: Stability and Remission of Anxiety Disorders. 
When examining the course and outcome of anxiety disorders it was evident that a 
significant number of children who had been diagnosed with anxiety disorders were 
missing from follow up.  It was difficult to make sense of this drop out as the sample 
configures slightly differently at each follow up and the number of those completing at 
all three follow ups is relatively low (N = 5614)  Figure 6 demonstrates the rates of 
attrition in children diagnosed with an anxiety disorder in comparison to  those who did 
not receive a diagnosis.  The figure sets out the drop outs as a percentage across the 
three study stages and shows that across the follow ups children previously 
diagnosed with an anxiety disorder appear to be somewhat more likely to drop out 
over the course of the study.  A Chi Square test was used to explore this difference; 
drop out between age seven and age 13 to 14 years was significantly more likely in 
those previously diagnosed with an anxiety disorder than those who had not received 
a diagnosis; 2  (1, N= 6070) = 8.2 p = 0.004.   
 
Figure 6. Comparing attrition of children previously diagnosed with anxiety disorders 
and attrition for those without. 
 
A stratified analysis using Mantel-Haenszel correction was used to examine the 
effects of confounding demographics on the drop out of anxious children. Maternal 
social class and maternal educational qualification were initially chosen as potential 
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confounds as they have previously been shown to predict completion of the DAWBA 
at baseline and these data were collected for the majority of completers at baseline.   
Stratified analysis has been described as “the primary tool (or, more accurately, 
should be the primary tool) for evaluating and controlling confounding…”  (pg 73, 
Rothman, 1971).   
 
Table 14. Completion of the DAWBA according to diagnostic status of anxiety at aged 
seven adjusted for maternal highest qualification 
 Completed 
DAWBA 
 
Dropped 
Out 
Total Proportion  
completing (%) 
Odds Ratio 
Total 6070 2182 8252 73.6%  
      
Non-
Anxious 
 
5981 2218 8199 73.0% OR = 1.6 (1.1-2.6) 
Anxious 
 
89 53 142 62.7%  
Highest Ed Q 
 
Non-
Anxious 
 
2505 616 3121 80.3% OR = 1.2 (0.7-2.2) 
Anxious 
 
47 14 51 72.5%  
Lowest Ed Q 
 
Non-
Anxious 
 
2931 1394 4325 67.8% OR = 1.8 (1.1-2.8) 
Anxious 40 34 74 54.1%  
     
 
Mantel-Haenszel 
adjusted OR = 
1.6 (1.1-2.2) 
 
When comparing non-completion of the DAWBA amongst anxious and non-anxious 
seven-year-olds we calculated that anxious children are more likely to fail to complete 
the DAWBA at age 13 (OR= 1.7; 95% CI 1.5-2.2).  When comparing families reporting 
themselves to be in the three lowest bands of social class to those in the three 
highest, the likelihood of non-completion of the DAWBA is slightly lower; (OR= 1.4; 
95% CI 1.2-1.7).  However, mothers with O level or vocational qualifications were 
shown to be at three times the odds of not completing the DAWBA at age 13 (OR = 
3.0, 95% CI 2.6-3.4) when compared to mothers with A levels or Degree level 
qualifications.  A stratified analysis compares the drop out of anxious and non-anxious 
children stratified by a third, possibly confounding variable.  In this analysis we used 
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maternal highest educational qualification as this factor has been shown to be 
associated with drop out.  Table 14 demonstrates that, when the data are stratified 
according to mother’s highest educational qualification, the relationship between 
anxiety status and drop out appears stronger for those whose mothers have the 
lowest educational qualifications (OR=1.8) rather than higher educational qualification 
(OR=1.2).  The pooled Odds Ratios with Mantel-Haenszel adjustment, however, 
showed that the effect of anxiety on DAWBA completion remains (OR = 1.6; 95% CI 
1.1-2.2).  Those children with anxiety at aged seven are less likely to complete the 
DAWBA at age 13 regardless of this confounding social factor. 
 
The finding that more children previously diagnosed with anxiety do not complete  the 
subsequent DAWBA might lead to the estimates of stability being conservative; 
however, these estimates were calculated for any anxiety disorder and are presented 
below. 
 
Of those children who took part in further diagnostic interviews, 21.1% (N = 30; CI 
95%; 15.2-28.6%) of the 142 children diagnosed with anxiety at age seven were also 
found to be currently anxious at age 10, and 8.5% (N = 12; CI 95%: 4.9 - 14.2%) of 
anxious seven year olds continue to meet criteria at age 13.  Stability appears to be 
further reduced between 10 and 13 years, with over 85% achieving remission (N = 22; 
13.3%; CI 95%: 8.9-19.3%).  When we look across the whole period only 3.5% (N = 5; 
CI 95% 1.5 - 8%) of anxious children received a diagnosis of a current anxiety 
disorder at age 7, 10, and 13; this is only 0.1% of the sample who completed the 
DAWBA at all three follow ups (N= 5614). 
Outcome. 
As the data we have access to only allow us to calculate disorders until the age of 14 
the outcome for this cohort cannot be explored further than the data presented above 
for the continuity and new onset of disorders in early adolescence.  It is clear that the 
majority of children diagnosed with a current anxiety disorder do not currently meet 
diagnostic criteria at three year follow up.  A significant minority, however, 
(approximately 20% of ten year olds and 10% of 13 year olds) continue to meet 
diagnostic criteria following an earlier diagnosis. 
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The New York “Children in the Community” study. 
The New York study began in the 1970’s and the whole cohort was aged 9-18 years 
at baseline.  The following data were released for the sample of children who were 9-
14 at baseline in order to carry out analysis on first incidence, continuity, and 
outcome. 
Prevalence 
Twelve month prevalence data across the age groups and follow ups for the New 
York sample are published and were included in the original review (Gallagher, 2008) 
so will not be presented here.  Prevalence in the younger sample that were released 
for the current project are presented in Figure 7 and were calculated for each age 
group by combining the number suffering from each disorder at each follow up, in the 
method used by the New York researchers in the original analysis. 
 
Figure 7. Prevalence of overanxious disorder and separation anxiety in early 
adolescence, later adolescence and adulthood in the New York study 
 
Any anxiety disorder was not calculated for this sample due to the limited data.  Data 
were released, however, for overanxious disorder/generalised anxiety disorder and 
social anxiety.  The DSM-III which included overanxious disorder was used at 
baseline (< 14 years) and first follow up (<17 years) and then replaced with 
generalised anxiety disorder in adulthood with the advent of DSM-IV.  The data 
demonstrate a reduction in the proportion of adolescents meeting criteria for 
overanxious disorder in later adolescence and an even greater reduction in the 
proportion of adults meeting criteria for generalised anxiety disorder.  It is unclear if 
this is due to a decrease in such symptoms (namely worry) as the sample reach 
adulthood, or if the decrease is due to the new diagnostic criteria assessing a different 
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constellation of symptoms.   The prevalence of social anxiety increases from early to 
later adolescence and then decreases (to below the prevalence in early adolescence) 
as the sample reach adulthood.   
Onset. 
The proportion of the sample with new onset of both overanxious disorder and social 
anxiety were calculated at all three follow ups.  Overanxious disorder shows a marked 
decrease in new onset between early and late adolescence suggesting a remission of 
the disorder and decreasing rates of new onset, adult onset of generalised anxiety 
appears consistent with onset of overanxious disorder in late adolescence.  Figure 8 
shows that despite the increasing prevalence of social anxiety in adolescence (see 
Figure 7) new cases are decreasing, suggesting that onset of social anxiety is not 
common in adulthood in this sample.  Chi square tests of Linear by Linear Association 
showed these trends to be significant for both overanxious disorder 2 (1, N=400) = 
53.8 p < 0.001 and social anxiety 2 (1, N = 300) = 5.2 p = 0.02 
 
Figure 8. New onset of overanxious disorder and social anxiety in adolescence and 
adulthood in the New York study. 
 
In line with the data presented above, which suggests that overanxious disorder has 
decreasing prevalence and onset as the young person gets older, the cumulative 
incidence is fairly flat (see Figure 9).  Social anxiety disorder demonstrates a more 
steady increase in cumulative incidence through adolescence and adulthood; 
however, there is a slight flattening as fewer new cases are diagnosed in later life and 
cases from later adolescence remit.   
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Figure 9. Cumulative incidence of overanxious/generalised anxiety disorder and social 
anxiety in the New York study. 
Course: Stability and remission of social anxiety and overanxious disorder. 
Only disorder specific homotypic continuity can be examined using the data made 
available for the current project.  The diagnostic data show social anxiety to be 
moderately stable from early to late adolescence, becoming increasingly stable into 
adulthood; 45% (95% CI: 21.3 – 72.4%) of those with social anxiety in early 
adolescence still meet criteria for social anxiety in late adolescence and this stability 
decreases in adulthood with 19.2% (95% CI: 8.5 – 37.9%) of those first diagnosed in 
early adolescence receiving an adult diagnosis.  Stability from late adolescence to 
adulthood is slightly lower at 17% (95% CI 8.9 – 30.1%), but confidence intervals 
show this estimate to be more precise.  
 
The stability of overanxious disorder shows a different picture.  Although 33% (95% 
CI: 16.3 – 56.3%) of those diagnosed with overanxious disorder meet criteria for the 
same disorder as older adolescents, this falls to 11% (95% CI: 3.1 - 32.8%) who meet 
criteria for generalised anxiety disorder in adulthood.  Of those diagnosed with 
overanxious disorder in later adolescence only 6.5% (95% CI: 1.8-20.7%) continue to 
meet criteria in adulthood.  The large confidence intervals’ suggest these estimates 
are only moderately precise.  
Outcome. 
Pine and colleagues (1998) examined stability and outcome of anxiety disorders in the 
New York sample, looking at the risk conferred in adulthood from childhood and 
adolescent disorders; this is discussed in the synthesis section which follows in this 
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chapter.  There is, therefore, relatively little novel analysis that might add to these 
findings.  However, in order to synthesise effectively and make direct comparisons 
with the Dunedin study it was thought to be useful to carry out “follow back analysis” 
with the data released for the current project.  Of the adults (aged 18+) meeting 
criteria for generalised anxiety disorder, 40% (95% CI 19.8-64.3%) had received a 
prior diagnosis of overanxious disorder in early adolescence (<14 years) and 14.3% 
(95% CI 4.0-39.9%) of adults had received a diagnosis of overanxious disorder in late 
adolescence (<17).  Follow back analysis of social anxiety shows that 27.8% (95% CI 
12.5-50.9%) of adults receiving a diagnosis of social anxiety had previously received a 
diagnosis in early adolescence, and 34.8% (95% CI 18.8-55.1%) had received a 
diagnosis of social anxiety in late adolescence.  Estimates of the number of adults 
with their “first” diagnoses in late adolescence will be confounded by those who also 
suffered in early adolescence, as continuity was moderate for these disorders and 
there was a lack of raw data to calculate overlap so these estimates may be 
somewhat inflated whenf added together.   
 
Appendix Three visually represents the overlap between the populations of anxious 
under fourteens, under seventeen’s and adults to allow a clearer understanding of the 
analysis and missing data for both overanxious and social anxiety disorder. 
Synthesis of Data: Understanding the contribution to the wider picture. 
It remains extremely difficult to synthesise data due to methodological differences 
between the prospective longitudinal studies that have collected standardised 
diagnostic data on anxiety disorders.  The original requests for raw data were to 
enable the synthesis of onset, course and outcome data for different age groups in a 
meaningful way. The data that were requested in order for these analyses were, 
unfortunately, not obtained.  The novel data analysed above and the relevant 
published data cover a range of ages with modest overlap and begin relatively late in 
development, Figure 10 demonstrates the relatively small degree of overlap and the 
late starting age for most longitudinal studies.  The novel data and the currently 
published data allow comparisons only for limited age ranges and for a small number 
of studies.  Only New York and Dunedin follow from childhood to adulthood, the 
ALSPAC and Great Smoky Mountains Study begin in childhood but do not yet provide 
data into adulthood, and the majority of studies begin in adolescence and allow only a  
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Figure 10. Age ranges of longitudinal prospective studies (reproduced from Chapter 
Three) 
 
short period of follow up.  However, it has been possible to compare patterns in the 
data using graphical displays.  
Prevalence. 
Figure 11 plots the reported prevalence of any anxiety disorder in a number of studies 
where data were available for comparison.  Due to a range of methodological 
differences and temporal or cultural differences comparisons must be made with 
some caution.   
 
The Bremen data were not included as they report only lifetime prevalence and New 
York could not be included as no prevalence can be calculated for any anxiety 
disorder.  Figure 11 shows clear discrepancy in both the magnitude of the prevalence 
and the changing patterns over time.  In the Dunedin data anxiety disorders increase 
in prevalence throughout childhood and into adolescence where other studies  
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Figure 11. Prevalence of anxiety disorders in longitudinal prospective studies. 
 
demonstrate a fluctuating pattern, as can be seen in the ALSPAC and Great Smoky 
Mountains data. Alternatively, there is also a fall in prevalence demonstrated by the 
Taiwan panel study.  It was proposed that the large differences between the findings 
of the studies demonstrated in Figure 11 may be attributable to the core period of 
assessment that is used in the diagnostic interview and so comparisons across the 
same age groups using different prevalence criteria are presented in Figure 12.  The 
comparisons demonstrate that studies which require symptoms to have been present 
in the last twelve months have much higher rates than those that require symptoms to 
be present only in the last six months which are in turn greater than in the last three 
months or currently present (point prevalence).    
 
Figure 12. Prevalence of any anxiety disorder at 10-11 and 13-14 years using different 
prevalence criteria. 
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More similar rates are seen when we compare the ALSPAC data with studies that 
require symptoms to be present in the last three months.  Figure 13 compares the 
Great Smoky Mountains Study in the USA with the ALSPAC data.   
 
Figure 13. Great Smoky Mountains Study (three months) and ALSPAC (point) 
prevalence data. 
 
Cumulative (lifetime) prevalence of anxiety disorders in late adolescence has 
previously been calculated by both the Oregon Adolescent Depression Project (8.8%; 
14-18 years) and Great Smoky Mountains Study (9.9%; 16 years).  These data were 
calculated from 12 month and three month prevalence data respectively and exactly 
how these data are calculated is unclear.  It must, therefore, be assumed from the 
study design that they are taken from lifetime prevalence estimates at interview.  They 
are higher than that calculated above using the ALSPAC cohort at aged 13 to 14 
years (4.7%)  This would, however, be expected in a younger sample and is also 
likely to be affected by the use of the point prevalence criterion.   
Onset 
No other studies have reported new incidence in children across more than one follow 
up.  The ALSPAC data demonstrates decreasing onset of anxiety disorders in 7 to 13 
year olds, with increasing proportions of new cases of generalised and social anxiety 
but progressively fewer new cases of separation anxiety and specific phobias.  The 
New York data show the peak onset of overanxious disorder to be before the age of 
14 and suggest significant onset of social anxiety before the age of 18, with relatively 
few cases of adult onset in either disorder.  Figure 14 compares the proportion of new 
cases of anxiety identified for each study, plotted against the period of follow up 
(represented by the age of sample) The seemingly conservative rates of onset over 
12 months reported by Lewinsohn et al (1993) in the Oregon study (0.6% in 14-18 
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year olds) affects the patterns considerably.  If it were taken in isolation (without 
looking at the Dresden or Bremen data) the Oregon data would suggest that new 
onset progressively reduces in later adolescence.  This finding is supported by the 
TH2K data which report an overall incidence for 11-16 year olds of 3% (Roberts et al. 
2009).  They then break this down by age; incidence increases from 2.6% to 3.6% 
between 11 and 14 year and then drops to 2.2% in 15 to16 year olds, suggesting 
peak incidence at around 14 years and that incidence begins to decrease in later 
adolescence.  However, there is a much higher proportion of onset reported in the 
Bremen and Dresden studies.  The Bremen study calculated an incidence rate of 
6.9% over a 15 month period in a sample of 12-18 year olds. The Dresden incidence 
data show similarly high figures of 8% over a 15 month period in 14-19 year olds. 
Incidence of social anxiety (2.1%) and specific phobias (5.7%) were particularly high; 
generalised anxiety shows incidence of only 0.1% in this population of adolescents. 
 
 
Figure 14. Proportion of young people with new incidence of anxiety disorders 
according to age range and length of follow up. 
 
Relatively high onset rates have been proposed by some authors to demonstrate the 
lack of stability in anxiety disorders in this age group.  If we use the Dresden data as 
an illustration, Wittchen et al (2000) report that over 15 months the overall prevalence 
of anxiety disorders drops and there are significant number of “new” cases (see 
Figure 15).  It has been postulated that anxiety disorders in younger samples may be 
less stable and we can see that the cumulative prevalence is only 0.6% less than 
adding point prevalence at all three follow ups together, so we examined the new 
ALSPAC data in this way.  Figures 16 and 17 demonstrate similar patterns to those in  
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Figure 15. Prevalence and incidence in the Dresden study at baseline (14-17 years) 
and first follow up (15-19 years). (Wittchen et al. 2000) 
 
Figure 16. Prevalence and incidence of anxiety disorders in the ALSPAC at age 7 and 
10 
  
Figure 17. Prevalence and incidence of anxiety disorders in the ALSPAC at ages 10 
and 13. 
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the adolescent Dresden data in the ALSPAC study in childhood and early 
adolescence.   
 
Figure 16 shows the prevalence and onset of anxiety at seven and ten years and 
Figure 17 shows the prevalence and onset between ten and thirteen years.  Both 
Figure 16 and Figure 17 show that new disorders make up a sizeable proportion of 
the disorders present, but there is evidence of increased stability as the child gets 
older with around half of the identified anxiety disorders being new cases and around 
a half stable, rather than two thirds or more being new disorders.  The data from all 
three figures taken together suggest that the onset of any anxiety disorder decreases 
through childhood and continues to decrease through adolescence with a possible 
spike in mid adolescence.  Separation anxiety has progressively fewer cases of new 
onset as the child gets older; social anxiety and generalised anxiety on the other hand 
have progressively more cases of new onset through childhood and into adolescence.      
Cumulative Incidence and patterns of onset. 
The Dresden study use cumulative incidence curves calculated using the Kaplan-
Meier survival method to demonstrate the patterns for new onset of cases in 
childhood, from the data that they have collected later in life.  Figure 18 uses data 
from Wittchen et al (2000) and Beesdo-Baum et al. (2009) and compares it with the 
cumulative incidence from the ALSPAC data.  The incidence of the Dresden data is of 
a greater magnitude (as they use 12 month prevalence and also a different method of 
calculating diagnostic criteria) and shows a clear pattern of flattening of new incidence 
at age 14 ; unfortunately the lack of data does not allow us to examine this truly 
prospectively in the ALSPAC data; predicted outcomes, however, using a log linear 
trend line show a less clear picture of flattening.  Cumulative incidence curves have 
not been produced for other studies with this data. We only have data for lifetime 
incidence calculated for later adolescence which may not be taken from prospective 
data and is reported at over 9% (Oregon and Bremen studies). 
 
When we look at the individual disorders that we have data for we can see that social 
anxiety has a cumulative prevalence that continues to increase into later adolescence.  
Although there is significant onset in childhood and early adolescence new cases are 
continuing to emerge later in life, supported by the adulthood incidence data in the 
New York data (see Figures 19 and 20).  Although the low prevalence of social 
anxiety in the ALSPAC study makes visual comparisons difficult Figure 19 
demonstrates the pattern of increasing onset of social anxiety through childhood into  
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Figure 18. Cumulative incidence/onset curves for anxiety disorders in the ALSPAC 
and Dresden studies. 
 
Figure 19. Cumulative Incidence/onset curves for social anxiety in the ALSPAC, 
Dresden, and New York studies. 
 
 
Figure 20. Cumulative Incidence (Onset curves) for overanxious/generalised anxiety 
disorder in the ALSPAC, Dresden and New York studies. 
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early adolescence.  Whereas Figure 20 shows that overanxious/generalised anxiety 
disorder has a lower cumulative incidence and a much more conservative increase 
with a flatter curve through later adolescence demonstrating a slowing of the number 
of new cases in this period. 
Stability of anxiety disorders in childhood and adolescence. 
The course and outcome of anxiety disorders over time is an area that has received 
far more attention in the existing literature.  The ALSPAC data, however, 
demonstrates the stability of anxiety disorders in a childhood sample, the course and  
outcome of anxiety in this younger age group is currently missing from the existing 
literature.  We can compare the stability of anxiety in this younger sample with the 
stability of internalising disorders in the BCAMHS sample. 
 
The  ALSPAC data demonstrate that approximately one in five children diagnosed 
with an anxiety disorder at age seven still meet criteria three years later at age 10 
(21.1%) and only 13% who were aged 10 at baseline meet criteria at age 13.  
BCAMHS used the DAWBA on a cohort of children who were aged five to seven 
years old at baseline and 26% continued to meet criteria for an emotional disorder 
three years later.  Mirroring the drop in the stability of anxiety in the ALSPAC data, 
only 12% of those who were 8-10 at baseline continued to meet criteria for an 
emotional disorder three years later; the stability rose sharply to 40% for children who 
were 11-13 years old at baseline; however there are no comparison group yet 
analysed for the ALSPAC cohort.  The BCAMHS data (like the TH2K study) are 
essentially splitting a sample by age rather than examining change over time as the 
ALSPAC data allows.  These data should be treated with appropriate caution but 
provide an interesting comparison, showing similar patterns of changing stability in 
childhood.   
Comparing stability of anxiety disorders in different samples.   
The stability of anxiety calculated from the ALSPAC data in early childhood contribute 
to a consistent picture of stability reported in prospective longitudinal studies, (see 
Table 15.)  These findings support the contention that around 20% of anxiety 
disorders are continuous across short periods of time, but that at least 30% of anxious 
children will suffer from anxiety again, over longer term follow up.  These findings 
appear to hold true regardless of the age group examined or the length of time 
between the diagnostic interviews. 
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Table 15. Stability of anxiety diagnoses 
 Study Follow up period Stable Disorders Method  
 
 ALSPAC 36 months 21.1% A 
 Bremen 15 months 22.6% A 
 Dresden 15-20 months 19.7% A 
     
 ALSPAC 6 years 36.6% B 
 Dresden 10 years 30% B 
 GSMS 8 years 28.6% B 
A = Stability between two points in time B = Anxiety present at two or more follow ups 
Stability of individual anxiety disorders – overanxious disorder. 
Due to the small numbers of children reaching diagnostic criteria, continuity of 
individual anxiety disorders were shown to have unacceptably large confidence 
intervals so are not reported for the ALSPAC sample.  The baseline and first follow up 
stability of overanxious disorder in the New York study was reported in Cohen et al. 
(1993) and were calculated for a sample of 250 9-18 year olds, with 22.8% of those 
with overanxious disorder continuing to meet criteria after 2.5 years (rising to 50% in 
those with “severe” overanxious disorder at both follow ups)  This finding for 
overanxious disorder presents more evidence to support the data in Table 15 that 
around 20% of disorders are stable in childhood and adolescence.  Odds Ratios were 
used to demonstrate the increase in risk of further overanxious disorder from a 
baseline diagnosis across the severity levels (mild overanxious disorder OR= 3.27, 
moderate overanxious disorder OR = 8.63, severe overanxious disorder OR = 17.25).   
 
The analysis of overanxious disorder in the younger data set looked at the stability of 
overanxious disorder in those who were under 14 at baseline and then in adolescence 
and early adulthood.  Moderate stability was shown from early to late adolescence 
(33% continue to meet diagnostic criteria from baseline, aged under 14 years and first 
follow up, aged under 17 years), suggesting that continuity is higher in a younger 
sample with the same follow up period; stability drops to only 11% of those diagnosed 
with overanxious disorder before the age of 14 meeting criteria for generalised anxiety 
in adulthood.  This could, however, be due to the changing diagnostic criteria in 
adulthood from overanxious to generalised anxiety disorder, and the overanxious 
symptoms may still be present but at a sub-threshold level for a generalised anxiety 
diagnosis.  This pattern of stability for overanxious disorder in adolescence is similar 
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to the findings reported in the Great Smoky Mountains Study (9-16 year olds) where 
stability of overanxious disorder in adolescence was shown to be moderate; 28.6% of 
the sample received an overanxious disorder diagnosis at two or more follow ups 
(Bittner et al. 2007).  
Stability of individual anxiety disorders – social anxiety disorder. 
Using the analysis of the younger sample of the New York study presented above, 
adolescent social anxiety appears to be moderately stable over a three year period, 
with nearly half the cases assigned in early adolescence (45%) continuing to meet 
diagnostic criteria in later adolescence.  When we look at stability from early 
adolescence into adulthood (19%) and late adolescence to adulthood (17%) these 
findings look far more similar to those reported for the sample as a whole, where 
stability of social anxiety over a six and a half year follow up was reported at 20%, 
(Pine et al. 1998).  The new analysis found 19% of those receiving a diagnosis of 
social anxiety in childhood or early adolescence were diagnosed with social anxiety in 
adulthood.  This decreases from 45% of those diagnosed with social anxiety in early 
adolescence continuing to meet criteria later in adolescence.  In the GSMS study (9-
16 years study period) social anxiety was shown to be stable in 14.3% of cases.  This 
is comparable to the 20% reported for the whole New York sample but is somewhat 
lower than that reported in the novel analysis of the New York data (45%) which 
covers a more similar age range.  The Dresden ten year follow up data, however, 
report stable social anxiety disorder in 35% of their sample of 14-24 year olds over ten 
years Beesdo-Baum et al. (2009) and only 15.8% over the 15 month follow up, 
suggesting  short term transience but remaining at increased risk for later social 
anxiety.  The New York data reported here suggest that early onset social anxiety is 
moderately stable in adolescence, but this stability reduces in adulthood.  Despite this, 
over half of the adult sample had met diagnostic criteria for social anxiety in childhood 
or adolescence.  
Stability of individual anxiety disorders – simple phobia. 
Simple phobia was also examined in the Dresden study, and has been shown to be 
highly predictive of adult mental disorders with only 10% of those who had received a 
simple phobia diagnosis being without psychopathology in adulthood; 41% continued 
to meet criteria for simple phobia and 73% having an anxious or depressive disorder 
(Beesdo-Baum et al. 2009).  Homotypic stability over the 15 month follow up was 
lower at 30.1% (Wittchen et al. 2000)  Unfortunately this cannot be corroborated by 
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the New York data as simple phobia had a number of issues with the data and so 
could not be shared for this purpose. 
Outcome: Follow back analysis of adult data. 
Follow back analyses were carried out for the whole data set by Pine and colleagues 
(1998).  In this analysis the proportion of adults with anxiety disorders that had 
received a prior diagnosis of anxiety disorder was over 90% across the anxiety 
disorders and Newman and colleagues (1996) similarly report that 80.5% of 21 year 
olds in the Dunedin study had received a previous diagnosis in childhood or 
adolescence, and of those suffering with anxiety disorders at age twenty six 54.5% 
had received their first diagnosis before the age of fifteen (Kim-Cohen et al 2003).  
When looking at longer term adult follow up Gregory et al. (2007) employed follow 
back analysis on the Dunedin cohort at age 32 found that 30% of adults with anxiety 
disorders had met criteria for an anxiety disorder at ages 11 to 15.   
 
Looking at the follow back analysis of generalised anxiety in the younger sample from 
the New York study suggests that a more modest but substantial proportion of adults 
diagnosed with generalised anxiety disorder were previously diagnosed with 
overanxious disorder in childhood (40%) and a smaller proportion diagnosed later in 
adolescence (14.3%).  The Dunedin study reports that 66% of adults with generalised 
anxiety disorder had their first diagnosis in childhood or adolescence (Kim-Cohen et 
al. 2003.   
 
Of adults with social anxiety disorder around a third received their first diagnosis in 
childhood or early adolescence (27.8%) and slightly more received their first diagnosis 
in later adolescence (34.8%).  Kim-Cohen et al (2003) report from the Dunedin data 
that 50% of 26 year olds received their first diagnosis of social anxiety between 11 
and 15.   
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Chapter Five: Discussion. 
Overview. 
This chapter will outline the findings of the novel analysis undertaken in this thesis and 
how these findings integrate with the published longitudinal prospective data reviewed 
in the Introduction (Chapter One) and Updated Review (Chapter Two).  These 
findings will then be discussed in the context of the wider field and assertions made 
regarding the descriptive epidemiology of anxiety disorders using retrospective and 
cross-sectional research.  The implications of the project for developing research 
methods to improve the understanding of the descriptive epidemiology of anxiety 
disorders will then be discussed.  The clinical implications for intervention and 
prevention will be briefly discussed followed by limitations and ideas for future 
research. 
Summary of findings. 
Avon Longitudinal Study of Parents and Children (ALSPAC). 
The ALSPAC analysis adds significantly to our understanding of the onset and course 
of anxiety in younger children. Anxiety disorders are present in approximately two to 
three of every hundred children at any one time in middle childhood to early 
adolescence, and prevalence is highest at age ten.  New onset of anxiety disorders 
decreases over this period of development and most disorders remit; they are not 
present at three-year follow up.  However a small but significant proportion of anxious 
children (around 20%) continue to meet diagnostic criteria at three-year follow up and 
over a third of anxious children meet diagnostic criteria at two or more follow ups, 
suggesting that disorders may wax and wane over time.     
 
Significantly more boys than girls met criteria for an anxiety disorder at age seven but 
this gender difference was not found at age 10 or at 13/14.  Boys were at around 50% 
more risk of anxiety disorders than their female counterparts.  Increased prevalence of 
anxiety in boys in middle childhood has been reported previously using diagnostic 
interviews (Mesman & Koot, 2001).  In some publications anxiety is reported 
separately for boys and girls and almost always girls are reported to be at increased 
risk of anxiety diagnoses; Costello et al (in prep), however, in their meta-analysis were 
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not able to examine gender differences as not enough studies reported boys and girls 
separately.  Lewinsohn, Lewinsohn, Gotlib, Seeley, & Allen, (1998) examined possible 
confounds of gender differences, and found that anxiety remained more prevalent in 
females but the differences are small and rarely significant.  However this was in an 
adolescent sample.  The fact that adolescent and adult anxiety disorder is more 
prevalent in females may have an impact on perceptions of gender differences in 
younger populations, and this data supports the contention that this may be 
erroneous.  There is data emerging that suggests in younger children males may be 
at increased risk.  Examining gender differences in these populations, therefore, 
appears an area for further examination. 
    
Stability of anxiety disorders in this sample seems low with nearly 80% of anxious 
seven-year-olds free from their diagnosis by age ten.  However, when we use the 
Great Smoky Mountains method of examining “continuous” disorder (anyone who has 
met criteria at two or more follow ups) nearly 40% of anxious children have a “stable” 
disorder.  This suggests that anxiety disorders wax and wane to some extent over this 
period of development with chronic disorders not taking a linear course in some 
cases.  Using the computer algorithm was shown in the current study to produce 
conservative estimates in comparison to clinician diagnoses, and using “point” 
prevalence (symptoms must be currently present) also reduces the proportion of 
children who are assigned a diagnosis of anxiety disorder.  It is therefore unsurprising 
that the prevalence of anxiety reported for the ALSPAC cohort is low in comparison to 
other studies in samples of a similar age.  An important finding is that, of those who 
receive a diagnosis of anxiety disorder, the proportion who have a stable diagnosis 
both in shorter term follow up (around 20%) and over multiple follow ups (between 30 
and 40 %) are consistent with the proportions found in studies using less conservative 
methods - even those that have examined stability of anxiety in older children and 
adolescents. 
Missing Data. 
Examination of missing data in this sample, both for those who chose not to complete 
the DAWBA at baseline and for those who did not complete at all follow ups, 
demonstrates a pattern of attrition that must be considered when interpreting the 
findings.  In support of the findings of Wolke and colleagues (2010), in the ALSPAC 
sample in relation to risk factors for behavioural problems, non-completion of the 
DAWBA appears to be associated with economic and social disadvantage - a 
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population that would be expected to have a high prevalence of mental disorders 
when we look at the data for adults, (Jenkins et al. 1997; Murali & Oyebode, 2000; 
Pollitt, 2004).  Furthermore, families that completed the DAWBA at baseline whose 
child met criteria for an anxiety disorder were less likely to complete the DAWBA at 
later follow ups than those who did not.  Non-completion occurred more often in 
families who reported social disadvantage but, when this was taken into account, 
anxiety status was still associated with increased drop out.  These findings suggest 
that prevalence might be conservative estimates in this sample, particularly for the 
stability estimates, as we do not know the outcome for a substantial proportion of 
anxious children who were lost to follow up.   
Children in the Community – The New York Study. 
The data released to me from the New York study also provide new and interesting 
findings in relation to onset and stability of social and generalised anxiety in later 
childhood and adolescence.   
Social Anxiety 
The findings show that the prevalence of social anxiety peaks in later adolescence 
and decreases to below the prevalence reported in childhood or early adolescence 
once the sample reach adulthood.  This is somewhat surprising as social anxiety is 
often referred to as a disorder of later adolescence rather than childhood.  As would 
be expected from this pattern the onset of new cases also decreases once the 
individual reaches adulthood - suggesting peak onset in adolescence; the proportions 
of new cases are similar for the samples in early and later adolescence, so identifying 
exactly when a first diagnosis is most likely may not be possible.  This may well reflect 
an extended period of “peak” onset in later childhood and early adolescence.  
Unfortunately, the breakdown of the data according to smaller age groups as originally 
planned was not possible, precluding the examination of these patterns in more detail.   
 
The stability of social anxiety in adolescence over a three year follow up was shown to 
be moderate with 45% of those receiving a diagnosis before the age of 14 continuing 
to meet criteria three years later.  Over a six year follow up, around a fifth of those 
diagnosed in early adolescence met criteria again in adulthood (19.2%) and slightly 
less (17%) who were diagnosed later in adolescence continued to meet criteria in 
adulthood, suggesting that social anxiety has greater stability in early adolescence 
and then remits.  Follow back analyses suggest that of the sample with adult social 
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anxiety around a third of cases began in early adolescence and around a third in later 
adolescence.  The majority of adult cases appear, therefore, to have received their 
first diagnosis in childhood or adolescence.  This finding must be treated with caution 
as there was considerable overlap (45%) between the early and late adolescent cases 
so this estimate may be inflated.  
Overanxious Disorder. 
Overanxious disorder has its peak prevalence in childhood or early adolescence (<14 
years) with the onset of new cases being highest at this time and remaining low for 
late adolescence and adulthood.  The stability of overanxious disorder is greatest over 
the three year follow up between early and later adolescence with only one in ten 
early disorders resulting in adult generalised anxiety disorder.  Around a third of 
children and early adolescents (<14) continued to meet diagnostic criteria for 
overanxious disorder three years later in later adolescence (<17).  Continuity between 
late adolescence and adulthood was lower than that between early adolescence and 
adulthood (6.5%) suggesting that disorders with later onset are less stable or perhaps 
reflecting the difference between the populations diagnosed with overanxious 
disorders and generalised anxiety disorder.  Using follow back analyses around 40% 
of adults with generalised anxiety disorder had received a prior diagnosis of 
overanxious disorder in early adolescence and less than 15% had met criteria for 
overanxious disorder in later adolescence, again suggesting that a substantial 
proportion of adult disorders have early onset, but that conversely most adolescent 
disorders have a benign outcome, particularly in adolescence.  Since the advent of 
DSM IV (APA 2000) overanxious disorder is not currently in commonly use but Bittner 
et al (2007) argue that it is useful as a predictor of later psychopathology and its use 
should be reconsidered; however as we only examined its relationship with 
generalised anxiety disorder in this sample, these data only suggest that early onset 
of overanxious disorder is somewhat stable and has a weak relationship with later 
generalised anxiety disorder.  Its predictive value may be associated with anxiety (or 
depressive) disorders other than generalised anxiety disorder which could, 
unfortunately, not be examined using the current data.       
 
Prevalence of anxiety disorders in the New York sample is high and it is possible that 
the use of DSM-III and the overanxious disorder diagnosis contributes to these high 
estimates, as the prevalence of GAD appears consistently lower than overanxious 
disorder.  The New York study also asked about symptoms at any time in the last year 
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(twelve month prevalence data), which has also been shown to increase the 
estimates.   
 
The proportion of adult disorders first diagnosed in adolescence in the younger 
sample of the New York cohort is substantial (although not as high as those reported 
by Pine et al. (1998) in the full cohort).  The high prevalence recorded by the New 
York study over a large number of follow ups, however, leaves a large pool of young 
people reaching criteria for anxiety disorders; it is, therefore, important that follow 
back data are examined in the light of the stability and outcome of childhood 
disorders, to determine a true picture of the outcomes of early anxiety and the true 
costs of early onset.  (Appendix Three presents these combined data visually).  Two 
thirds of all adolescents diagnosed with overanxious disorder are diagnosis-free at 
three-year follow up.  This is a substantial proportion who still suffers the same 
diagnosis; however, nearly 90% of those children or young adolescents are free from 
a worry related diagnosis in adulthood.  Of those diagnosed with social anxiety in 
childhood and adolescence, social anxiety is estimated to be stable over three years 
in just under half of cases, and around 20% of cases from childhood are still present 
in adulthood.  Although it appears that most adult disorders have their onset earlier in 
life, due to the smaller proportions of adults receiving these diagnoses it appears 
crucial to the targeting of resources that those young people with stable and chronic 
anxiety disorders are identified if effective intervention and relapse prevention are to 
be offered. 
 
It was unfortunately not possible to determine differences in the attrition from the New 
York sample as the necessary demographic data were not released for analysis here.  
The New York sample is representative of New York State, from where it was taken.  
Previous publications, however, have alluded to the drop out of those with increased 
social disadvantage following baseline data collection and supplementation with a 
group of children meeting certain demographic criteria was undertaken to address this 
attrition (Cohen et al. 1993a).  No further detailed analysis of this drop out is to be 
found in the published literature.   
Synthesis 
Directly synthesising data, (combining the data sets) from different studies was not 
possible for a number of reasons that are discussed in the “Implications for 
methodology” section later in this chapter.  However, every effort was made to make 
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meaningful comparisons and determine common patterns and discrepancies between 
the new data and the existing prospective longitudinal studies. 
Prevalence criteria. 
When attempting the synthesis and comparisons of data from different studies it 
became clear that there is a robust effect of the amount of time preceding the 
interview that symptoms are required to have been present in order to contribute to a 
diagnosis.  This has been discussed briefly in reference to the discrepant magnitudes 
of prevalence reported here for the ALSPAC and New York data.  Some studies (e.g. 
Bremen study) have used a “lifetime” criterion when first asking young people or their 
parents about mental disorders “Have you ever experienced…” However it has been 
shown using the same samples that asking “Have you in the last twelve months 
experienced…” demonstrates twelve month and lifetime prevalence of mental 
disorders to be almost identical.  When attempting to make sense of this finding 
Costello et al (2004) suggest that there was either an epidemic of anxiety in the 12 
months preceding the interview or there are high rates of forgetting for disorders 
before this period.  When people are asked about the presence of symptoms or 
disorders in the last six months, prevalence reduces.  Prevalence reduces further 
using a three month criterion and even further when the disorder is required to be 
currently present.  
 
Costello and colleagues (2004) conclude in their review that prevalence of anxiety is 
robustly reported at 2-4% using three month or point prevalence and between 10 and 
20% using six or twelve month prevalence criterion.  The lack of difference between 
lifetime and 12 month prevalence is discussed by the authors with reference to high 
rates of forgetting for disorders occurring longer than twelve months ago; there is little 
discussion, however, of what this difference means in terms of low estimates using 
point prevalence.  If the lifetime prevalence reduction is due to “forgetting” is the 
increase in prevalence using twelve month criteria rather than shorter periods also 
due to misremembering?  It has already been shown that asking about symptoms 
from over three months ago has limited reliability (Angold et al. 1996).  It is possible, 
therefore, that some of the “diagnoses” may not have met diagnostic criteria had the 
parent or child been questioned about their symptoms closer to the time that they 
were experiencing them.  Twelve month prevalence might, therefore, include a 
number of subthreshold cases and reflect an over estimation of true “caseness”.  
Alternatively, this discrepancy (which appears to have a “dose-response” relationship; 
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see Figure 12, Chapter Four) may add weight to the argument that anxiety disorders 
in childhood and adolescence are usually transient disorders.  If a disorder is stable 
and symptoms occur continuously over a year or more, then we would expect limited 
differences between point and twelve month prevalence.   
 
As the effect of different prevalence criteria have been investigated within the same 
sample (e.g. the EDSP in Dresden, Wittchen et al. 2000) and robust prevalence has 
been reported for different anxiety disorders in samples that use the same prevalence 
criterion (Gallagher, 2008), we can conclude that these discrepant findings are not 
due to true differences in the prevalence of anxiety in the samples compared. 
Diagnostic interviews have a minimum duration as well as impairment criteria; for 
example generalised anxiety disorder symptoms must have been present for at least 
three months, specific phobias symptoms must have been present for at least six 
months.  Consequently, it is important to be clear that this assertion is not suggesting 
that these transient disorders are not significant, distressing, and associated with 
functional impairment for children.  However it does suggest that the twelve month 
prevalence data be treated with some caution, and adds weight to the contention that 
anxiety disorders are present in a large number of children, most of who will 
experience spontaneous remission relatively quickly and may not be at risk for future 
disorders.  
 
One of the main difficulties with this robust finding is that the use of differing 
prevalence criteria precluded the combination of data sets, as this difference is 
activated during the interview and unless multiple interviews are used then this data 
cannot be deconstructed.  Agreement on the prevalence criterion that allows sufficient 
reliability but also sufficient sample size is important in helping prospective studies to 
produce comparable data.  This would allow the amalgamation of data sets as 
originally proposed in this thesis; in these sets stringent prevalence criteria can be 
applied and the combination of large samples ensures that the anxious sample is 
large enough to carry out appropriate analysis.  
Onset data. 
The use of different prevalence criteria (twelve month versus three month versus point 
prevalence) contribute to difficulties in comparing prevalence, course, and outcome of 
anxiety disorders in different studies.  Patterns in onset can also be affected by these 
inconsistencies as studies may provide onset data based upon a new disorder in the 
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last twelve months (Dresden and New York) or since the last diagnostic interview 
(Oregon and Bremen studies) or alternatively stipulate that the disorder must be 
present at the time of interview (ALSPAC).  The biggest problems, however, are that, 
until the current study, only onset between two time periods has been reported, large 
age ranges have been explored as a single group, and there has been very little 
exploration of the changing patterns of onset for the different anxiety disorders.  It 
does not appear to be the case that the incidence is as clearly affected by the different 
criteria as prevalence has been shown to be.  Extremely low onset was reported in the 
Oregon study of 14 to 18 year olds and these researchers include all symptoms in the 
preceding 15 months - a similar time frame to Dresden and Bremen which also 
examined onset in adolescence over a period of 12-24 months but found 13 times the 
number of new cases.  The TH2K study in Holland on the other hand found more 
moderate onset in this period (under half of the Bremen and Dresden incidence) with 
a peak in mid adolescence. There are no clear answers for this discrepancy; however 
the diagnoses included in “any anxiety disorder” may have been instrumental in these 
differences.  Unfortunately this is not clear from the published data.  The Great Smoky 
Mountains study report age at onset for the sample at age 21 years and report very 
early onset for a number of anxiety disorders, with a median age at onset for any 
anxiety disorder of only seven years.  Specific phobia and separation anxiety have a 
median age at onset of six years, but also the median onset for social anxiety and 
generalised anxiety is only nine years old.  It is unfortunately unclear from what data 
these findings were calculated from as the study began collecting data when the 
children were nine years old; it does however, offer support for the picture of onset we 
see in the ALSPAC data in an adult sample.  The late starting age of most of the 
samples is a serious issue for determining age at onset from the prospective data.   
 
The existing onset data are unimpressive in describing onset in adolescence.  The 
new ALSPAC data confirm the cross-sectional findings regarding the onset of 
separation anxiety and specific phobia in early childhood and support the contention 
that these disorders have a short window of peak onset (particularly separation 
anxiety) whereas other disorders (such as generalised anxiety disorder) appear to 
have a much longer window, supporting the findings of Costello and colleagues (in 
prep) regarding the periods that might be considered “peak” onset.  The New York 
data suggest that adolescence may well be the key period of onset for social anxiety 
and that this is consistent from late childhood into adolescence, perhaps suggesting 
social anxiety also has a wide window of onset.   It is important to note that many of 
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the studies reviewed begin data collection late in the child’s development meaning 
that many apparently new cases may not represent the first time that the disorder has 
been present - missing “peak” onset for early disorders such as separation anxiety 
and specific phobias.  The patterns illuminated by the ALSPAC sample over three 
follow ups in childhood and early adolescence support the contention of peak onset of 
many anxiety disorders in childhood that was reported in the Great Smoky Mountains 
data.  
 
Cumulative incidence (onset curves) from survival analysis have been used in the 
Dresden publications; using this method to compare data from the ALSPAC, New 
York, and Dresden studies  shows clear patterns of onset in social and generalised 
anxiety despite differences in the magnitude of prevalence in the different studies.  
When excluding the New York data and looking at all anxiety disorders we can see 
that, after 14 years of age, onset appears to flatten significantly suggesting that 
childhood and early adolescence are the key developmental stages for the onset of 
anxiety.  When examining the New York data alongside the Dresden and ALSPAC 
findings social anxiety shows incidence continuing to increase into late adolescence 
whereas generalised anxiety flattens off.  These synthesised data support the 
contention that anxiety disorders have their peak onset in early life.  The data 
regarding course, stability and outcome, however, suggests that as these numbers fall 
the majority of these disorders will remit.  
Course and stability. 
Exploring the course and stability of anxiety disorders as a group of disorders offers a 
clear and consistent picture across different samples and age ranges.  When we use 
the Dresden data in adolescence and the ALSPAC data in childhood we can see that 
the vast majority of identified anxiety disorders are incident disorders in both younger 
and older samples.  When looking specifically at the anxious children in three samples 
(Dresden, Bremen, and now ALSPAC) we can see that they have all reported stability 
of close to 20% over the course of one to three year follow up.  Similarly robust 
findings can be seen when stability is measured by reporting those who meet 
diagnostic criteria at two or more follow ups.  It is reported that 30-40% of childhood 
and adolescent disorders can be classified as stable according to the Great Smoky 
Mountains Study (Bittner et al. 2007), the ALSPAC data, and in an adolescent-to-adult 
sample in the Dresden study, (Beesdo-Baum et al. 2009).   
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Stability appears greater for this sample of the New York cohort in childhood and 
adolescence (over the three year follow up) than from adolescence into adulthood.  
This is to be expected in the light of the falling prevalence of overanxious and social 
anxiety disorders in adulthood, as the majority of early anxiety disorders remit and 
fewer new cases have their onset.  Overanxious disorder in particular appears to have 
limited stability when adulthood generalised anxiety is the outcome.  Looking at the 
heterotypic continuity reported in the Dresden study for generalised anxiety disorder 
(Beesdo-Baum et al 2009) and Great Smoky Mountains study for overanxious 
disorder (Bittner et al. 2007) it is possible that these “worry” disorders may well have 
greater heterotypic predictive power (being predictive of other forms of 
psychopathology and other anxiety disorders).  This could, unfortunately, not be 
investigated in the current study.   
 
Wittchen et al. (2000) first suggested the theory that anxiety disorders wax and wane 
over the course of childhood and adolescence, appearing transitory but conferring 
increased risk for adult mental disorders - other anxiety disorders and also depressive 
disorders.  This was later given additional credence from the ten year follow up data 
from the Dresden study where Beesdo-Baum et al (2009) reported that 35% of cases 
of social anxiety diagnosed at 14 to 17 years are present at ten year follow up.  When 
we look at the relationship with other mental disorders they report an additional 29% 
meeting criteria for any anxiety or depressive disorder and a further 19% meeting 
criteria for another form of psychopathology.  Therefore, only 13% of adolescents 
diagnosed with social anxiety are diagnosis free at ten year follow up.   Generalised 
anxiety in adolescence is associated with 100% stability over the ten year follow up, 
but the proportion of stable cases of generalised anxiety and other mental disorders 
are not reported, most likely due to the small sample size (N=3).  We can see this 
pattern to some extent in the ALSPAC data where a third of the stable disorders 
remitted and then reappeared in adolescence.  When we include heterotypic 
continuity in this way, or look at anxiety disorders as a whole group, the more 
moderate stability and favourable outcomes shown from the New York data looking 
solely at homotypic stability look less encouraging.     
 
Summary of stability synthesis. 
There is a great deal of consistency in the findings relating to the stability of anxiety 
disorders in the synthesised data.  The ALSPAC data demonstrates this level of 
stability to be present in a much younger sample than has been examined before.  It 
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appears that around one in five cases of anxiety in childhood and adolescence are 
stable in the short term and that a larger proportion (over a third) remit and then 
reappear, demonstrated in the greater degree of stability calculated over multiple 
follow ups, often covering longer periods of time.  Stability of both social anxiety and 
overanxious disorder were shown, in the New York data analysed in this thesis, to be 
greater in adolescence with both disorders remitting in the majority of cases in 
adulthood; they may well however, be associated with other anxiety disorders or other 
psychopathology.  The Dresden data provides interesting findings regarding the 
association between these early anxiety disorders and later psychopathology.  
Homotypic continuity in the study is moderate and comparable to those proportions 
reported above; however, when we look at who is “well” in adulthood ten years later 
there are very few of the sample who do not meet criteria for a mental disorder of 
some kind.  The data analysed here could not examine these patterns but suggest 
that even when we use the most stringent diagnostic homotypic continuity criteria a 
substantial proportion of anxiety disorders have poor long term outcomes.    
Outcome. 
As very few studies follow children or adolescents into adulthood, the data for 
studying outcome are also somewhat limited.  Anxiety disorders, however, have been 
shown in the existing literature and in this thesis to be a prevalent mental disorder in 
childhood and adolescence, which in most cases appear to remit by adulthood but are 
stable in a sizable minority of cases across adolescence (overanxious and social 
anxiety in particular).  Adult follow up of adolescent disorder suggests that early 
anxiety is harmful in a number of domains that include the risk of future 
psychopathology (Woodward and Fergusson, 2001).  The conclusions of the 
Gallagher (2008) review included the contention that most adult anxiety disorders had 
their first onset in childhood or adolescence, based largely upon the findings from the 
original New York sample and the Dunedin data.  The new finding from a large UK 
cohort, reported in Chapter Two - that only adolescents who met criteria for an 
internalising disorder at both follow ups (stable disorder) were at increased risk of 
internalising disorders in adulthood (forty years later) provides an interesting context 
to examine findings regarding outcome and risk associated with the early onset of 
anxiety disorders, (Colman et al. 2007).   
 
The consistent finding that anxiety disorders are prevalent in childhood but most often 
remit in the short term, and are even less stable into adulthood should not be ignored 
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as robust predictors of adult disorder are required for effective intervention.  The data 
presented here suggest that early disorder itself may not be a good enough predictor 
of adult anxiety disorders.  The lack of a clear relationship in the New York data is 
troubling in light of the Mian and colleagues (2011) model which suggests that early 
symptoms are the best predictors from early development of later anxiety disorder 
status. This is perhaps because early childhood is a period where anxiety symptoms 
are less common and, therefore have a stronger predictive relationship.  It is also 
clear that the self report measure is a general measure of anxiety symptoms and the 
homotypic continuity examined here is less useful in predicting outcomes.  Pine and 
colleagues (1998) used the whole sample of the New York study to conduct a follow 
back analysis.  Despite finding that 98% of adults with social anxiety were diagnosed 
at an earlier wave of data collection they urge the reader to exercise caution in their 
interpretation.  This is due to the extremely high prevalence of anxiety in the New York 
sample and the moderate to low stability of many anxiety disorders, which led to a 
large proportion of the sample receiving a diagnosis of an anxiety disorder at some 
point in the study.  Unfortunately cumulative prevalence is not reported to tell us 
exactly what proportion received a diagnosis over the whole time frame; however it is 
presumably high from the high prevalence and moderate stability reported.  This 
supports the contention that early anxiety may not be a good predictor of adult anxiety 
disorder, as they can make up nearly a third of the sample in some cases and the 
majority of these disorders remit.  This is also supported by the significant but modest 
Odds Ratios with those with early onset anxiety at two to three times the odds of 
suffering from an anxiety disorder in adulthood as those without an early disorder.  
Better predictive value is ascertained from rating anxiety disorders on severity; where 
severe disorders confer up to 11 times the risk (Pine et al. 1998). 
   
The younger sample examined here from the New York study showed that 
overanxious/generalised anxiety and social anxiety demonstrated the pattern 
described by Pine et al (1998) in the sample as a whole.  Although a significant 
proportion of adult disorders begin earlier in life, most childhood and adolescent 
disorders have remitted.  The proportion of adult disorders with early onset was, 
however, more moderate than the earlier reported findings for the whole sample.  
Unfortunately we were not able to examine these patterns in other anxiety disorders.  
The homotypic stability of anxiety disorders reported in the ten year follow up of the 
Dresden sample are somewhat higher, suggesting that anxiety in adolescence might 
be more closely related to anxiety later in life than childhood disorders.  This was not, 
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however, supported in the New York data where late adolescent disorder appears 
less stable  This may relate to the findings of Costello and colleagues (in prep) who 
found estimates of anxiety in adolescence much more precise and reliable with much 
smaller confidence intervals than estimate in childhood samples.  Issues of the 
“stability” of disorders may reflect issues with the measurement in anxiety in younger 
populations as much as the “true” course of anxiety.  However, some of the 
preliminary data from the New York analysis reported here actually suggests that 
adult social anxiety and overanxious disorder is more commonly diagnosed in 
childhood than later in adolescence.  This presents a somewhat confusing picture, but 
may suggest that disorders with an earlier onset can have less favourable outcomes, 
as reported by Kessler et al. (2007).                     
Results in the wider context. 
More recently the literature relating to childhood and adolescent anxiety often begins 
with statements regarding the high prevalence, early onset, persistent course, and 
poor outcomes of anxiety disorders.  This thesis, although in part aiming to provide 
more clear evidence to support some of these claims, and direct the reader to the 
importance of a better understanding of anxiety in younger populations, it 
simultaneously hopes to highlight some of the complexities of the descriptive 
epidemiology of anxiety.  This is in part due to the complexity of measuring anxiety 
disorders in these populations and the different picture of anxiety that is gained from 
examining its trajectory at different points in the lifespan.  By determining the patterns 
of anxiety in time and space more accurately it is hoped that resources can be used 
more effectively to identify risk factors for persistent anxiety with a poor outcome.   
 
So what do the collected findings from the well designed, prospective longitudinal 
studies presented in this thesis tell us about the descriptive epidemiology of anxiety 
disorders that we did not already know from cross-sectional and/or self report data 
and what findings do they merely confirm? 
 
In terms of prevalence the extremely high prevalence cited (usually one in ten 
children) although a fairly robust finding when asking about symptoms in the previous 
12 months, it is clear that a much smaller number of children suffer from anxiety at 
any given time when we look to more accurate point prevalence data and that the 
transience of disorders also finds some support within these data.  This finding is 
replicated in adult data where point prevalence was reported at less than half of the 
twelve month prevalence (Alonso et al. 2004).  Many children may forget about 
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previous diagnoses when asked about lifetime, and it is likely that when we try to 
measure symptoms from longer than three months prior to the interview, a degree of 
overestimation may be possible, as respondents struggle to remember whether 
symptoms met criteria.  The reduction in reliability when using longer windows to 
assess prevalence has been documented previously (Angold et al 1996).  The 
consistent discrepancies either point to overestimation or that anxiety diagnoses are 
transient over a 12 month period.     
 
The findings regarding the patterns of prevalence and new onset support the 
contentions made from retrospective and cross sectional studies regarding the age at 
onset for anxiety disorders being particularly early for separation anxiety and specific 
phobia and show that even for the disorders that are more rare and associated with 
later onset there are significant cases appearing in very young samples.  Age at onset 
data is still very limited in prospective data for many of the reasons outlined earlier in 
this discussion.  However, the significant trends found in patterns of onset using the 
ALSPAC data provides robust age at onset data in a sample that has previously been 
explored only retrospectively or in clinical samples and support the very early onset of 
anxiety disorders reported in the Great Smoky Mountains study (Costello et al. in 
prep).  In their review of cross sectional data Ost & Treffers, (2001) suggest mean age 
at onset for social anxiety to be between 15.7 and 20 years; this is contested by the 
prospective findings from the New York study which suggest the onset in this sample, 
which follows the young people into early adulthood was much earlier.  Separation 
anxiety patterns of onset in the ALSPAC data similarly suggest an earlier onset than 
has previously been suggested in cross sectional studies (Keller et al 1992) and this is 
supported by the adult data from the Great Smoky Mountains (Costello et al. in prep).  
Although previous cross sectional findings which use enhanced methods for 
determining age at onset to examine specific phobias and social anxiety report 
remarkably similar “mean age” to support the findings from the ALSPAC data 
(Giaconia et al. 1994; Wittchen  et al 1998; 1999).   
 
The use of standardised diagnostic interviews to determine disorder rather than 
measures of symptoms is far more precise and ensures that these disorders are of 
sufficient duration and associated with impairment.  Self report data from parents has 
suggested that internalising symptoms are “persistent” or at least predictive from 
preschool to preadolescence in between 38 and 50% of cases, suggesting a high 
degree of stability in these symptoms (Briggs-Gowan et al. 2006).  We cannot 
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comment on preschool data as diagnostic interviews with this sample have not been 
carried out, however, the persistence of diagnosable anxiety disorder between seven 
and ten appears to be low in comparison (one in five) and this figure has also been 
repeated in adolescence (Wittchen et al. 2000; Essau et al. 2002).  Persistence of 
diagnosable anxiety in young samples, therefore, appears relatively low compared to 
when using parent reports of symptoms.  It must be noted that this study is only able 
to examine homotypic continuity, so those who are diagnosis free may be suffering 
from another mental disorder.  In a clinical sample the persistence of anxiety 
diagnoses over a period of three to four years has previously been found to be around 
a fifth of cases (18%; Last et al. 1996) which is remarkably similar to the stability or 
persistence reported from the ALSPAC data, Dresden study (Wittchen et al. 2000) 
and Bremen study (Essau et al. 2002).  The transience of anxiety disorders appears 
to be confirmed by prospective data in large community samples; however, where 
these data really add to the picture of the descriptive epidemiology of anxiety 
disorders is in the long term follow up into late adolescence and in some cases 
adulthood as described above.   
 
Retrospective findings that adults with anxiety report the onset of their symptoms in 
early life (Kessler et al. 2005) are supported to a degree by the prospective 
longitudinal findings.  However, the picture is far more complex.  Prevalence of 
anxiety in adulthood in a large US sample was found to be 18% using a 12 month 
criterion (Kessler et al. 2005) and 14% in a large European study (Alonso et al. 2004).  
These represent high proportions of the adult population.  Point prevalence data for a 
large adult sample in Europe is reported at 6% (Alonso et al. 2004), which is 
substantially higher than the point prevalence of anxiety in childhood or adolescence 
reported in the ALSPAC sample.  Magnitude of prevalence aside, we know that there 
continue to be new cases of most anxiety disorders (with the exception of separation 
anxiety) throughout the life span and the current New York data suggests that over 
half the cases of generalised anxiety disorder and nearing two thirds of the adult 
cases of social anxiety had their first onset in childhood or adolescence.  This does, 
however, leave a larger proportion to be categorized as “adult onset” than reported in 
the early adulthood Dunedin data or the whole sample New York analyses.  It is 
possible that a large number of cases had early onset but due to their transience were 
not picked up in the period of data collection, were forgotten, or that first onset was 
prior to the first diagnostic interview and then latent or subthreshold until adulthood. 
These estimates may, therefore, be conservative.   
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Colman and colleagues’ (2007) study of internalising disorders at 40 year follow up 
suggest very few cases of adult onset of severe disorder (less than 3%) and even for 
moderate disorders (less than 12%).  However, the Dunedin study with its multiple 
follow ups that are closer together, so decreases the chances of cases being 
“missed”, report that childhood onset decreases as the sample get older (80% at 21 
years of age, 65% at 26 years of age, 40% at 32 years of age).  This pattern suggests 
that there is significant onset of anxiety disorders in later adulthood.  It could be that 
there are two types of anxiety sufferers; those who have early onset and wax and 
wane through childhood and adolescence with a substantial proportion with a stable 
anxiety disorder, but for whom the majority are diagnosis free in adulthood, and those 
without anxiety in early life and pure adult onset.  This group may have anxiety with a 
different aetiology and be more closely related to environmental/social factors or 
events rather than temperament and early experiences.  The evidence that early 
psychopathology has particularly poor outcomes could be seen to support this 
(Kessler et al. 2007).  The lack of studies with multiple follow ups in adulthood, 
however, precludes further examination of this hypothesis. 
Implications for methodology. 
The ALSPAC data regarding patterns of prevalence and onset fully support Beesdo-
Baum et al. (2009) contention regarding the applicability of distinct anxiety diagnoses 
to a sample of children as young as seven.  The temporal trends are clear and 
significant and would be unlikely to emerge if all anxiety disorders were measuring 
similar constructs or symptoms.  
 
There are a number of reasons why this thesis was not able to answer the research 
questions about the epidemiology of anxiety disorders that it set out to answer in the 
manner that was intended.  Firstly, the difficulties in gaining access to longitudinal 
prospective data that is very expensive to collect and can be used to answer a 
plethora of research questions relating to psychopathology, prevented the planned 
breakdown of “raw” diagnostic data which would have allowed more synthesis of data.  
Secondly, despite a vast amount of diagnostic data having been collected around the 
world, the complexities of measuring anxiety in child and adolescent populations and 
the many differences in the design of the studies means that comparison of the 
available and published data is challenging.  Some of these challenges have already 
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been discussed in some detail earlier in the discussion.  The main challenges to 
making sense of the plethora of data are the changing prevalence criterion, changes 
to diagnostic categories, the attrition of those who are more socially disadvantaged 
and anxiety disordered, and the small sample of anxious children that are left even 
when we use extremely large birth cohorts.  There is also a distinct lack of data on 
young children and studies that continue to follow children past adolescence.   
 
The use of 12 month prevalence criterion appears to be common in prospective 
studies (e.g. Christchurch, Dresden, Dunedin, and New York) however, with the 
finding of Angold et al (1996) that using greater than three month prevalence 
decreases reliability has led to the Great Smoky Mountains to report three month 
prevalence, and the Oregon study use point prevalence.  Even with the raw data it 
would not be possible to combine across these studies as the difference lies in the 
way that the participants are asked the questions.  Although 12 month prevalence 
may be less reliable, the increased estimates it provides allow analysis of a larger 
sample of anxious children, (e.g. exploring patterns of continuity within individual 
anxiety disorders and examining gender differences which were not possible with the 
ALSPAC data due to small numbers).  The “subthreshold” disorders may well be 
important but it is important that they are correctly identified and dealt with as such.   
The change in prevalence criterion appears to have little impact on the calculations of 
stability or course of anxiety disorders, suggesting that the choice to use this criterion 
may affect only the prevalence estimates, which appear to be robustly affected by the 
application of such criteria. 
 
Another factor affecting the precision of estimates of prevalence, onset, stability and 
outcome may well be the representativeness of the samples - even in large birth 
cohorts such as the ALSPAC study.  The analysis of missing data in prospective 
studies is somewhat lacking and inconsistent in its findings.  The New York data 
report drop out of the most disadvantaged of their cohort and so took steps to recruit 
to fill this gap (Cohen et al. 1993).  Representative birth cohorts with wide ranging 
demographic data offer a unique opportunity to examine the difference between 
families who choose to take part in diagnostic interviews.  Dunedin in New Zealand 
report no demographic differences apart from more single mothers in the small 
proportion of the birth cohort who did not take part (14%; Anderson et al. 1987); 
however, the ALSPAC cohort in the UK shows a much larger proportion of families 
choosing not to complete the diagnostic measure (54%) and, as has been reported 
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previously (Wolke et al 2010), non-completion is associated with social disadvantage 
in a number of domains.  Some studies have found attrition to be unrelated to 
diagnostic status (e.g. Great Smoky Mountains Study; Bittner et al 2007) but the 
ALSPAC data demonstrated that anxiety status was associated with drop out even 
when social disadvantage was taken into account. The Dresden study have shown 
specific phobia to predict drop out (Bruckl et al. 2007), suggesting that anxiety may 
well be a predictor of drop out and further impact upon the epidemiological picture, 
particularly of the stability and outcome of anxiety disorders.  
 
Figure 1 (also 9) demonstrates the lack of overlap in studies of childhood and 
adolescence; there are many studies which collect these data but comparisons of 
different samples at different points in development are not as straightforward as 
might be hoped due to the reasons outlined above and that data are mostly available 
for a short window in later childhood and adolescence with relatively few in middle 
childhood, none in early years to examine the earliest cases of onset, and even fewer 
with data into adulthood in order to examine long term outcomes and distal risk from 
childhood anxiety.  Studies that collect data from birth into adulthood often appear to 
see late childhood or early adolescence as the key period to examine mental 
disorders; however, data for these earlier time points may be warranted due to the 
extremely early onset of separation anxiety and specific phobias, and to answer the 
question regarding whether the early onset of many adult disorders is missed in the 
early years.  There are now standardised diagnostic tools to establish diagnostic 
status in children aged two to five years (The Preschool Age Psychiatric Assessment; 
Angold, Egger, & Carter, 2007)  
Clinical Implications. 
The clinical implications of the data presented and synthesised here are limited.  
However, they are often cited in support of the direction of clinical resources and so 
this section will discuss the possible implications of the current picture of anxiety and 
raise questions regarding the feasibility of a population based approach or a “high 
risk” approach (Rose, 1992) to the prevention of anxiety disorders and the 
identification of those requiring intervention. 
 
So is early anxiety a useful predictor of adult anxiety?  If it is can we intervene 
successfully?  In the whole sample analysis of the New York data (Pine et al 1998) 
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and the Dunedin study (Gregory et al. 2007) although early onset was present in the 
vast majority of adult cases both these studies report extremely high prevalence and 
moderate stability of anxiety disorders.  Unfortunately neither study reports cumulative 
prevalence; however, we can assume from the available evidence from prevalence 
and stability data that it was high.  So although a substantial proportion of adult 
disorders have their first onset early in life, most cases of anxiety disorder that are 
identified early will remit.  The adult population is smaller and so the percentages can 
become confusing.  When we look at actual sample size in these studies they are 
small, which is why the amalgamation of data sets is vital to gaining a better 
understanding of the patterns in specific anxiety disorders and their relationship to 
other disorders.  If we combine across multiple follow ups then we see the same 
patterns; there is a sizable proportion of chronic sufferers, and the large pool of 
anxious youths contribute to the adult sample more than would be expected by 
chance, but not necessarily at a rate that makes early anxiety a good predictor of later 
anxiety status.  Therefore, due to their transience, screening for mental disorders may 
not be a useful method of determining the risk of later disorder and any required 
intervention.   
 
The multiple follow up studies suggest that anxiety disorders are “stable” (i.e. present 
at two or more follow ups) in around a third of cases (or more) in later childhood and 
adolescence, the fact that these studies use diagnostic interviews means that we 
know that these are of suitable duration, severity and impact upon the individuals 
functioning to suggest that intervention would be required and helpful in many cases.  
It would also be likely that intervention could have long term impacts on the 
prevalence of anxiety in adulthood as we know that in many studies despite actual 
number being relatively small, over half (and in some studies as many as 98% of 
cases) have been reported to have their onset early in life.  It is also important to look 
to studies that have looked at prediction of other mental disorders and heterotypic 
continuity which suggest that early anxiety is a predictor of other mental disorders and 
other forms of anxiety which it may be possible to prevent with timely and effective 
intervention in childhood or adolescence (Beesdo-Baum et al 2009; Woodward & 
Fergusson, 2001) 
 
The acceptance of claims regarding the extremely high prevalence of anxiety, its early 
onset, and malign outcomes ignores the subtle and complex trajectory that anxiety 
takes, and may well be as erroneous as earlier claims that anxiety is transient in early 
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life and can be ignored.  Employing the most stringent diagnostic criteria, increasing 
awareness of the effects of the prevalence criterion employed, and recognising the 
effects of drop out on large longitudinal studies can help this more nuanced view of 
anxiety disorders be explored and examined.  Most cases of early anxiety appear to 
remit but there are a consistent proportion of those who are suffering chronic anxiety 
through their early development, and some whose anxiety appears to follow them into 
adulthood. It seems important that this smaller population are correctly identified and 
intervention offered to have an impact on the burden of disease.  This would suggest 
a more specific “high risk” strategy than simply identifying those at risk of anxiety 
disorders.  We are not yet at a stage where we are able to accurately identify those 
who will go on to develop anxiety disorders, so we are not yet able to accurately 
identify high risk “subgroups” within anxious populations. Current examples of taking a 
“high risk” approach include identifying children who exhibit behavioural inhibition 
(Rapee, 2002).  However, as with anxiety disorders themselves, a high proportion of 
these toddlers will not go on to develop anxiety.  Is this strategy precise enough to 
justify the expense of intervention and the stigmatisation of the young child as “at risk” 
of mental disorder?        
   
If, in answer to the difficulties in identifying those at risk early on we argue for the 
screening of young children for anxiety disorders we may well reveal an enormous 
sample of young people – do we have the resources to intervene in all cases and 
more importantly should we?  It seems clear that if we were to screen groups of 
children then we would not be able to use such time intensive and stringent methods 
as diagnostic interviews and would, therefore, find substantial proportions of children 
and young people meeting criteria for anxiety disorders. The use of population wide 
prevention programmes (such as FRIENDS) in order to cut out screening and reach 
all young children without stigmatising could, therefore, be argued to be the best 
approach and has been rolled out in Australia and is beginning to be used in other 
parts of the world.  The rationale for such programmes often includes citation of the 12 
month prevalence studies that show 10 to 20% of young people suffering from an 
anxiety disorder.  It could be argued that there are a number of difficulties in the 
accuracy and reliability of these figures for supporting this approach (Angold et al. 
1996).  The results from the Dresden study, however, suggest that adolescent anxiety 
disorders may have multiple pathways leading to poor outcomes, and the Dunedin 
data strongly links treatment seeking anxiety disorders in adulthood to early onset, 
providing support for this use of resources.  There is no available evidence that the 
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prevention programmes reduce anxiety in adulthood, only in childhood and 
adolescence (due to the relatively recent set up and evaluation of the projects) – is it 
possible that as most childhood anxiety disorders are remitted by adulthood that we 
could be removing an “inoculation” effect of experiencing anxiety early in life?  Or is it 
more likely that by taking a population approach and preventing distress and 
impairment from anxiety in childhood the prevention programmes will lead to adult 
outcomes? 
 
This is of course not a question that can currently be answered.  It is clear, however, 
that even when using the most stringent criteria (as seen in the ALSPAC data 
presented in this thesis) a substantial proportion of children meet diagnostic criteria in 
the course of their early development, and of those who do not, evidence is emerging 
that a sizable proportion suffer impairment from the subthreshold symptoms of anxiety 
(e.g. Wille, Bettge, Wittchen, Ravens-Sieberer & the BELLA study group 2008). Is it 
not, therefore, ethical to attempt to identify and offer the effective interventions that 
have been developed for such children?  In order to do this we would need to direct 
resources to better screening and education for parents, health and education 
professionals regarding identifying young people’s anxiety. 
Limitations.  
One of the major limitations of the analysis of stability and outcome is that despite the 
large sample size from the ALSPAC data and the moderate sample size for the New 
York data when we begin to look at determining estimates from the anxious sample 
they are relatively small.  This may provide an argument for using more relaxed 
prevalence criterion, or including a measure of subthreshold disorders in order to be 
able to study the course and outcomes of children suffering from anxious symptoms 
and associated impairment.  Combining data sets would allow us to get larger 
samples without compromising the precision of our estimates but this is not currently 
viable, as the current project testifies.  The large confidence intervals in the New York 
data are due to the relatively small number of children falling into each disorder, and 
caution must be taken when interpreting results from such small samples.  Appendix 
Three which illustrates the numbers involved in the New York analysis of course and 
outcome attempts to highlights this problem, and if we look to the Dresden data 
regarding generalised anxiety disorder we can see that although 100% continued to 
meet criteria for a mental disorder, as this is a relatively rare disorder in both 
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childhood and adulthood the actually sample size is three, despite the moderate 
cohort size (N= 1035).   
 
It would be expected when we look to the vast number of prospective studies that 
have taken place around the world that the data to answer the most simple questions 
would be readily available and that it would be relatively easy to combine samples that 
use standardised measures in order to create adequate sampling; this thesis is 
testament to the fact that it is not at all easy due to the many methodological 
differences and logistical difficulties described above. 
 
Due to the data for only two anxiety disorders being released from the New York study 
and the small numbers of anxious children in the ALSPAC sample this thesis has not 
been able to add to the understanding of the temporal patterns of prevalence, onset of 
different disorders and the risk conferred from many early anxiety disorders (e.g. 
separation anxiety and specific phobia), for other mental disorders later in life.  There 
is strong evidence from the Dresden study that separation anxiety in early life is a 
strong predictor of other anxiety disorders later in childhood and adolescence with a 
steadily increasing risk of anxiety in comparison to children without the disorder 
(Bruckl et al. 2007) and evidence that heterotypic continuity of many anxiety disorders 
is high, with people reporting experiencing symptoms for the majority of the ten year 
follow up (Beesdo-Baum et al. 2009).  Investigation of the relationship between early 
anxiety and later depressive disorders that has also been demonstrated in the 
Dresden sample was also not possible for the same reasons.  This is an important 
area of anxiety disorders research that appears to be growing and the current data 
from the Dresden study suggests that the relationships between anxiety and 
psychopathology is specific (as reported in the New York data, Pine (1998)) but also 
confers risks for other mental disorders later in life (Beesdo-Baum et al. 2009) and this 
has big implications for prevention and intervention.  It is unfortunate that further 
examination of these relationships was not possible in the current thesis, as only 
examining homotypic continuity seriously limits the applications of the longitudinal 
analyses conducted.  
 
Another similar limitation, which may also be considered strength, is the use of strict 
diagnostic thresholds rather than examining data at different levels of severity.  There 
is discussion and preliminary evidence that there are also a group of children who do 
not meet diagnostic criteria, but are suffering serious impairment from their anxious 
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symptomotology, they are ignored by the current study (Angold & Costello, 1995; 
Costello et al. in prep; Wille et al. 2008).  However, the use of a method which uses a 
high threshold for caseness can also be very useful when arguing for the redirection 
of resources to the children and adolescents most in need.  The very high prevalence 
estimates sometimes cited in relation to anxiety may be difficult for policy makers to 
make sense of and appear to pathologise a large proportion of children.  
 
The analysis completed on the new data could have used more complex modelling of 
the data to test the relationships between early and late anxiety, but instead uses 
descriptive statistics and Odds Ratios.  This simple approach was taken because the 
complex nature of the confounding factors would have required extensive 
demographic data on the sample in order to make meaningful models.  At this stage in 
understanding descriptive epidemiology of anxiety the use of complex models was 
judged to be less important than deconstructing the data to see what story they tell us 
about the distribution of anxiety disorders in time and space.  The current methods 
were judged to be most appropriate from looking at the methods of other prominent 
researchers in the field (see for example, Dunedin study Gregory et al. 2007, GSMS 
Costello et al 2004) and appropriate literature on research methods (Kelsey, 
Whittenmore, Evans, & Thompson, 1996).   
Future Directions. 
Access to the adult data from the ALSPAC sample (at age 18) will soon be available 
and examining the outcomes for this sample will provide an interesting comparison to 
the existing studies for outcomes in adulthood.  The planned metaanalysis of data 
proposed in this thesis appears an even more worthy endeavour when examining the 
current picture.  Amalgamation of some of the large data sets reviewed would allow 
the planned comparisons of onset, stability, and outcome with large enough samples 
of anxious children and adolescents to look at heterotypic continuity across anxiety 
disorders even when using the most stringent criteria.  Many of the studies described 
in this thesis are ongoing and more data is due to be released that will provide more 
pieces for the puzzle and almost certainly raise new questions. 
 
Tracking the prevalence of anxiety is undoubtedly important for planning services and 
interventions, it is also important, however, in providing a standardised measure to 
determine the mental health of young people in society.  If the increases reported in 
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the UK continue to increase then this may be indicative of the need for change in not 
only mental health services but in wider social policy.  Standardised criteria allow 
these changes in cohorts to be accurately tracked and large birth cohorts offer a 
unique opportunity to understand the changes in anxiety diagnoses through the 
generations. 
 
Work to prevent increasing childhood anxiety and effectively intervene for young 
sufferers is increasing around the world.  In order to effectively deploy diminishing 
resources it will be crucial to have accurate models of risk for anxiety disorders, and 
specifically for chronic anxiety, to target resources efficiently.  Recent models suggest 
that child factors (anxious symptoms and anxious temperament) are the best 
predictors of childhood disorders compared with social and environmental factors 
(Mian et al 2011).  The continued investment in research to better understand these 
early manifestations of anxiety, therefore, appears a valuable approach in attempting 
to better understand the risk and how to prevent poor outcomes for young children.  
Looking at impairment associated with symptoms that do not reach diagnostic 
thresholds will also be an important area for future research.      
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Appendix One - Search, Inclusion and Exclusion criteria of Gallagher 
(2008) 
Search Criteria. 
Studies relevant to this review were identified using a number of search strategies.  First, 
electronic databases were searched using the search terms [(CHILD* or ADOLESCEN*) and 
(ANXIETY* or PSYCHIATRIC* or DISORDER) and (EPIDEMIOLOG* or PREVALENCE or 
INCIDENCE or ONSET or LONGITUDINAL).  PsycInfo (1906 -2006) and Medline (1950-
2006) were both searched using these terms.  In consultation with experts in the area, a list 
of relevant papers, authors working in the field, and ongoing studies was also compiled in 
order to try to access unpublished data.  Finally, the reference lists of all relevant papers 
were scrutinised for further relevant studies, and a manual search was conducted of The 
Archives of General Psychiatry for issues not available for electronic searching (1959-1993).   
 
Inclusion Criteria. 
Studies were included if they had a psychiatric, epidemiological focus, conducted the first 
diagnostic assessment before the age of 18, and followed up the participants at least once 
with a further diagnostic assessment.  It was a requirement that the diagnosis be made 
through the use of a standardised diagnostic interview, (either with the parent or child or 
both) and that it assess current diagnoses.  Studies either employing large community 
samples or a two stage screening process were included.  Two stage studies test a large 
sample using a screening tool and then carry out further diagnostic assessment in a high risk 
sample and a control sample, selected from the screening, in order to weight the prevalence 
of diagnoses to the general population  
 
Exclusion Criteria. 
Studies were excluded if they used self-report measures to reach diagnosis because of the 
limited diagnostic validity.  Studies where data were retrospectively reported were also 
excluded because of potential memory biases, which might lead to lack of reliability in 
determining accurate age at onset of symptoms and syndromes.  Studies that reported 
diagnoses of “emotional disorders,” “neuroses” or “affective disorders” without reporting “any 
anxiety disorder” or specific anxiety disorders were also excluded.  If anxiety disorders were 
only reported at one stage of the longitudinal design, these studies were also excluded.     
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Appendix Two:  Prospective longitudinal studies identified for Gallagher 
(2008) review. 
Study/Authors Design Data Included/ 
Excluded 
Bremen Adolescent Study (BJS.) 
Germany. 
Essau (2005) 
Essau, Conradt & Petermann 
(1999) 
Essau, Conradt & Petermann 
(2000) 
Essau, Conradt & Petermann 
(2002) 
 
Diagnostic 
interviews in 
adolescence and 
15 months later.  
Reported for 
“any anxiety 
disorder” and 
specific 
anxiety 
disorders at 
T1 and T2. 
INCLUDED 
 
Christchurch Health &  
Development Study, (CHDS).   
New Zealand 
Fergusson, Horwood & Lynskey 
(1993) 
Fergusson & Horwood (2001) 
Horwood & Fergusson (1998) 
 
 
Birth cohort 
study.  Diagnostic 
interviews at 15 
and 18 years old 
with both parent 
and child.  
 
Reported for 
“any anxiety 
disorder” at 
T1 and T2 
 
INCLUDED 
Dunedin Study. 
New Zealand.  
Anderson, Williams, McGee, &  
Silva (1987) 
Feehan, McGee, Raja &  
Williams (1994) 
Gregory et al (2007) 
Kim-Cohen et al (2003) 
McGee et al (1990) 
Newman et al (1996) 
 
Birth cohort 
study.  Diagnostic 
interviews with 
children/adolesce
nts at 11, 13, 15, 
18, 21, 26, & 32 
Reported for 
“any anxiety 
disorder” and 
(in some 
cases specific 
anxiety 
disorders) at 
baseline and 
six follow ups. 
INCLUDED 
Early Developmental Stages of  
Psychopathology (EDSP). 
Dresden, Germany. 
Wittchen, Nelson & Lachner (1998) 
Wittchen, Stein & Kessler (1999) 
Standardised 
Munich CIDI 
used to reach 
diagnosis, 
followed up at 15 
and 30 months. 
Only data 
analysed & 
reported 
regarding 
anxiety 
disorders is 
for baseline. 
EXCLUDED 
From Boy to Man. 
Finland 
Puura et al (1998) 
Sourander et al (2004) 
Sourander et al (2005). 
Uses self-report 
measures/medica
l records to 
determine 
diagnosis at 
follow up. 
------------ EXCLUDED 
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Great Smoky Mountains  
Study (GSMS) 
USA 
Costello et al (1996) 
Costello et al (1998) 
Costello, Mustillo, Erkanli. Keeler  
& Angold (2003) 
 
Overlapping 
cohorts using 
CAPA diagnostic 
assessment. 
Reported for 
each age 
group and 
individual 
disorders at 
9-13.  
INCLUDED 
Isle of Wight Study 
GBR 
Graham & Rutter (1973) 
Rutter & Graham (1966) 
Rutter, Tizard, Yule, Graham  
& Whitmore (1976),  
Rutter, Tizard & Whitmore (1970) 
 
Diagnostic 
assessments 
(specially 
developed for this 
study) at 10-11 
and 14-15. 
Reports data 
for “emotional 
disorders” or 
“neurotic 
disorders” no 
data for 
anxiety 
disorders. 
(Anxiety 
disorders 
reported at 
baseline only) 
EXCLUDED 
 
Mannheim Study 
Germany 
Esser Scmidt & Woerner (1990) 
 
 
Children 
interviewed using 
Isle of Wight 
interview at 8, 18 
and 25. 
 
Reports data 
for “emotional 
disorders” or 
“neurotic 
disorders” not 
anxiety 
disorders. 
 
EXCLUDED 
 
New York Longitudinal Study. 
USA 
Cohen, Cohen & Brook (1993) 
Cohen et al (1993) 
Pine, Cohen, Gurley, Brook 
& Yuju (1998) 
Velez, Johnson & Cohen (1989) 
 
 
Overlapping 
cohorts design of 
children from 10-
20 using 
diagnostic 
assessments at 
2.5 and 8 year 
follow up.  
 
Reported for 
“any anxiety 
disorder” and 
specific 
anxiety 
disorders. 
 
INCLUDED 
 
Ontario Child Health Study. 
Canada 
Bowen, Offord & Boyle (1992) 
Boyle et al (1987) 
Offord et al (1987) 
Offord et al (1992) 
 
 
Single follow up 
on children from 
4-11 (8-16 at T2) 
 
Reported for 
“emotional 
disorders” at 
T1 and T2. 
 
EXCLUDED 
Oregon Adolescent Depression  
Project. 
Lewinsohn, Hops, Roberts, Seeley 
& Andrews (1993) 
Single follow up 
on children from 
14-18 after a 
year. 
Point 
prevalence 
and lifetime 
prevalence at 
T1 and T2. 
INCLUDED 
 
 
 
 
 
 
 
 
---------------  
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Psychopathology from 
Adolescence into Adulthood. 
Holland. 
Ferdinand & Verhulst (1995) 
Self report data 
collected at two 
yearly intervals 
for eight years. 
EXCLUDED 
 
 
 
Taiwan Epidemiological Study of 
Mental Disorders.  
Taiwan. 
Gau, Chong, Chen & Cheng (2005) 
 
 
 
Cohort of 12-13 
years followed up 
using diagnostic 
interviews yearly 
for three years.  
 
 
 
Reported for 
any anxiety 
disorders and 
specific 
anxiety 
disorders at 
T1, T2 & T3. 
 
 
 
 
INCLUDED 
TRAILS (Development of 
Psychopathology 
In Early Adolescence). 
Holland. 
Oldehinkl & Ormel (EMBARGO) 
Uses self-report 
rather than 
diagnostic 
interview. 
------------- EXCLUDED 
 
Zurich Adolescent Psychology & 
Psychopathology Study (ZAPPS) 
Zurich Epidemiological Studies 
of Child  
And Adolescent Psychiatric 
disorders 
(ZESCAP) 
Switzerland. 
Merikangas, Zhang, Aveneoli, 
Acharaya, Neuenschwander, & 
Angst, (2003) 
Steinhausen, (2006) 
Steinhausen & Winkler Metzke 
(2003) 
Steinhausen, Winkler Metzke, 
Meier, &  
Kannenberg, (1998)   
 
A longitudinal 
study using 
diagnostic 
interviews with 
parents of 7-16 
year olds and 
adolescents at 
first follow up. 
 
Only data 
analysed and 
reported is for 
baseline. 
 
EXCLUDED 
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N = 28 
Anxious  
Adolescents 
Anxious Children 
Anxious Adults 
Anxious Children 
Anxious Adults 
Anxious Adolescents 
N = 41 
N = 7 
? 
N = 9 
N = 20 
N = 9 
N = 1 
Appendix Three.  Visual representations of the stability and follow back 
analysis in the New York data. 
Social Anxiety 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overanxious Disorder 
 
 
 
 
 
N = 9 
N = 11 
N = 10 
N = 6 
? 
N = 8 
NB Circles areas are to scale in order to represent the number of people in each 
population, positioning however is merely estimated, as are the number in each 
group from the overlapping cohorts. 
